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Abstract 
Lysine demethylases are a newly discovered group of enzymes that have 
rapidly expanded over evolutionary time by the acquisition of multiple functional 
domains, in addition to the unifying catalytic JmjC domain. There are thirty members 
of the JmjC-domain family in humans. A proportion of lysine demethylases catalyse 
the removal of methyl modifications from lysine residues of histones and non-histone 
proteins.  
The discovery of mutations in histone demethylase genes, in a number of 
human syndromes, stresses the functional importance of these enzymes in 
development and disease. Therefore, the phenotypic dissection of animal models of 
histone lysine demethylases will provide invaluable insights into the molecular 
mechanisms that underlie human disease. 
In mammals, the Kdm3 family of histone demethylases includes Kdm3a, 
Kdm3b, Jmjd1c and Hairless. However, in zebrafish, there are two kdm3 genes, one 
of which encodes a protein similar to both the mammalian Kdm3a and Kdm3b. 
Morpholino knock-down of the kdm3 gene in zebrafish faithfully recapitulates 
classical ciliary phenotypes, although the underlying causalities are still unclear. In 
recent years, Kdm3a function has been extensively dissected through the use of 
mouse models and cell culture studies, focusing on the nuclear histone demethylation 
function. Kdm3a gene-trap and knock-out mouse models present with obesity, 
infertility, sex reversal and predisposal to diabetes, reminiscent of a human ciliopathy 
syndrome. No mouse models for Kdm3b have been characterised yet. 
In this study, I hypothesized that the murine Kdm3a and Kdm3b histone 
demethylases have diverged biological roles and that the zebrafish kdm3 fulfils the 
functions of both. The aims of my thesis were: 1) to compare the evolutionary 
conservation of the zebrafish kdm3 and murine Kdm3b in function and check their 
spatial expression, 2) to dissect the phenotype of Kdm3b gene-trapped mice and 3) to 
characterise an alternative murine Kdm3a isoform. 
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Protein sequence comparison studies show that the zebrafish kdm3 protein is 
closer in sequence to the mammalian Kdm3b. Both the zebrafish kdm3 and murine 
Kdm3b are di-methyl lysine 9 (H3K9me2) demethylases, however, they have 
diverged spatial expression during embryogenesis. In agreement with the phenotype 
of kdm3 morphants, over-expression of the zebrafish kdm3 reduces ciliation 
efficiency when transfected into animal cells. 
Notably, the phenotype analysis of Kdm3b gene-trapped mice does not resemble 
classical ciliary phenotypes, as one would expect from the zebrafish data. 
Homozygous Kdm3b gene-trapped mice are postnatally growth retarded, with 
plausible defects in thymus organ development. 
Interestingly, an alternative murine Kdm3a isoform (Kdm3a-i2) shows both 
nuclear and cytoplasmic localisation. Over-expression studies revealed that Kdm3a-
i2 retains its histone demethylation function, and a proportion of the over-expressed 
construct localises to the centrosome. In addition, over-expression of Kdm3a-i2 
reduces ciliation efficiency. 
Overall, the data from my studies suggests that: 1) the zebrafish kdm3 is more 
similar in sequence to the murine Kdm3b than Kdm3a, is a histone demethylase and 
has a distinct spatial expression during embryogenesis. However, the phenotype of 
kdm3 zebrafish morphants is more closely related to the Kdm3a-than Kdm3b-
deficient mice, 2) the murine Kdm3a and Kdm3b have distinct biological roles, as 
evidenced by the mouse models, 3) the Kdm3a-i2 isoform shares the same nuclear 
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DAB 3,3′-Diaminobenzidine tetrahydrochloride 
DAPI 4',6-diamidino-2-phenylindole 
dH2O distilled water 
DIG Digoxigenin 
DMEM Dulbecco's Modified Eagle's medium 
DMEM/F12 Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12 
DN Double negative 
DNA Deoxyribonucleic acid 
DNase I Deoxyribonuclease I 
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DOC deoxycholate 
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DTT Dithiothreitol 
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ESC embryonic stem cells 
EtOH ethanol 
EUCOMM European Conditional Mouse Mutagenesis 
FAD flavin adenine dinucleotide 
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Fe(II) iron 
GFP green fluorescent protein 
H&E haematoxylin and eosin 
H1.4K26me2 dimethyl lysine 26 histone 1.4 
H1.4K26me3 trimethyl lysine 26 histone 1.4 
H2O2 hydrogen peroxide 
H3K27ac acetylation  lysine 27  histone 3 
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H3K4me2 dimethyl lysine 4 histone 3 
H3K4me3 trimethyl lysine 4 histone 3 
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Mb mega base pairs 
MEF mouse embryonic fibroblasts 
MeOH methanol 
mg milligram 
MgCl2 Magnesium chloride 
 
   xxv 
 




mTEC medullary thymic epithelial cells 
n.s not significant 
NaCl Sodium chloride 
NBT 4-nitro blue tetrazolium chloride 
NH4Cl Ammonium chloride 
NLS nuclear localisation signal 
NP-40 nonyl phenoxypolyethoxylethanol 
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oncogene homolog 1 signaling pathway 
PMSF phenylmethylsulfonyl fluoride 
PPRE peroxisome proliferator hormone response element 
PRC2 Polycomb Repressive Complex 2 
qRT-PCR real time quantitative polymerase chain reaction 
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signaling pathway 
Rat sarcoma/mitogen-activated protein kinase signaling pathway 
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RNA Ribonucleic acid 
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rpm rounds per minute 
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SDS Sodium dodecyl sulfate 
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T4 thyroxine 
TBE solution containing Tris, borate, and EDTA 
 
   xxvii 
 
TEG buffer solution containing Tris base and EGTA 
TEMED Tetramethylethylenediamine 
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Apoa4 apolipoprotein A-IV 
ATR ataxia telangiectasia and Rad3 related 
Bbs4 bardet-Biedl syndrome 4 
CD25 interleukin 2 receptor, alpha chain 
CD4 CD4 antigen 
CD44 CD44 antigen 
CD8 CD8 antigen, alpha polypeptide 
CEP152 centrosomal protein 152kDa 
Chmp3 charged multivesicular body protein 3 
CoREST REST corepressor 
Cyp26a1 cytochrome P450, family 26, subfamily a, polypeptide 1 
Egr1 early growth response 1 
EHMT1 euchromatic histone-lysine N-methyltransferase 1 
EHMT2 euchromatic histone-lysine N-methyltransferase 2 
Etf1 eukaryotic translation termination factor 1 
Exoc6 exocyst complex component 6 
Ezh2 enhancer of zeste homolog 2 (Drosophila) 
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H2A histone H2A 
H2B histone H2B 
H3 histone 3 
H4 histone H4 
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Ifgn interferon, gamma 
Ift88 intraflagellar transport 88 
Igf1 insulin-like growth factor 1 
Igf1r insulin-like growth factor 1 receptor  
Igf2 insulin-like growth factor 2 
Igfals insulin-like growth factor acid labile subunit 
Igfbp3 insulin-like growth factor binding protein 3 
Insr insulin receptor 
Irs insulin receptor substrate 
Jak2 Janus kinase 2 
Jarid2 jumonji, AT rich interactive domain 2 
Jhd1 JmjC domain-containing Histone Demethylase 
Jhd2p JmjC domain-containing Histone Demethylase 
JMJD1C jumonji domain containing 1C 
 
   xxx 
 
JMJD6 jumonji domain containing 6 
KDM1A lysine (K)-specific demethylase 1A 
KDM1B lysine (K)-specific demethylase 1B 
KDM2A lysine (K)-specific demethylase 2A 
KDM3A lysine (K)-specific demethylase 3A 
KDM3B lysine (K)-specific demethylase 3B 
KDM4A lysine (K)-specific demethylase 4A 
KDM4B lysine (K)-specific demethylase 4B 
KDM4C lysine (K)-specific demethylase 4C 
KDM4D lysine (K)-specific demethylase 4D 
KDM5A lysine (K)-specific demethylase 5A 
Kdm5b lysine (K)-specific demethylase 5B 
Kdm6b lysine (K)-specific demethylase 6B 
KDM7A lysine (K)-specific demethylase 7A 
Lmo2 LIM domain only 2 (rhombotin-like 1) 
MDC1 mediator of DNA-damage checkpoint 1 
Mrpl35 mitochondrial ribosomal protein L35 
Ndufs8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa 
(NADH-coenzyme Q reductase) 
NF-κB nuclear factor kappa-light-chain-enhancer of activated B cells 
NSD1 nuclear receptor binding SET domain protein 1 
Nt5c1a 5'-nucleotidase, cytosolic IA 
Nudt18 nudix (nucleoside diphosphate linked moiety X)-type motif 18 
ORC origin recognition complex 
Pdgfra platelet-derived growth factor receptor, alpha polypeptide 
PHF2 PHD finger protein 2 
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PHF8 PHD finger protein 8 
Pparα peroxisome proliferator-activated receptor alpha 
PKD2 polycystic kidney disease 2  
PPARγ peroxisome proliferator-activated receptor gamma 
Ran RAN, member RAS oncogene family 
Reep1 receptor accessory protein 1 
Reep2 receptor accessory protein 2 
Reep3 receptor accessory protein 3 
Reep4 receptor accessory protein 4 
Rph1 Regulator of PHR1 
SETD7 SET domain containing (lysine methyltransferase) 7 
SETD8 SET domain containing (lysine methyltransferase) 8 
Shc src homology 2 domain-containing transforming protein 
Smo Smoothened, frizzled class receptor 
SMYD2 SET and MYND domain containing 2 
Sox2 SRY (sex determining region Y)-box 2 
Src v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene 
homolog 
Sry sex determining region Y 
Stat signal-transducer and activator of transcription 
SUV39H1 suppressor of variegation 3-9 homolog 1 (Drosophila) 
SUZ12 SUZ12 polycomb repressive complex 2 subunit 
Tbx21 t-box 21 
Thra thyroid hormone receptor, alpha 
Thrβ thyroid hormone receptor, beta 
TP53 tumor protein p53 
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Trh thyrotropin-releasing hormone 
Tsh thyroid stimulating hormone 
Tshr thyroid-stimulating hormone receptor 
Ucp1 uncoupling protein 1 
α-tubulin alpha tubulin 

























1.1 Histone methylation as a chromatin modification 
 The core particle of chromatin is the nucleosome, an octamer composed of 
four pairs of histones called H2A, H2B, H3 and H4 (Kornberg, 1977). The histone 
tails are unstructured (Luger et al., 1997) and can be decorated with a number of 
post-translational modifications, for example methylation, acetylation, 
phosphorylation and ubiquitylation (Kouzarides, 2007). 
 Several lysine and arginine residues on histone tails can be methylated by 
histone methyltransferases. Each methyltransferase shows substrate and degree of 
methylation specificity: it methylates specific lysine or arginine residues without 
affecting others and can mono- (me1), di- (me2) and/or tri-methylate (me3) its 
histone substrate. For example, lysine methyltrasferase SETD8 monomethylates 
lysine 20 on H4 from an unmethylated state. Others, such as lysine methyltransferase 
SUV39H1 di- and trimethylates lysine 9 on H3 from a monomethylated state. 
Arginine residues on histone proteins can be symmetrically or asymmetrically 
dimethylated by a group of enzymes known as arginine methyltransferases (Black et 
al., 2012; Di Lorenzo and Bedford, 2011; Greer and Shi, 2012; Kouzarides, 2007).  
Methylation on different lysine residues of histones has been associated with 
either transcriptional activation or repression (Figure 1.1). Methylation of lysine 4, 
36 and 79 on H3  are generally associated with actively transcribed genes (Briggs et 
al., 2001; Santos-Rosa et al., 2002; Schaft et al., 2003; Steger et al., 2008). On the 
other hand, methylation of lysine 9 and 36 on H3, and lysine 20 on H4 are associated 
with transcription repression (Litt et al., 2001; Müller et al., 2002; Nakayama et al., 
2001; Noma K et al., 2001; Plath et al., 2003; Schotta et al., 2004).  
Moreover, regardless of their functional state, enhancers seem to be 
associated with H3K4me1 (Spicuglia and Vanhille, 2012). Active enhancers were 
found to be additionally marked by H3K27 acetylation (Pekowska et al., 2011; 





Figure 1.1: Occupancy of histone methylation marks on chromatin of active and 
inactive genes. 
(A)When a gene is in an active state, it is characterised by the occupancy of 
H3K4me1/2/3 epigenetic marks within the promoter and transcription start site, as 
well as intragenic H3K79me1/2/3 in the intragenic region. Repressive H3K9me2/3 
and H3K27me3 are excluded. (B) When a gene is in an inactive state, the promoter 
region is characterised by elevated H3K27me3 and decreased H3K4me3. The 
promoter and intragenic region is additionally occupied with H3K9me2. (C) 
Enhancers are marked by H3K4me1. Active enhancers are additionally characterised 




 In addition, the histone code, established in part by lysine methyltransferases 
and demethylases, provides a platform for the binding of chromatin remodelling 
complexes. These complexes can in turn affect the chromatin state and activate or 
repress transcription (Ho and Crabtree, 2010; Wu et al., 2009). 
Therefore, histone modifications, including histone lysine methylation, and 
the action of lysine methyltransferases and demethylases, play key roles in the 
regulation of the chromatin state and consequently gene expression.  
1.2 The two families of lysine demethylases 
 Lysine demethylases are divided into two evolutionary conserved families 
that catalyse the removal of methyl groups using distinct modes of action (Figure 
1.2). The first family that includes lysine-(K) specific demethylase 1A and 1B 
(KDM1A and KDM1B) remove methyl groups utilising the amine oxidase domain 
using flavin adenine dinucleotide (FAD) as a cofactor. Formaldehyde and hydrogen 
peroxide are the products of this reaction (Karytinos et al., 2009; Shi et al., 2004).  
The second family of demethylases is composed of 30 members in humans, 
which contain the catalytic JmjC domain and a diverse arrange of extra domains. 
Phylogenetic analyses have suggested that the acquisition of the motifs/domains of 
the ancestral JmjC-domain containing genes happened before the divergence of the 
major eukaryotic groups, that was later accompanied by gene duplication events 
(Zhou and Ma, 2008). 
JmjC-domain lysine demethylases belong to the cupin metalloenzyme 
superfamily. Cupins are ancient protein domains, which are found in archaea, 
bacteria and eukarya (both animals and plants). The JmjC domain of lysine 
demethylases shows sequence similarities to other protein members of the 
superfamily that adopt the cupin fold. Different cupin metalloenzymes use different 
metal ions within the cupin fold to carry out their enzymatic functions, such as 
manganese, zinc, iron and nickel. Lysine demethylases use iron ions (Clissold and 




In humans, JmjC-domain lysine demethylases have been divided into seven 
subfamilies according to their degree of homology and the presence of additional 
motifs/domains (Klose et al., 2006b). Due to their sequence similarities, members of 
the same subfamily often share the same or similar substrate specificities. For 
example, the KDM4 subfamily comprises of KDM4A, KDM4B, KDM4C and 
KDM4D. They all contain a Jumonji N (JmjN) domain, a JmjC domain, and, 
excluding KDM4D, the rest of the subfamily members also have CW-type zinc 
finger and TUDOR domains. All KDM4 subfamily members have H3K9me1/2, 
H3K36me1/2 and histone 1.4 di- and tri-methyl lysine 26 (H1.4K26me2/3) substrate 
specificities (Kooistra and Helin, 2012). 
 The demethylation reaction of JmjC-domain demethylases involves the 
hydroxylation of the methyl group in the presence of Fe(II) , oxygen and α-
ketoglutarate to produce succinate, formaldehyle and cardon dioxide as by-products 
(Figure 1.2) (Klose and Zhang, 2007). Whereas FAD-dependent demethylases are 
only able to demethylate mono- and di-methyl groups, JmjC-domain demethylases 
can also demethylate tri-methyl post-translational lysine modifications. 
 
Figure 1.2: The demethylation reactions mediated by amine oxidase containing 




(A) Lysine demethylases, such as KDM1A, utilise the amine oxidase domain for 
lysine demethylation. In this reaction, FAD is used as a co-factor to reduce the 
mono-methyl lysine substrate to unmethylated lysine. Hydrogen peroxide (H2O2) and 
formaldehyde (CH2O) are produced as a result of this reaction. (B) JmjC-domain 
containing demethylases utilise iron II (Fe (II)), alpha ketoglutarate (αKG) and 
oxygen for the reaction. Carbon dioxide (CO2), succinate and formaldehyde form as 
by-products. In both the amine oxidase and JmjC-driven demethylations, the target 
methyl lysine goes through an intermediate state before it is fully demethylated.   
1.3 Functions of histone demethylases 
1.3.1 Chromatin regulation 
1.3.1.1 Control of transcriptional activation 
One of the best-studied functions of lysine demethylases is the control of 
transcription initiation. This is accomplished through both the histone lysine 
demethylation activity and the interaction of the demethylases with transcription 
factors, such as the androgen receptor (Metzger et al., 2005; Shin and Janknecht, 
2007; Wissmann et al., 2007; Yamane et al., 2006). One such example is that of the 
H3K4me1/2 and H3K9me1/2 demethylase KDM1A and of the H3K9me2/3 and 
H3K36me2/3 demethylase KDM4C. For instance, the KDM1A and KDM4C 
demethylases interact with each other and with the androgen receptor, and co-
localise at the androgen receptor-responsive elements in promoters and enhancers of 
target genes. Subsequently, KDM1A removes the H3K9me1 and H3K9me2 marks, 
whereas KDM4C removes the H3K9me3 marks from the androgen receptor-
responsive elements, leading to the activation of androgen receptor targets. 
Interestingly, knock-down of either KDM1A or KDM4C reduces the expression of 
the androgen receptor target genes. Therefore, transcription initiation through the 
action of lysine demethylases is accomplished via the removal of repressive histone 
marks from gene regulatory regions (promoters and enhancers) (Metzger et al., 2005; 
Wissmann et al., 2007). 
Given the importance of demethylases in the activation of the androgen 
receptor target genes, it will be interesting to investigate whether knock-out mice of 
each demethylase recapitulate the phenotype of the androgen receptor knock-outs 




for this is the possible redundancy. Since many demethylases are known to be 
involved in the activation of androgen receptor targets, including many members of 
the same subfamily (KDM4), redundancy may lead to no observable phenotype, as 
illustrated by the Kdm4d knock-out mice (Iwamori et al., 2011). Therefore, in order 
to obtain a better insight into the importance of the demethylases in transcription 
initiation, it may be necessary to simultaneously knock-out more than one 
demethylases. 
During development, the interaction of a lysine demethylase with 
transcription factors operates to promote the expression of the transcription factor 
target genes. This will also be influenced by the specific expression pattern of the 
lysine demethylase itself. Therefore, the activation of gene expression through 
histone lysine demethylation seems to be a common theme for a subset of lysine 
demethylases, which ultimately depends on their particular histone lysine substrates.  
1.3.1.2  Control of transcriptional repression 
Opposite to transcriptional activation, the histone demethylase function of 
lysine demethylases can result in transcriptional repression. This is due to the 
substrate specificity of a subset of these enzymes, removing transcriptionaly-
activating marks from the enhancers and promoters of target genes. For instance, 
KDM1A was shown to localise at enhancer regions of embryonic stem cell (ECS) 
genes, including the enhancers of pluripotency factors. Differentiation of ESCs is 
accompanied by a reduction of H3K4me1 at the enhancer regions, including those of 
ESC pluripotency factors, thus repressing their expression (Whyte et al., 2012). The 
proposed function of KDM1A as a transcriptional repressor is not surprising since it 
is also associated with members of the NuRD remodelling protein complex, whose 
ATP-dependent and histone deacetylase activity represses the transcription of target 
genes (Reynolds et al., 2012). Members of this complex co-localise with KDM1A 
enhancer-bound regions on ESC chromatin (Whyte et al., 2012). In another example, 
the knock-down of the H3K4me2/3 demethylase KDM5A derepress the silencing of 
the embryonic-expressed β-globin gene Hbb-y
 
in differentiated murine erythroid 




knock-down, with concomitant H3K4me3 increase. Also, KDM5A interacts with the 
EHMT2 and EHMT1 methyltransferases and thus a cross talk between demethylases 
and methyltransferases activity is proposed to maintain gene silencing (Chaturvedi et 
al., 2012). 
Therefore, lysine demethylases may mediate the repression of their target 
genes by being part of larger protein complexes that fulfill a range of enzymatic 
functions. Furthermore, depending on the biological context, it is also likely that each 
demethylase may associate with a range of different protein complexes, as illustrated 
by KDM1A (Rudolph et al., 2013). 
1.3.1.3 Maintenance of transcriptional competence 
In recent years, with the advent of genome wide studies, a new function has 
been proposed for lysine demethylases. Under this model, although lysine 
demethylases have the capacity to bind the regulatory regions of several genes, the 
knock-down of the demethylase only confers modest changes in gene expression 
(Schmitz et al., 2011). In particular, ChIP-seq for Kdm5b, a H3K4me2/3 
demethylase, showed that Kdm5b is enriched on transcription start sites of 
embryonic stem cells. However, when Kdm5b is knocked-down, only 22 genes show 
more than 3-fold change in expression, despite a median 2.2-fold increase in 
H3K4me3. Therefore, a proposed function of lysine demethylases is not to directly 
affect gene expression per se, but rather to keep the chromatin in a desirable state, as 
to allow transcription, when necessary (Schmitz et al., 2011). 
Although compelling, the proposed function still requires further 
investigation. In particular, apart from the ChIP-seq for the demethylase enzyme and 
its histone substrates, ChIP-seq should also be performed for other histone 
modifications, factors that affect transcription such as the RNA polymerase II, 
general transcription factors and chromatin remodelling complexes. These 
experiments will provide in-depth information of the target gene state, i.e. whether 
they are active or repressed. Furthermore, functional redundancy between 




1.3.2 Modulation of non-histone protein function through methylation and 
demethylation  
A less well-studied area of research is the modulation of non-histone protein 
function through methylation and demethylation. Despite that, there are some 
examples that illustrate the importance of the methylation-demethylation interplay, 
mediated by methyltransferases and demethylases. 
The best and most well-studied example is that of the tumor protein p53 
(TP53). TP53 is methylated and demethylated on a number of lysine residues that 
promote or inhibit its pro-apoptotic and cell-cycle checkpoint functions upon DNA 
damage. For example, upon DNA damage, SETD7 methyltransferase 
monomethylates lysine 372 of TP53, which leads to its activation and the induction 
of TP53 downstream effectors (Chuikov et al., 2004). On the other hand, the 
monomethylation of TP53 on lysine 370 and lysine 382 by SMYD2 and SETD8, 
respectively, represses its transcriptional inducing capacity (Huang et al., 2006a; Shi 
et al., 2007). Interestingly, TP53-K372 methylation by SETD7 (Chuikov et al., 2004) 
prevented TP53-370 methylation, suggesting antagonistic functions of the same post-
translational medication (methylation) to finely control TP53 function (Huang et al., 
2006b).  
The dimethylation of TP53 at lysine 370 is counteracted by the KDM1A 
demethylase. KDM1A removed the dimethyl moiety, set by an unknown 
methyltransferase. This demethylation represses TP53-mediated gene expression, 
and siRNA knock-down of KDM1A resulted in upregulated of expression of the 
TP53 target genes (Huang et al., 2007).  
Therefore, methylation and demethylation of lysine residues on TP53 
represent a novel mode for the functional control of this protein. 
 In a similar fashion to p53, the p65 subunit of nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB) is methylated at lysines 218 and 221 by 
NSD1 in response to cytokines and demethylated by the H3K36me1/2 demethylase 




represses it. Therefore mutation of either lysine residue, or both, or the over-
expression of KDM2A resulted in the reduced ability of NF-κB to drive the 
expression of its target gene selectin E. These observations led to the proposal that 
lysine methylation and demethylation of NF-κB presents a way to regulate the 
functions of this transcription factor (Lu et al., 2010). 
 Apart from transcription factors, the repertoire of proteins with diverse 
cellular roles, tightly regulated via methylation and demethylation, is expected to 
expand. This is highlighted by the identification of methylated residues on proteins 
of the translational apparatus, and the respective methyltransferases which deposit 
those methyl marks (Clarke, 2013; Egorova et al., 2010). Furthermore, large scale 
approaches are now being employed in order to identify several more proteins with 
lysine as well as arginine post-translational modifications (Bremang et al., 
2013).Therefore, methylation and demethylation represents an additional level to 
control the functions of non-histone proteins, which have important cellular roles. 
1.3.3 Demethylation-independent functions 
Apart from their enzymatic capacity to demethylate lysine residues on histone 
and non-histone substrates, lysine demethylases display additional demethylase-
independent functions. For example, the catalytically inactive Jarid2 demethylase 
(Klose et al., 2006b) was shown to be essential for development, by targeting the 
PRC2 complex, that possesses histone methyltransferase activity required for 
transcriptional gene silencing (Simon and Kingston, 2009), to its designated gene 
promoters. This function was mediated via the ARID domain of Jarid2. Chip-seq 
revealed that 90% of Jarid2 bound genomic sequences in mouse ESCs were also 
bound by the PRC2 complex protein Suz12. Knock-down of Jarid2 by short hairpin 
RNA (shRNA) in mouse ESCs resulted in a significant reduction of Suz12 and Ezh2 
binding to their target gene promoters. Most importantly, transient transfection of 
wild type Jarid2, but not of Jarid2 lacking the ARID domain, partly rescued the 
PRC2 targeting to its gene promoters (Pasini et al., 2010).  
Another example illustrating the importance of demethylase-independent 




for the T-box21 (Tbx21)-dependent chromatin remodelling, by acting as a link 
between Tbx21 and the SWI-SNF remodelling complex. Both a catalytically active 
and an inactive form of Kdm6b are able to induce the expression of the Tbx21 target 
gene interferon, gamma (Ifng). Subsequent, immunoprecipitation assays 
demonstrated that Kdm6b interacts with Tbx21, as well as with some members of the 
SWI-SNF remodelling complex. Thus, Kdm6b seems to function as a scaffold in 
order to bring together factors required for chromatin remodelling (Miller et al., 
2010). 
 In summary, an array of distinct domains of the JmjC- containing have been 
shown to be essential for the histone demethylation function (Klose et al., 2006a; 
Whetstine et al., 2006). However, as exemplified above, they also provide the 
opportunity to expand the functions of these enzymes beyond lysine demethylation. 
1.4 Conservation of function through evolution 
Control of the chromatin state via the deposition and erasure of epigenetic 
histone marks is not only important in mammals but also in lower eukaryotes. This is 
exemplified by the capacity of demethylases, identified in S. cerevisiae and C. 
elegans, to erase methyl marks from their histone methyl targets (Klose et al., 2007; 
Liang et al., 2007; Tsukada et al., 2006; Kleine-Kohlbrecher et al., 2010; Lin et al., 
2010 ). 
The level of JmjC domain homology and the presence of additional domains 
within the full length proteins were used as parameters to trace homologues of the 
human JmjC-domain containing subfamilies in the mouse (Mus musculus), the worm 
(Caenorhabditis elegans), the fly (Drosophila melanogaster), the fission yeast 
(Schizosaccharomyces pombe) and the budding yeast (Saccharomyces cerevisiae). 
The search showed that some subfamilies had homologues up to S. cerevisiae (i.e. 
KDM2 and KDM5), whereas for other subfamilies, homologues were found up to C. 
elegans (PHF2/PHF8) or D. melanogaster (KDM3) (Klose et al., 2006b). 
Five JmjC-domain containing demethylases have been identified in S. 




Jhd1 (a KDM2 orthologue) retained their histone demethylation potentials (Klose et 
al., 2007; Liang et al., 2007; Tsukada et al., 2006). In vitro studies, suggested that 
Rph1 and Jhd1 proteins function as H3K36 demethylases, and Jhd2 as an H3K4 
demethylase. Further evidence supporting their demethylation potential came from 
the generation of mutant protein forms of the proteins, where critical residues within 
the JmjC domain, responsible for iron binding, were substituted. Under these 
conditions, the demethylation activity of the proteins was abolished. Interestingly, 
Rph1 was additionally shown to demethylate H3K9me3, just like its mammalian 
orthologues, although in the S. cerevisiae genome H3K9 is not methylated. This 
observation suggests that H3K9 methylation could have existed in S. cerevisiae and 
was subsequently lost. Therefore the methylation potential of Rph1 represented a 
functional vestige that was maintained due to the capacity of this enzyme as an 
H3K36 demethylase. Moreover, two independent studies demonstrated that a C. 
elegans orthologue of the mammalian PHF2/PHF8 subfamily, ceKDM7A, 
functioned as an H3K27me2 and H3K9me2 demethylase (Kleine-Kohlbrecher et al., 
2010; Lin et al., 2010). Interestingly, similarly to its mammalian orthologue PHF8, 
targeting of ceKDM7A to chromatin was dependent on its PHD domain. Over-
expression of a ceKDM7A mutant, lacking its PHD domain, abrogated its 
demethylation potential. 
The conservation of histone demethylation function through evolution 
stresses the functional importance of these enzymes to modulate chromatin state. 
Therefore, it will not be surprising if more members of the histone demethylases in 
lower organisms display the same histone substrate specificities as those of the 
human counterparts. 
1.5 Alternative isoforms of epigenetic regulators 
To date, two demethylase genes are known to encode more than one 
functional protein isoform. Interestingly, different isoforms perform different 
functions, highlighting the need to study alternative isoforms, in addition to full 




The production of protein isoforms can be achieved via alternative splicing 
(Lois et al., 2007), as well as the use of different promoters (Cooper et al., 2006; 
Sandelin et al., 2007). About 70% of epigenetic modulators in humans can express 
isoforms by alternative splicing. The changes in the sequence of the alternative 
isoform(s) can partly or completely affect the catalytic domain, the interaction 
domain or even both leading to a drastic reduction of the protein size, affecting its 
function (Lois et al., 2007). Moreover, genes can have more than one active 
promoters, and the use of alternative promoters can affect the gene expression levels 
of the particular isoforms, giving rise to different expression patterns across tissues 
(Cooper et al., 2006). Further, alternative promoters can determine the 
inclusion/exclusion of the 5’ prime exons while leaving the rest of the exons 
unaffected (Sandelin et al., 2007). 
A shorter KDM4A isoform was shown to be important for skeletal muscle 
differentiation. The expression of this shorter isoform, but not of the full-length 
isoform, is elevated during terminal differentiation of mouse myoblast cells. The 
same was observed during the differentiation of human satellite cells (progenitor 
muscular cells). A comparison of siRNA knockdown of the full-length KDM4A 
isoform only versus the knockdown of both KDM4A isoforms revealed, by 
microarray technology, downregulation of genes related to muscle development and 
differentiation, specifically related to the shorter isoform. Since this short isoform is 
missing the catalytic JmjC domain, the demethylation function is presumably 
mediated via its interaction with full-length KDM4C, another member of the KDM4 
sub-family, which removes the repressive H3K9me2/3 marks (Cloos et al., 2006; 
Verrier et al., 2011b). 
Furthermore, alternative isoforms of the KDM1A protein have been 
discovered in mammalian neurons. In particular, alternative splicing generates the 
KDM1A-8a isoform, which is only expressed in the brain. KDM1A-8a expression in 
the brain is upregulated during the perinatal window up to p7 and is the predominant 
isoform over the other KDM1A isoforms. Interestingly, knock-down of the KDM1A-
8a, but not the other isoforms, affects the neurite morphology (Zibetti et al., 2010). 




results in the detachment of KDM1A-8a from the corepressor CoREST complex and 
as a result KDM1A-8a presumably functions in a dominant negative fashion, 
inhibiting the “conventional” KDM1A isoform repressor activity (Toffolo et al., 
2014). 
Alternative isoforms of lysine demethylases seem to play important roles in 
development. Fortunately, the sequence similarity of rodent and human genomes 
facilitates the discovery and functional characterisation of many more lysine 
demethylase alternative isoforms.  
1.6 The KDM3 subfamily of JmjC-domain histone demethylases 
In the present study, I concentrated on the Kdm3 subfamily demethylases 
Kdm3b and Kdm3a. In this section, I compare the sequence similarity of Kdm3 
subfamily proteins, their biological roles from mouse studies and their substrate 
specificities, as described to present. 
 In humans and mice, the KDM3 subfamily consists of four genes: KDM3A, 
KDM3B, JMJD1C and HAIRLESS (Figure 1.3) (Klose et al., 2006b; Kooistra and 
Helin, 2012). Homologues for the KDM3 subfamily are absent in the genomes of 
Caenorhabditis elegans, Schizosaccharomyces pombe and Saccharomyces 
cerevisiae. A homologue is present in Drosophila melanogaster, but has not been 
functionally characterised (Klose et al., 2006b).  
 




All members of the KDM3 protein family contain a C2HC4-zinc finger (Zf), 
followed by a nuclear receptor motif (LXXLL) and C-terminal JmjC domain. 
Proteins not drawn to scale. Numbers indicate sizes of mouse proteins. 
1.6.1.1 Sequence identity of KDM3 subfamily members 
 Alignment of protein sequences of all human and mouse subfamily members 
in Uniprot shows that KDM3A and KDM3B are the closest paralogues and that 
HAIRLESS is the most distant. All human and mouse KDM3 members share only 5% 
sequence identity when full length proteins are aligned. Within the JmjC domain and 
the zinc finger, the sequences show greater conservation and share 25% and 38% 
identity, respectively. The nuclear receptor sequence is identical in 3 out of 5 
positions (60% identity). Moreover, with the exception of HAIRLESS, all metal and 
α-ketoglutarate binding sites are conserved in KDM3A, KDM3B and JMJD1C 
(Klose et al., 2006b).  
 As mentioned above, KDM3A and KDM3B are the closest paralogues. The 
sequence identity across the full-length KDM3A and KDM3B proteins is 34% 
between human and mouse (Figure 7.1 in Appendix). Interestingly, the sequence 
conservation within the JmjC and the zinc finger is 83% and 77%, respectively. The 
nuclear receptor sequence differs only by one residue (80% identity) (Figure 1.4). 
 Moreover, the cNLS mapper was used to predict the nuclear localisation 
signals (NLS) for the human and mouse KDM3A and KDM3B proteins. Both 
KDM3A and KDM3B have predicted NLS. The KDM3A and KDM3B homologues, 
in human and mouse, share a high percentage of sequence identity (86% and 92% for 
the predicted bipartite NLS of KDM3A and KDM3B homologues, respectively) 
within the predicted NLS, but there is no conservation in the predictions between 





Figure 1.4: Alignment of the human and mouse KDM3A and KDM3B 
paralogue sequences with Uniprot identifiers: Q7LBC6, B9EKS2, Q9Y4C1 and 
Q6PCM1.  
Highlights: Grey: predicted NLS; light blue- zinc finger; green- nuclear receptor 
motif; yellow-JmjC domain; red-predicted iron binding sites and dark blue- α-
ketoglutarate binding sites.  
* indicates fully conserved residue 
: indicates residues of strongly similar properties 
. indicates residues of weakly similar properties 
 
Similar properties of amino acids are defined by the presence of: hydrophobic 
aliphatic side chains, hydrophobic aromatic side chains, polar neutral side chains, 
electrically charged-acidic side chains, electrically charged-basic side chains and 





1.6.2 The Kdm3 subfamily: diversity in biological roles 
Although Kdm3a, Kdm3b, Jmjd1c and Hairless belong in the same protein 
sub-family, the characterisation of gene-trapped, knock-out and mutant mice 
demonstrates that each of these demethylases fulfils distinct/non-overlapping 
biological role(s). For example, both Kdm3a and Jmjd1c male knock-out mice 
exhibit infertility, although the time of infertility onset and the underlying causes are 
distinct. To date, mouse models have been characterised for Kdm3a, Jmjd1c and 
Hairless, but not for Kdm3b (this study). The phenotypes of gene-trapped and knock-
out mice are summarised in Table 1 and further discussed in sections 1.1.6.2.1-
1.1.6.2.3.  







Male infertility, obesity, 
predisposal to diabetes, 
frequent male sex-reversal 
(Inagaki et al., 2009; Kasioulis et al., 
2014; Kuroki et al., 2013a; Liu et al., 
2010a; Okada et al., 2007; Okada et 
al., 2010; Tateishi et al., 2009) 
Kdm3b Not available/unpublished 
(this study) 
Not available 
Jmjd1c (knock-out) Progressive age-dependent 
male infertility 
(Kuroki et al., 2013b) 
Hairless (mutants) Permanent hair loss, reduced 
white adipose tissue, inner 
ear defects 
(Cachón-González et al., 1999; 
García-Atares et al., 1998; Kumpf et 
al., 2012; Thompson, 2009) 
1.6.2.1 The Kdm3a lysine demethylase 
Kdm3a was initially identified in 1991 as a zinc finger-containing protein (known as 
testis specific gene A- TSGA), specifically expressed in the testis of rats, during the 
first wave of spermatogenesis (Höög et al., 1991). The characterisation of Kdm3a as 
a H3K9me1/2 demethylase enzyme was elucidated by Yamane et al. (2006) by 
means of biochemical and in vivo assays. Consistent with the fact that JmjC-domain 




Schofield, 2008), the demethylase activity of Kdm3a requires the Fe (II) and α-
ketoglutarate as co-factors, with the release of formaldehyde. Both the catalytic JmjC 
domain and the zinc finger are essential for this demethylation function (Yamane et 
al., 2006). 
 To date, several gene-trap and knock-out mouse models for Kdm3a have been 
characterised. So far, it has been demonstrated that Kdm3a is essential for 
spermatogenesis (Kasioulis et al., 2014; Liu et al., 2010a; Okada et al., 2007; Okada 
et al., 2010), energy homeostasis and resistance to obesity (Inagaki et al., 2009; 
Okada et al., 2010; Tateishi et al., 2009) and regulation of sex determination (Kuroki 
et al., 2013a). 
 Kdm3a gene-trapped (Kasioulis et al., 2014; Okada et al., 2007) or knock-out 
(Kasioulis et al., 2014; Liu et al., 2010a) male mice are infertile, with significantly 
smaller testes. Spermatogenesis arrests around spermatid stage 9 (Liu et al., 2010a) 
or stage 11 (Okada et al., 2007) with very few mature spermatozoa in the epididymal 
ducts (a condition known as oligozoospermia) (Kasioulis et al., 2014; Liu et al., 
2010a; Okada et al., 2007), most of which are immotile (Okada et al., 2007). 
Interestingly, spermatids of Kdm3a-deficient mice fail to condense their chromatin 
(Okada et al., 2007) and show aberrant acrosome and manchette formation (Kasioulis 
et al., 2014). The latter two structures are necessary for proper sperm-head shaping 
(Dam et al., 2007; Kierszenbaum and Tres, 2004). It is proposed that Kdm3a 
functions as a transcriptional co-activator by mediating the expression of protamines 
and transition proteins, essential for chromatin compaction in spermatids, via 
promoter H3K9me2 demethylation (Okada et al., 2007). Furthermore, tubulin and/or 
actin subunits may be necessary for the proper assembly of microtubular and actin-
based structures seen altered during spermatogenesis of Kdm3a knock-out mice 
(Kasioulis et al., 2014). Kdm3a may also function as a non-histone protein 
demethylase, by demethylating lysine residues on tubulin and/or actin subunits. 
Furthermore, adult Kdm3a-deficient mice are obese (Inagaki et al., 2009; 




increased brown adipose tissue (BAT). In addition, they show increased levels of 
blood triglycerides, cholesterol, insulin and leptin, resembling a pre-diabetic state.  
By the use of microarray technology coupled with qRT-PCR, Tateishi et al. 
(2009) demonstrated that the expression of the peroxisome proliferator-activated 
receptor alpha (Pparα) and a number of its downstream pathway genes, involved in 
lipid metabolism, are significantly downregulated in skeletal muscle of Kdm3a-
deficient mice. Kdm3a binds and removes H3K9me2 from  the peroxisome 
proliferator hormone response element (PPRE) sequences of Pparα.  
Moreover, Kdm3a knock-out mice are unable to maintain their body 
temperature when exposed to cold (Tateishi et al., 2009). In line with this result, 
BAT expression of Uncoupling protein 1 (Ucp1), responsible for thermogenesis 
(Lowell and Spiegelman, 2000), is not upregulated during cold exposure in Kdm3a-
deficient mice. Kdm3a binds to the Ucp1 enhancer, and when not present, the 
H3K9me2 levels at the Ucp1 enhancer are increased (Tateishi et al., 2009). 
 More recently, Kdm3a was shown to be important for sex determination in 
male mice (Kuroki et al., 2013a). A non-Mendelian proportion of Kdm3a male 
knock-out mice are often found to be sex reversed, either partially (with XY knock-
outs having a testis and an ovary) or fully (with XY knock-outs having two ovaries). 
Sex reversal is presumably due to the reduced expression of the Sex determining 
region Y (Sry) transcription factor (driven by sertoli cell differentiation), essential for 
the development of male genitalia (Barrionuevo et al., 2006; Jäger et al., 1990). 
Consistent with the function of Kdm3a as a transcriptional co-activator, Kdm3a 
binds and reduces the H3K9me2 mark in the Sry regulatory regions of gonadal 
somatic cells, which is expected to promote the Sry expression (Kuroki et al., 2013a). 
 In summary, Kdm3a is involved in many different biological functions and 
reduced/absent levels of Kdm3a have been associated with infertility, obesity and 
male sex reversal. Finally, although most studies focus on the histone demethylation 
function of Kdm3a, work from our laboratory suggests that this demethylases may 




1.6.2.2 The Jmjd1c lysine demethylase 
To date, a single knock-out mouse for Jmjd1c has been generated and 
characterized (Kuroki et al., 2013b). Jmjd1c female knock-out mice are normal and 
fertile, whereas male mice are initially fertile but show an age-dependent infertility 
due to the progressive reduction of germ cells, commencing at about three months of 
age. The infertility in Jmjd1c-deficient male mice is attributed to increased apoptosis 
and by eight months of age, these mice are completely infertile. Jmjd1c is highly 
expressed in spermatogonial stem cells, which correlates with the infertility 
phenotype observed, provided that this demethylase performs an essential, yet 
unidentified function for the maintainance of male germ cells. Absence of Jmjd1c did 
not change the global H3K9me2 levels in the testes, suggesting that Jmjd1c controls 
the expression of a subset of genes via H3K9me2 demethylation or that it influences 
the function of non-histone substrates via lysine demethylation. The second 
statement is reinforced by in vivo demethylation assays, where over-expression of 
tagged-Jmjd1c does not result in global demethylation of H3K9me1/2, contrary to its 
orthologues Kdm3a and Kdm3b (Brauchle et al., 2013; Kuroki et al., 2013b; 
Sroczynska et al., 2014). 
1.6.2.3 The Hairless lysine demethylase 
Hairless is the best studied gene of the Kdm3 subfamily. Mutations in the 
HAIRLESS gene have been found in patients with Alopecia universalis and popular 
atrichia, hereditary forms of hair loss (Ahmad et al., 1998; Kruse et al., 1999; 
Sprecher et al., 1999). In the mouse mutants of Hairless, the initial hair growth is 
normal. However, when the hair is shed, it does not grow back owing to the inability 
of hair follicles to regenerate. Subsequently, the skin becomes wrinkled, the hair 
follicles widen near the epidermis, the lower part of the follicle eventually 
degenerates and cysts form in the dermis (Thompson, 2009). Hairless is expressed in 
the hair follicle after it is shed and during the initial stages of regeneration. Its 
expression is lost at stages of active hair growth. Hairless presumably controls hair 
regeneration/hair cycle by modulating Wnt signaling, whose action reinitiates hair 




In addition to its dynamic expression during hair regeneration, Hairless is 
highly expressed in the brain, and its absence results in neurological phenotypes, 
such as altered neuronal morphology and defects of the inner ear (Cachón-González 
et al., 1999; García-Atares et al., 1998). 
Furthermore, Hairless mutant mice display reduced mass of the white, but not 
the brown adipose tissue (Kumpf et al., 2012). Hairless is upregulated during 
adipogenesis (Kumpf et al., 2012) and its knock-down results in the reduced 
expression of the early regulators of adipocyte differentiation, such as Peroxisome 
proliferator-activated receptor gamma 1  (PPARγ1) and Peroxisome proliferator-
activated receptor gamma 2 (PPARγ2) (Rosen and MacDougald, 2006; Sarjeant and 
Stephens, 2012). As a result, the accumulation of lipids in differentiating Hairless 
knock-down 3T3-L1 preadipocytes is impaired. Hairless is thought to control the 
expression of PPARγ1 and PPARγ2, irrespective of the JmjC domain, suggesting that 
this demethylase interacts with other transcriptional co-activator proteins (Kumpf et 
al., 2012). 
1.6.3 Substrate specificities for the Kdm3 subfamily members 
A number of publications have, to date, attributed H3K9me1/2 substrate 
specificity for the Kdm3 subfamily members, although, in the case Jmjd1c, this is 
still unclear. Also, Jmjd1c was the first to show non-histone protein demethylation, 
but non-histone substrates for the other members have not yet been uncharacterised. 
Kdm3a was the first of the Kdm3 subfamily to be attributed a H3K9me1/2 
demethylase activity, as demonstrated by in vitro and in vivo assays (Brauchle et al., 
2013; Yamane et al., 2006). It functions as a transcriptional co-activator through its 
H3K9me2 demethylase activity (Yamane et al., 2006). Additionally, the closest 
homologue of Kdm3a, Kdm3b, retains the same H3K9me1/2 substrate specificity 
(Brauchle et al., 2013; Kim et al., 2012). Kdm3b is potentially a transcriptional 
activator, as it promotes the expression of the haematopoietic transcription factor 
LIM domain only 2 (rhombotin-like 1) (Lmo2) via H3K9me2 promoter 




The histone lysine demethylase activity of Jmjd1c is still debated. Although it 
was primarily shown to function as a H3K9me1/2 demethylase (Kim et al., 2010), 
later publications contradicted this finding (Brauchle et al., 2013; Kuroki et al., 
2013b; Sroczynska et al., 2014), suggesting that Jmjd1c controls transcription via an 
indirect mechanism. It is possible that Jmjd1c may function as a H3K9me1/2 
demethylase depending on the biological context, i.e. interaction with other 
transcriptional regulators. Thus, further research is necessary to clarify the histone 
demethylation potential of Jmjd1c. Interestingly, Jmjd1c was found to demethylate 
lysine 45 of Mediator of DNA-damage checkpoint 1 (MDC1), a protein involved in 
the DNA damage response (Coster and Goldberg, 2010; Watanabe et al., 2013). 
Hairless is known to function as a corepressor of liganded and unliganded nuclear 
receptors, and to interact with histone deacetylases (Hsieh et al., 2003; Potter et al., 
2001; Potter et al., 2002; Thompson, 2009). In vitro and in vivo assays have indicated 
that Hairless has strong H3K9me1 and weak H3K9me2 demethylase activity (Liu et 
al., 2013), which further supports its function as a corepressor, as part of a 
multiprotein complex. 
To date, the functions of H3K4, H3K9, H3K27, H3K36, H3K79 and H4K20 
methylation on the chromatin state have been the focus of research (Black et al., 
2012; Martin and Zhang, 2005). Lately, many more modifications on the histone tails 
have been identified, including methylation of additional lysine residues (Tan et al., 
2011). Therefore, it is possible that members of the Kdm3 subfamily have additional, 
yet unidentified methyl histone substrates. Furthermore, given the importance of 
lysine methylation and demethylation as a means of non-histone protein-function 
control, it is also possible that Kdm3a, Kdm3b and Hairless, as already demonstrated 
by Jmjd1c, have non-histone nuclear and/or cytoplasmic substrates.  
1.7 Growth 
In this study, Kdm3b gene-trapped mice show a post-natal growth retardation 
phenotype. In this section the growth determinants as well as the pathways that 




Growth is the increase in size, which is mainly accomplished via cell 
proliferation and cell size. In mammals, cell proliferation is the determining factor 
for body size, whereas in lower animals, such as the C. elegans, cell size is also 
important (Efstratiadis, 1998; Klingseisen and Jackson, 2011).  
 Two of the main determinants of growth are hormones and growth factors 
(Efstratiadis, 1998). Hormones are chemicals that signal away from their site of 
production. For example, the growth hormone-releasing hormone (Ghrh) is produced 
in the hypothalamus and exerts its effect at the anterior pituitary to promote the 
expression of the growth hormone (Gh). Growth factors, like the insulin-like growth 
factor 1 (Igf1), are polypeptides that can have an effect on the cell from which they 
are secreted or on neighbouring cells (autocrine and paracrine effect, respectively), as 
well as a systemic (endocrine) effect as they can be released in the bloodstream. 
Generally, prenatal growth is determined by growth factors, whereas postnatal 
growth is affected by both growth factors and hormones. In particular, mice knock-
outs of the growth hormone and thyroid hormone pathways result in postnatal growth 
retardation, whereas mice knock-outs of growth factors or growth factor receptors 
result in prenatal and postnatal growth retardation. Insulin hormone is the exception 
to the “rule”, since insulin receptor knock-out mice are prenatally mildy retarded. 
Furthermore, some mouse mutants or knock-outs of the growth hormone pathway 
display increased longetivity, whereas knock-out mice of the thyroid hormone 
receptor alpha and the insulin receptor die early in postnatal life (Table 1-2) (Alba 
and Salvatori, 2004; Coschigano et al., 2000; Coschigano et al., 2003; DeChiara et 
al., 1990; Efstratiadis, 1998; Flurkey et al., 2001; Fraichard et al., 1997; 
Holzenberger et al., 2003; Joshi et al., 1996; Kappeler et al., 2008; Liu et al., 1993; 










Lifespan to WT mice References 
Growth hormone releasing hormone  Ghrh Postnatal n/a (Alba and Salvatori, 2004) 
Growth hormone releasing hormone 
receptor  
Ghrhr Postnatal Increased (Eicher and Beamer, 1976; Flurkey et 
al., 2001) 
Growth hormone receptor  Ghr Postnatal Increased (Coschigano et al., 2000; Coschigano 
et al., 2003; Zhou et al., 1997) 
Thyroid hormone receptor alpha Thra Postnatal Decreased (Fraichard et al., 1997) 
Insulin-like growth factor 1 Igf1 Prenatal n/a (Liu et al., 1993; Lupu et al., 2001) 
Insulin receptor Insr Prenatal (mild) Decreased (Joshi et al., 1996; Louvi et al., 1997) 
Insulin-like growth factor 2 Igf2 Prenatal n/a (DeChiara et al., 1990) 
Insulin-like growth factor 1 receptor  Igf1r Prenatal Most die at birth, the 
rest survive 




1.7.1 Perturbation of pathways that affect growth 
 To date, perturbation of the Gh-Igf1 axis, Igf2, the thyroid hormone (Th) and 
the insulin pathways affect growth either prenatally, postnatally or both (Efstratiadis, 
1998). Interestingly, Gh and insulin act through the same pathways and there is 
evidence of cross talk between them, as illustrated below.  
1.7.1.1 The Growth hormone and insulin-like growth factor1 axis 
 Since growth is a fundamental biological process, then the Gh pathway 
(summarised in Figure 1.5), central for protein synthesis, cell proliferation, glucose 
metabolism and other processes, is tightly controlled at multiple levels via the 
secretion of hormones by different tissues, and the presence of negative feedback 
loops (Alba and Salvatori, 2004; Clemmons, 1997; D’Ercole et al., 1984; 





Figure 1.5: The growth hormone pathway.  
The Gh pathway initiates in the hypothalamus by the expression of the Ghrh. The 
Ghrh binds to the Growth hormone-releasing hormone receptor (Ghrhr) in the 
pituitary gland and stimulates the expression of the Gh. The Gh is then released in 
the bloodstream and binds to the growth hormone receptor (Ghr) in several organs of 
the body. Growth hormone signaling in the liver results in the expression of Igf1, 
which acts as the mediator of Gh hormone action. Hepatic Igf1 does not only 
function in an autocrine and paracrine fashion, but is also secreted in the bloodstream 
and acts in a systemic way, similar to a hormone. Serum Igf1 is stabilised by IGF-
binding proteins, mainly Igfbp-3. Gh release is inhibited via a negative feedback loop 
by Igf1 and also by the Growth hormone inhibiting hormone (or somatostatin). 
 At the molecular level, Ghr functions as a dimer. The binding of the Gh to its 
transmembrane receptor activates a number of signalling pathways that result in the 
transcription of target genes, necessary for growth (Brooks and Waters, 2010; 
Herrington and Carter-Su, 2001). Figure 1.6 summarises the pathways activated by 





Figure 1.6: Signaling pathways activated by binding of the Gh on the Ghr. 
 Ghr functions as a dimer. Binding of its Gh ligand induces a conformational change 
in one of the receptor proteins, which in turn allows the binding of the Janus kinase 2 
(Jak2). The Jak2 kinase phosphorylates itself and the Ghr, and these events allow the 
subsequent phosphorylation of signal-transducer and activator of transcription 
proteins (Stats). Finally, phosporylated Stats translocate to the nucleus and promote 
gene transcription of their target genes. Ghr phosphorylation can additionally activate 
the v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (Src) and 
initiate the Rat sarcoma/mitogen-activated protein kinase (Ras/MAP) signaling 
pathway. Moreover, insulin receptor substrates (Irs), that function through the insulin 
binding, can also be activated and thus promote transcription of their target genes via 
the phosphatidylinositol 3-kinase - v-akt murine thymoma viral oncogene homolog 1 
(PI3K/Akt) signaling pathway. 
  Hepatic Gh stimulation results in the expression and release of Igf1 in the 
bloodstream. However, the prenatal growth retardation of Igf1, Igf1r, as well as Igf2 
knock-outs implies that Igf1/2 are able to activate growth-promoting pathways in the 




the insulin pathway, as both growth factors bind the insulin receptor. The signalling 
pathways activated by Igf1/2 are depicted in Figure 1.7 (Siddle, 2011; Zha and 
Lackner, 2010).  
1.7.1.2 Insulin pathway 
 Insulin is a peptide hormone, which is expressed by the beta-cells of the 
pancreas and released in the bloodstream. Similarly to Igf1, insulin can bind the Igf1 
receptor and activate common downstream signalling pathways. Figure 1.7 






Figure 1.7: The signalling pathways activated by Igf1 and insulin.  
Systemic Igf1/2 circulation binds to insulin-like growth factor 1 receptor (Igf1r) and 
also the insulin receptor (Insr), which leads to the activation of docking proteins (src 
homology 2 domain-containing transforming protein C) Shc and Irs, and the 
initiation of downstream Ras/MAP and PI3K/Akt signalling. Igf1/2 signaling drive 
protein synthesis, cell proliferation, glucose metabolism and other processes. Insulin 
binds Insr but can also bind the Igf1r. Reciprocally, Igf1 peptides can bind the insulin 
receptors. Activation of the receptors via insulin binding activates the adaptor 
proteins Shc and Irs, which initiate the Ras/MAP and PI3K/Akt signalling pathways, 
respectively. Therefore, signalling through insulin binding is also crucial for cell 
proliferation, glucose uptake, protein synthesis and other. 
The convergence of the Gh, Igfs and insulin to common signalling pathways, 




demonstrates that the control of growth is complex and finely tuned. However, the 
differences in the commencement of growth retardation between the Igfs and insulin 
receptor knock-outs suggests that different growth-promoting factors may control the 
expression of a distinct subset of gene targets (in addition to common targets). 
1.7.1.3 The thyroid hormone pathway 
Like the Gh pathway, the thyroid hormone pathway is tightly regulated via a 
multistep hormone stimulation that initiates from the hypothalamus. Furthermore, the 
levels of T3 and T4 are balanced by a negative feeback loop to the pituitary, which 
suppresses the expression of the Tsh. The pathway is summarised in Figure 1.8 





Figure 1.8: The thyroid hormone pathway 
 The thyroid hormone pathway initiates in the hypothalamus, by the 
expression and release of the thyrotropin-releasing hormone (Trh). Trh exerts its 
effect in the pituitary gland, which produces and releases the thyroid-stimulating 
hormone (Tsh). The latter hormone binds to the thyroid-stimulating hormone 
receptor (Tshr) into the thyroid gland and stimulates the release of triidothyronine 
(T3) and thyroxine (T4). They also exert a negative feedback to the pituitary gland to 
repress Tsh release.The thyroid signaling pathway functions through the T3 
hormone. Thus, T4 is converted to T3 or an inactive form, known as rT3, by different 
deiodinase enzymes (D). In the nucleus, the thyroid hormone receptors (Tr) are kept 
in an inactive state by association with co-repressor complexes (CoR). In the 
presence and direct binding of T3 to the Tr, transcription is activated by the 
recruitment of co-activators (CoA). The thyroid hormone signalling pathway is 




1.7.2 Proteins that directly affect cell proliferation and result in primordial 
dwarfism 
 The Gh, insulin and thyroid hormones discussed above promote cell 
proliferation by activating a number of downstream signalling pathways. Therefore, 
they modulate growth indirectly. Recently, downstream cell proliferation and cell 
survival proteins have also been identified. In humans, mutation of the latter genes 
can result in a distinct class of dwarfism, known as primordial dwarfism. 
 Primordial dwarfism initiates prenatally and continues postnatally. Affected 
individuals are characterised by an extreme global growth failure. Its most distinctive 
feature is the decrease in head size in proportion to body size (Klingseisen and 
Jackson, 2011).  
Mutations in ten genes have been identified, whose protein products are 
involved in DNA damage control, centrosomal function and integrity, and DNA 
replication (Klingseisen and Jackson, 2011). For example, a homozygous mutation 
has been found that affected the splicing of the ATR gene. As such, patient-derived 
cells were unable to respond ATR-dependent damage induction (O’Driscoll et al., 
2003). Mutations were also found in genes encoding centrosomal proteins such as 
PERICENTRIN and CEP152 (Guernsey et al., 2010; Rauch, 2011). Patient cell lines 
with PERICENTRIN mutations exhibited abnormal mitosis due to their inability to 
correctly assemble the mitotic spindle (Rauch, 2011). Furthermore, mutations have 
also been identified in several ORC genes. These genes encode proteins that 
assemble as a complex at the origins of replication (Bicknell et al., 2011). 
In summary, growth retardation can also result from mutations in genes that 
are directly involved in the control of cell division, irrespective of proper hormonal 
and growth factor signalling. 
1.7.3 A dynamic postnatal genetic program to determine organ size 
 As discussed previously, several hormones and growth factors are essential 
for normal prenatal and postnatal growth. If hormones and growth factors were the 




peptides to decline with age. However, this is not the case. For example, the levels of 
circulating GH and IGF1 remain high even postnatally (Kwan and Hartman, 2007; 
Rose et al., 1991). Therefore, if organ, and consequently body size, was a result of 
the systemic action of GH and IGF1, then body growth would never cease.  
 A current working hypothesis to explain how organs attain their final size and 
how this is orchestrated in a systemic fashion is through the existence of a common 
genetic program, operating in all organs (Finkielstain et al., 2009; Lui et al., 2010). 
This genetic program will promote cell proliferation (in this sense meaning growth), 
and will become limiting in postnatal life so that organs reach a certain final size. 
 Analysis of the gene expression profile in several mouse and rat organs 
shows that several genes are down regulated from an earlier to a later postnatal stage. 
Interestingly, there is extensive overlap of downregulated gene expression between 
organs, with many genes being involved in cell proliferation. A total of 235 genes are 
found to be downregulated in all mouse and rat tissues analysed, suggesting a 
common mechanism for organ growth control (Lui et al., 2010). Among the genes 
that show a sharp decline in expression with age include transcription and growth 
factors. Furthermore, when the expression of a selected number of genes is knocked 
down by siRNA, the proliferation of primary murine hepatocytes declines. Also, by 
inducing hypothyroidism, or putting young rats on a tryptophan-deficient diet (that 
results in growth retardation), the decline in the expression of the identified growth 
promoting genes is reduced. These results, suggest that: 1) the normal decline in the 
expression of growth promoting genes is mainly determined by growth per se and 
not by age and 2) postnatal growth deceleration is a result of a multiorgan genetic 
program that involves the decrease in gene expression of several growth promoting 
genes. This decrease occurs concurrently in multiple tissues, in a concerted fashion, 
in order to maintain body proportions (Finkielstain et al., 2009; Lui et al., 2010). 
Therefore, growth is a process that requires: 1) the proper function of signalling 
pathways, regulated by hormones and growth factors and 2) underlying multigenetic 




1.8 The formation of primary cilia and their functions 
The primary cilium, an immotile organelle found in almost all eukaryotic cell 
types, has recently gained lots of attention. This is due to the appreciation that this 
organelle is vital for sensory perception and signal transduction. As such, 
perturbations in primary ciliary formation or function result in a group of disorders, 
collectively known as ciliopathies. Another type of cilia, the motile cilia are quite 
similar in structure to the primary cilia. Functional defects of the motile cilia give 
rise to primary ciliary dyskinesia, which also form another group of ciliopathies 
(Berbari et al., 2009; Gerdes et al., 2009b; Goetz and Anderson, 2010; Hildebrandt et 
al., 2011; Ishikawa and Marshall, 2011; Nigg and Raff, 2009). 
1.8.1 Ciliogenesis 
Primary cilia form following mitosis by the migration of the mother centriole 
near the cell surface to form the basal body. Ciliogenesis begins by the attachment of 
a Golgi-derived visicle at the distal region of the basal body, which will form part of 
the ciliary membrane. The basal body serves as a microtubule organising centre- the 
growing ciliary axoneme is composed of nine microtubule doublets that terminate to 
a singlet at the very tip of the cilium. The region just above the distal part of the basal 
body is called the transition zone, which is thought to function as a gatekeeper, 
controlling which proteins move into the cilium. In the meantime, attachment of 
more Golgi-derived vesicles extend the ciliary membrane to accommodate the 
elongating axomene. Anterograde transport of cargo proteins (from the ciliary base 
to the tip) is carried out by the intraflagellar transport protein complex B (IFT B) and 
the kinesin-2 heterotrimeric motor, and retrograde transport (from the ciliary tip to 
the base) is carried by the intraflagellar transport protein cimplex A (IFT A) protein 
complex and the dynein motor. IFT transport is essential for building up and 
maintaining the primary cilium, as well as for the localisation of proteins that signal 





1.8.2 Functions of primary cilia 
Several functions have been proposed for the primary cilium. These functions 
include mechanosensation, light and odorant detection (Berbari et al., 2009). 
Mechanosensation is thought to be mediated via fluid flow through the renal tubules. 
Loss of ciliary proteins that reside in the renal epithilia such as polycystic kidney 
disease 2 (PKD2) result in the formation of kindey cysts (Mochizuki et al., 1996). 
Further, the retina photoreceptor outer segments represent a modified cilium 
responsible for light detection. Defects in the maintainance of photoreceptos caused 
by mutation of intraflagellar transport 88 (Ift88) (Pazour et al., 2002) or the loss of 
the Bardet–Biedl syndrome protein 4 (Bbs4) results in retinal degeneration (Abd-El-
Barr et al., 2007) . Moreover, odorant detection is accomplished via specialised 
sensory neurons whose dendritic knobs end in ciliary clusters. The proteins 
responsible for odour sensation reside in the cilium (Berbari et al., 2009), therefore 
individuals with loss of function of the basal body BBS proteins present partial or 
complete anosmia (Kulaga et al., 2004).  
 The primary cilium also functions as a signalling centre, from where 
pathways operate in responce to external stimuli. The Hedgehog pathway is one of 
the best studied examples. When the hedgehog ligand is absent, the transmemberane 
protein Patched resides in the primary cilium and inhibits the cytoplasmic protein 
Smoothened (Smo). Upon Hedgehog binding, Smo inhibition is released, and Smo 
translocates in the cilium where it activates the Gli-Kruppel family zinc finger 
proteins 1, 2 and 3 (Gli1, Gli2 and Gli3) which also reside in the cilium. Activated 
Gli proteins translocate in the nucleus and stilumate gene expression (Berbari et al., 
2009; Gerdes et al., 2009b; Goetz and Anderson, 2010). Another signalling pathway 
proposed to operate through the primary cilium is the Wnt pathway (Berbari et al., 
2009). In addition, the platelet-derived growth factor receptor, alpha polypeptide 
(Pdgfra) was found to localise and proposed to signal through the primary cilia of 






1.9 Aims and Objectives  
  Kdm3a and Kdm3b belong to the Kdm3 subfamily of JmjC-domain 
demethylases (Klose et al., 2006b). Work on knock-out and gene-trap mouse models 
have demonstrated that Kdm3a is important for spermatogenesis, metabolic gene 
expression and male sex-determination. These functions were accomplished by 
H3K9me2 demethylation of its target gene promoters (Inagaki et al., 2009; Kuroki et 
al., 2013a; Liu et al., 2010a; Okada et al., 2007; Okada et al., 2010; Tateishi et al., 
2009). No mouse model has been characterised for Kdm3b, but was demostrated to 
function as a H3K9me1/2 histone demethylase. Interestingly, kdm3b is present in the 
zebrafish genome, but not kdm3a. The phenotype of morpholino kdm3b zebrafish 
knock-outs resembles a ciliary defect (Dr. Patricia Yeyati, Insitute of Genetics and 
Molecular Medicine, University of Edinburgh), as does the phenotype of Kdm3a 
knock-out and gene-trapped mice. Moreover, equally interesting is the fact that 
different isoforms of lysine demethylases can perform non-redundant functions 
(Verrier et al., 2011b; Zibetti et al., 2010). 
 The above observations are important because they suggest that lysine 
demethylases can have futher uncharacterised functions, which could possibly extend 
beyond histone lysine methylation. Furthermore, since the phenotype of the mouse 
models of Kdm3a, Jmjd1c and Hairless are non-redundant (Cachón-González et al., 
1999; García-Atares et al., 1998; Inagaki et al., 2009; Kumpf et al., 2012; Kuroki et 
al., 2013a; Kuroki et al., 2013b; Okada et al., 2007; Tateishi et al., 2009), then it was 
interesting to investigate the functions of Kdm3b in a mouse model. 
 The aims of the present study were to: 
 Compare the evolutionary conservation of the zebrafish kdm3 and murine 
Kdm3b in function and check their spatial expression 
 Dissect the phenotype of Kdm3b gene-trapped mice 
 Characterise an alternative murine Kdm3a isoform 




 Investigate the protein sequence conservation of the zebrafish kdm3b with the 
human and mouse homologues 
 Clone and check the demethylation function of the zebrafish kdm3b and of 
the mouse Kdm3a-i2 isoform 
 Investigate the sub-cellular localisation of zebrafish kdm3b and mouse 
Kdm3a-i2 
 Check if kdm3b and Kdm3a-i2 over-expression could result in a ciliation 
defect 
 Check the spatial expression of the zebrafish and murine Kdm3b 
 Quantify the levels of Kdm3a-i2 transcription  
 Provide a thorough phenotypic description of heterozygous and homozygous 
Kdm3b gene-trapped mice 



























2.1 Generation of mouse lines 
ES cell lines (Table 2-1) were obtained from the Sanger Institute Gene Trap 
Resource (http://www.genetrap.org) and EUCOMM 
(http://www.mousephenotype.org/martsearch_ikmc_project/about/eucomm), 
respectively. Kdm3a and Kdm3b gene-trapped mice were generated by 
microinjection of the ES cell lines into C57BL/6J blastocysts, with transmission of 
the mutation on a C57BL/ 6J background. 
Table 2-1: ES cell lines for the generation of mouse gene-trap lines 
Gene-trap mouse line ES cell line 





2.2 DNA extraction from murine tissues 
Mouse ear clips were incubated with DirectPCR Lysis Reagent (Viagen, 401-E), 
supplemented with 0.4µg/ml proteinase K (Promega, V3021), overnight at 55
o
C. The 
next day, proteinase K was then deactivated at 85
o
C for one hour. 2µl of this crude 
DNA extract was used as input for the genotyping PCR. 
2.2.1 Genotyping polymerase chain reaction 
Each PCR was performed in a 25μl reaction, using 2 units of MyFi polymerase 
(Bioline, BIO-21117), 5x MyFi reaction buffer, 10μM forward and 10μM reverse 
primers (Table 2-2)(Sigma-Aldrich), 2µl of crude DNA and bought to the final 
volume with dH2O. 2µl of dH2O was used instead of DNA template as a negative 
control for all the primer sets. PCR products were amplified in DNA Engine tetrad 2 






Table 2-2: Genotyping primers 
Kdm3b-b07 5’- 3’ 
A CTCTGACCGGCGTGGCTTCC 
B AGACCGAGGCAAGCGGCCAAA 
C (common for both Kdm3b 
mouse lines) 
CCCGAAAACCGCTTCTAGCAAC 
Kdm3b-g12 5’- 3’ 
A ACTTGAAGAAAGGCCCCTCCGATGT 
B TGGGGGATGGAGGCAGAGAAAAAGG 
β-gal Forward GCCGTCACTCCAACGCAGCA 
β-gal Reverse GTTGCGCAGCCTGAATGGCG 
Table 2-3: Genotyping PCR conditions 
Kdm3b-b07 line A-B or B-C primers Β-gal primers 
Initial denaturation 95°C for 1 minute 95°C for 1 minute 
Denaturation 95°C for 15 seconds 95°C for 15 seconds 
Annealing 65°C for 30 seconds 61°C for 30 seconds 
Extension 72°C for 25 seconds 72°C for 20 seconds 
Repeat denaturation, 
annealing and extension 
34 cycles 29 cycles 
Final extension 72°C for 1 minute 72°C for 1 minute 
Holding 15°C forever 15°C forever 
The same protocol was used for the genotyping of the Kdm3b-g12 line, except for 
the annealing temperature of the A-B and A-C primers at 58°C. 
All PCR products were run on 2% agarose gels in 1% TBE (with 1% TBE 
running buffer) with 100bp molecular DNA size marker (Bio-Rad, 170-8202). 




2.3 Tissue retrieval for wax embedding and sectioning 
2.3.1 Tissue retrieval 
 Tissues from sacrificed mice were fixed in 4% formalin at 4°C on a roller. 
Eyes were fixed with Davidson’s fix (EtOH, formalin, glacial acetic acid, distilled 
water) The next day, they were washed extensively with PBS (3 times, 30 minutes 
each) at room temperature. They were then dehydrated in a series of alcohols (30% 
 50%  70%) and stored at 4°C until embedding. 
2.3.2 Wax embedding and sectioning 
Wax embedding of tissues was accomplished with the Tissue-Tek VIP 5 Jr (Sakura). 
Details of the protocols are shown in Table 2-4 below. 
Table 2-4: Wax embedding protocols of mouse tissues 
Station No. Solution Time (minutes) 
  Eyes Testis, pancreas, 
kidney 
Thymus 
1 70% Ethanol 40 20 1 
2 70% Ethanol 40 20 1 
3 85% Ethanol 40 20 10 
4 95% Ethanol 40 20 10 
5 100% Ethanol 40 20 10 
6 100% Ethanol 40 20 10 
7 100% Ethanol 40 20 10 
8 Xylene 30 20 10 
9 Xylene 30 20 10 
10 Xylene 30 20 10 




Wax-embedded tissues were sectioned at 7µm and sections attached on superfrost 
slides. The slides were dried overnight at room tempetature and then baked overnight 
at 55°C. 
2.4 Hematoxylin and eosin staining (H&E) 
Tissue sections were deparaffinised in xylene (2 x 5 minute washes), and hydrated 
through graded alcohols (100% EtOH for 2 x 5 minutes and then 90%  70%  
50%  30%, one minute each). The slides were washed in running water, 
haematoxylin stained (acidified Harris haematoxylin, Thermo Scientific, 6765003) 
for 4 minutes and then washed in running tap water for five minutes. The sections 
were differentiated in acid:alcohol for a few seconds, washed in running tap water 
and stained with lithium chloride for a few seconds. After brief washing in running 
tab water the sections were stained with eosin for two minutes, washed in tap water, 
placed in 100% alcohol for 10 minutes (2 x 5 minutes) and then to xylene for 10 
minutes (2 x 5 minutes). The sections were mounted on DPX media. 
2.5 Periodic acid-Schiff (PAS) staining 
Tissue sections were deparaffinised in xylene (2 x 5 minute washes), and hydrated 
through graded alcohols (100% EtOH for 2 x 5 minutes and then 90%  70%  
50%  30%, one minute each). The slides were washed in running water and 
incubated in 0.5% periodic acid for 7 minutes. They were then washed well in dH2O 
and incubated in Schiffs solution for 25 minutes. After a thorough wash in running 
tap water for 10 minutes, the slides were counterstained with Harris haematoxylin for 
45 seconds, differentiated in acid alcohol, and blued up in LiCl. Following a 3 
minute wash in running water, the slides were dehydrated in 100% alcohol and then 
placed in xylene for 10 minutes (3 times for 3 minutes each). The slides were 
mounted in DPX. 
2.6 Immunohistochemistry 
Slides were placed in xylene overnight. They were then placed in 100% EtOH (3 
changes of 10 minutes each) and then in 96% EtOH. The slides were then blocked 




EtOH and dH2O. Antigen retrieval was achieved by microwaving the slides for 15 
minutes in TEG buffer (Tris base, EGTA, pH 9). After cooling down, the slides were 
incubated in NH4Cl for 30 minutes and washed with wash buffer 1 (PBS with 1% 
BSA, 0.2% gelatine [Sigma, G1890], 0.05% saponin [Sigma, S7900]) for 30 
minutes. The slides were then incubated overnight at 4°C, in a humidity chamber, 
with the Kdm3b-NT primary antibody (Sigma, 1/100) in antibody solution (PBS with 
0.1% BSA and 0.3% Triton X-100). The following day, the slides were washed with 
wash buffer 2 (3 times, 10 minutes each) (PBS with 0.1% BSA, 0.2% gelatine and 
0.05% saponin) and incubated for 1 hour at room temperature with peroxidase-
conjugated antibody (1/200) (Jackson Immunoresearch, 111-035-003). The slides 
were then washed with wash buffer 2 (3 times, 10 minutes each). Antibody binding 
was revealed with DAB solution (1 DAB tablet [Kem-En-Tec Diagnostics, 4170] in 
10ml of dH2O and 10µl H2O2) for 10 minutes, and then the slides were rinsed in 
running water. They were then dehydrated with 1 minute incubations in graded EtOH 
(30%  50%  70%  90%) and then in 100% EtOH (3 changes, 5 minutes each). 
The slides were incubated in xylene for 30 minutes (10 minute changes) and 
mounted on DPX. 
2.7 Immunofluorescence 
2.7.1 Antigen Retrieval 
Eye and testis sections were deparaffinised for 10 minutes, hydrated through graded 
alcohols (90%  70%  50%  30%), rinsed in distilled water and then PBS. 
Slides were placed in a staining dish and filled container with 10mM citrate buffer, 
0.1% Tween-20, 1mM EDTA, pH 6.0. Slides were boiled in the microwave for 15 
minutes at 900W, equilibrated to room temperature and then washed with PBS. 
2.7.2 Immunostaining 
The slides were incubated for 1 hours in block (1% BSA, 0.5% Triton-X100 in PBS), 
and then overnight with primary antibodies (Table 2-7) at 4
o
C. The slides were then 
washed in PBS, incubated with fluorescent secondary antibodies (Table 2-9) for 1 




2.8 Alcian Blue and Alizarin Red staining of skeletal preparations 
Sacrificed mice were skinned and eviscerated. They were then submerged in 95% 
EtOH for 5 days and then into 100% acetone for 5 more days to dissolve lipids. The 
skeletal preparations were then submerged in stain solution (1 part acetic acid, 1 part 
Alizarin red [0.1% in 96% EtOH, Sigma, A5533], 1 part Alcian blue [0.3% in 70% 
EtOH, Sigma, A5268] and 17 parts 70% EtOH) for a week. The staining solution 
was then replaced with 1% KOH in H2O until the bones were fully visible. Once the 
bones were fully visible, the skeletal preparations were taken through a 
KOH/glycerol series (25%, 50%, 75% glycerol, changed after 1 week) until they 
were preserved in 100% glycerol.  
2.9 Weight monitoring 
E18.5 embryos were dissected out of their uteri in ice cold PBS. They were quickly 
put on whatman paper sitting on ice, photographed, then weighted and culled by 
decapitation. Weight of the embryos was rounded up to two decimal places. The 
weights, to 1 decimal place, of p14, p21 and p42 live mice was performed in the 
animal facilities. 
2.10 Preparation of primary mouse embryonic fibroblasts (MEFs) 
Mouse embryos E12.5 were obtained from female, sacrificed by cervical dislocation. 
Embryos were removed with the uterus and placed in sterile PBS. Individual 
embryos were exposed by cutting the uterus. Each embryo was then transferred in 
fresh PBS where its head and abdominal cavity were removed. The remaining part of 
each embryo was transferred in a 20cm
2
 culture dish (Corning) containing 10ml 
DMEM supplemented with 10% FCS, 1% penicillin/streptomycin and 0.1mM β-
Mercaptoethanol. The embryos were severed into small pieces using sterile blades, 
and placed in a 3% O2 incubator. Fresh media were added every twenty-four hours 
for two days. The cells in each plate were then trypsinised and all passed into 75 cm
2 
plates. This was named as passage 1. About four days later, when MEFs had reached 
almost full confluence were passaged again. MEFs from passage 2 onwards were 




2.11 Generation of SV-40 transformed MEFs 
MEFs close to 70% confluency were transfected with 2µg of the SV-40 –expressing 
plasmid (Constructed by Dirk-Jan Kleinjan, School of molecular, Genetic and 
Population health sciences, University of Edinburgh), using Lipofectamine 2000 
(Invitrogen). Transfected cells were selected with puromycin (2µg/ml) (Invitrogen, 
A11138-03). When transformed MEFs were close to confluency, they were passaged 
and maintained with growth media supplemented with puromycin at 2µg/ml. 
Transformed MEFs were used for experiments till passage 25. 
2.12 Maintainance of TERT-RPE1 cells 
Human telomerase immortalised retinal pigmented epithelial cells (hTERT- RPE1) 
(ATCC, CRL-400) were maintained in DMEM/F12 (Gibco, 31331-028) media 
supplemented with 10% FCS, 1% penicillin/ streptomycin, and sodium bi-carbonate. 
These cells are easy to transfect and also produce a cilium in low serum or upon 
serum srarvation. Thus, they were ideal for my cell culture studies. 
2.13 RNA extraction and cDNA synthesis 
2.13.1 Generation of cDNA libraries 
Tissue from sacrificed mice or embryos was immediately incubated in RNAlater 
(Qiagen, 76104) or Trizol reagent (Life Sciences, 15596-026) to preserve RNA 
integrity. 
2.13.2 RNA extraction 
RNA extraction was performed with either the Trizol reagent or the RNeasy plus kit 
(Qiagen, 74134) according to manufacturer’s instructions. 
2.13.2.1  Trizol 
Cells were lysed in Trizol reagent. Tissues were manually homogenised in TRizol 
reagent with micro pestles on a drive motor. Chloroform was added to separate the 
RNA from the DNA and proteins, by retaining only the upper aqueous phase. RNA 




10899232103) and 100% isopropanol. After centrifugation, the RNA pellet was 
washed with 75% ethanol, briefly dried and resuspended in dH2O.  
2.13.2.2  RNeasy plus mini kit 
 Tissue was homogenised in RLT plus buffer with micro pestles on a drive motor, 
and DNA removed using the genomic DNA eliminator columns. RNA was 
precipitated with 70% ethanol, captured into RNeasy spin column and washed. RNA 
was eluted in dH2O in a clean collection tube. 
RNA concentration and quality was assessed using the nanodrop ND-1000 (Thermo 
Scientific). RNA quality was further validated by the presence of the 28S and18S 
rRNA bands and the absence of smearing when 1µl of RNA was run in a 2% TBE 
gel, supplemented with ethidium bromide, in 1x TBE running buffer. 
2.13.3 DNA elimination 
DNA elimination was accomplished with DNase I (Invitrogen, 18068-015). Up to 
1µg of RNA was incubated with 1µl 10x DNase I reaction buffer, 1µl DNase I and 
dH2O to 10µl for 15 minutes at room temperature. DNase I was deactivated with 
EDTA and a 10-minute incubation at 65°C. 
2.13.4 Reverse transcription 
cDNA was synthesized using Superscript III (Invitrogen, 18080-044). 1 μg RNA was 
mixed with 250ng random primers,10mM dNTP mix and dH2O to 13µl. This was 
incubated at 65°C for 5 minutes, and placed immediately on ice. A reverse-
transcriptase mix was then prepared in ice (4 µl reverse transcriptase 5x buffer, 1 µl 
Superscript III reverse transcriptase, 1 µl 0.1M DTT and 1 µl RNase inhibitor 
[Roche- 03335399001]) and mixed well with the RNA mix. The final mix was 
incubated for 60 minutes at 55°C and then at 70°C for 15 minutes to inactivate the 
reaction. 
2.13.5 cDNA quality control 
The 18S rRNA PCR was used to check the cDNA quality. The MyFi polymerase 




input. The PCR protocol was used as above, except for the annealing temperature at 
61°C and the usage 30 cycles. The PCR products were run in 2% agarose gels in 1% 
TBE, with 1% TBE running buffer. 
2.13.6 Confirming Kdm3a-i2 transcript by RT-PCR 
cDNA from Kdm3a homozygous gene-trapped MEFs was used for the RT-PCR. The 
Phision Flash polymerase (FINNZYMES, Cat. No. F-548) was used for the reaction 
as instructed by the manufacturer (Table 2-5). Primers are in Table 2-6. 
Table 2-5: Kdm3a-i2 PCR protocol 








98 1 minute 
Denaturation 98 1 second 
Annealing 67 5 seconds 
Extension 72 35 seconds 
Repeat cycles Back to step 2 for 29 more 
cycles 
Final extension 72 1 minute 
Table 2-6: Primers to amplify Kdm3a-i2 trancript 








2.14 Protein extraction 
2.14.1 Potein extraction from cultured cells and tissues 
Proteins were extracted from cultured cells and tissues in RIPA buffer (50mM Tris-
HCl, 200mM NaCl, 1% NP40, 0.5% DOC, 0.05% SDS, 2mM EDTA), supplemented 
with protease inhibitors (Roche, Cat. No. 11697498001) and Benzonase Nuclease 
(Novagen, Cat. No. 70746-4). Tissues were homogenised with micro pestles on a 
drive motor. Lysates were incubated on ice for about 20 minutes, vortexing 3-4 times 
during the incubation. They were then centrifuged at full speed (13,300rpm) for 15 
(cultured cells) or 30 minutes at 4
o
C and supernatants transferred in fresh chilled 
tubes. Protein concentration was determined with the Bradford assay. 
2.14.2 Histone extraction from MEFs 
MEFs were harvested by trypsinisation, washed twice with PBS and lysed in Triton 
lysis buffer (0.5% Triton X-100, 2mM PMSF, 0.02% sodium azide) on ice for 10 
minutes, with gentle stirring. Nuclei were pelleted with centrifugation at 6,500 rpm 
for 10 minutes at 4
o
C and the supernatant was discarded. The nuclear pellets were 
washed (resuspended) with Triton lysis buffer and re-centrifuged as before. Histones, 
in the pellet, were extracted with 0.2 N HCl overnight at 4
o
C. The next day, the 
samples were centrifuged to pellet the debris and the histone extracts in the 
supernatant were transferred in fresh tubes. 
2.15 Western blot 
Protein extracts were mixed with 3x loading buffer (240mM Tris-HCl pH6.8, 6% 
SDS, 30% Glycerol, 2.1M β-Mercaptoethanol, 0.06% bromophenol blue), incubated 
at 95
o
C for 5 minutes, loaded into 4-12% NuPAGE pre-cast gels (Invitrogen) or 
15%-SDS in-house made gels (histone extraction) (Resolving gel: 2.3 ml H2O, 5 ml 
30% acrylamide mix, 2.5 ml 1.5M Tris pH 8.8, 0.1 ml 10% SDS, 0.1 ml 10% 
ammonium persulfate and 4 µl TEMED; Stacking gel: 3.4 ml H2O, 0.83 ml 30% 
acrylamide mix, 0.63 ml 1M Tris pH 6.8, 0.05 ml 10% SDS, 0.05 ml 10% 
ammonium persulfate and 5 µl TEMED ) and run at 150 volts at room temperature. 
The proteins were then transferred to nitrocelluloce membranes (Thermo Scientific, 
Cat. No. 88018) for 75 minutes at 4
o




hour at room temperature with 5% milk (Marvel) in PBS/0.1%Tween and incubated 
overnight at 4°C with primary antibodies (Table 2-7). The next day, the membranes 
were washed with PBS/0.1% Tween-20, incubated with secondary antibody (Table 
2-8) at room temperature for 1 hour, washed with PBS/0.1% Tween-20 and 
developed with ECL (Amersham, RPN2109). 
2.16 Immunofluorescence 
Cells grown on coverslips were rapidly but gently washed twice with ice-cold PBS 
and fixed with 4% formalin for 10 minutes at room temperature and washed with 
PBS/0.1% Tween-20. The fixed cells were permeabilised with PBS/0.2% Triton X-
100 for 10 minutes and washed with PBS/0.1% Tween-20. They were then blocked 
for ≥ 1 hours at room temperature (blocking buffer: 1% BSA, 0.1% Triton X-100, 
0.05% Tween-20). They were then incubated overnight with primary antibodies 
(Table2- 8) in blocking buffer, at 4
o
C, in a humidity chamber. The next day, the cells 
were washed with PBS/0.05% Tween-20 and incubated with secondary antibodies 
(Table 2-10) in blocking buffer, for one hour at room temperature in a humidity 
chamber. Following secondary antibody incubation, the cells were washed with 
PBS/0.05% Tween-20 and mounted in Vectashield/DAPI (Vector Labs, H-1000). 
For the pre-extraction, cells were treated with PBS/0.2% Triton X-100 for 40 
seconds followed by immediate fixing as above. 
Table 2-7: Primary antibodies 






Kdm3a Rabbit Proteintech, 13967-
1-AP 
1/600 ---- 
Kdm3a-i2 Rabbit Syd labs 1/2000 ---- 
Kdm3b-NT Rabbit Sigma, 
HPA016610 
1/500 1/100 
Kdm3b-CT Rabbit Bethyl, A300-
833A  
1/500 1/100 






Mouse Sigma, T7451 ---- 1/500 
γ-tubulin Mouse Sigma, T5326 ---- 1/500 
Pericentrin Rabbit Abcam, ab4448 ---- 1/2,000 
GFP Mouse  Invitrogen, A11120 1/500 1/150 
RFP Rabbit Evrogen, AB234 1/5000 ---- 
H3K9me1 Mouse Millipore, 
CMA306 
1/1000 1/300 
H3K9me2 Mouse Abcam, ab1220 1/1000 1/300 
H3K9me3 Mouse Millipore, 
CMA308 
1/1000 1/300 
H3K27me3 Mouse Abcam, ab6002 ---- 1/80 
pan-H3-CT Mouse Millipore, 07-690  1/10,000 ---- 
Islet 1 Mouse DSHB, 39.4D5 
(concentrated) 
 1/200 
Table 2-8: Secondary antibodies used in Western Blot 
Name Host Supplier, Catalog Number Dilution 
Anti-rabbit Donkey GE Healthcare 1/10,000 
Anti-mouse Sheep GE Healthcare 1/10,000 
 
Table 2-9: Secondary antibodies used in immunofluorescence 
Name Host Supplier, Catalog number Dilution 
AlexaFluor anti-mouse 488 Goat Invitrogen, A11017 1/800 
AlexaFluor anti-mouse 594 Goat Invitrogen, A11020 1/800 
AlexaFluor anti-rabbit 488 Goat Invitrogen, A11070 1/800 





hTERT-RPE1 cells were seeded in plates close to confluency, with growth media 
devoid of penicillin and streptavidin and left to settle overnight. Transfections were 
performed with Lipofectamine 2000 (Invitrogen, 11668-027) according to 
manufacturer’s instructions. Briefly, Lipofectamine 2000 and the constructs (Table 
2-10) were incubated with OPTI-MEM separately, mixed and incubated at room 
temperature for 20 minutes. The latter mixes were added to cells for 6 hours. The 
cells were then incubated with growth media for 24 or 48 hours before fixing. For the 
demethylation assays, cells were fixed 24 hours post-transfection. For the ciliation 
experiments, the cells were grown in 0.25% FCS-containing media for 48 hours in 
order to induce ciliation, fixed and processed for immunofluorescence as on section 
2.16. The table below shows the amount of each construct, in ng, transfected in each 
condition. For Western blot experiments, cells were lysed 24 hours post-transfection. 
Table 2-10: Amount of construct transfections in ng 
Construct Per well in 24 well plate 20 cm
2
 corning plate 
Halo-Ms-Kdm3b 400 ---- 
Halo vector 800 ---- 
GFP-Kdm3a-i2 200 4000 
GFP vector 40 2000 
Kdm3a-i2-RFP 200 4000 
Kdm3a-FL-RFP 200 4000 
RFP vector 40 2000 
GFP-γ-tubulin 1000 ---- 





2.18.1 PCR amplification and purification 
The Kdm3a-i2 and Kdm3a-FL isoforms were amplified from wild type testis and 
homozygous gene-trapped Kdm3a MEF cDNA. The zebrafish Kdm3b was amplified 
from an already ordered plasmid (Invitrogen). Primers are listed in Table 2-11. The 
amplification was a two-step process – firstly, the Kdm3 constructs were amplified 
using the Phusion Flash polymerase (Finnzymes, F-548) and then the PCR product 
were used in a second PCR round with Taq platinum polymerase (Invitrogen, 10966-
034) to incorporate T-overhangs and the restriction enzyme cut sites (Table 2-12 & 
2-13). For the zebrafish kdm3b, the first amplification step was omitted, thus the Taq 
platinum polymerase was directly used. The PCR products were purified with the 
QIAquick PCR purification kit (Qiagen, 28104). In case that the PCR contained 
unspecific bands, then, the band of the right molecular size was extracted using the 
QIAquick gel extraction kit (Qiagen, 28704) 
Table 2-11: Primer sequences for cloning of Kdm3 constructs 




















Table 2-12: PCR conditions for the amplification of Kdm3 constructs to be 
inserted in the P-Gem T-easy plasmid vector 












98 1 minute 94 2 minutes 
Denaturation 98 1 second 94 30 seconds 
Annealing 62 5 seconds 62 30 seconds 




Repeat cycles Back to step 2 for 29 more 
cycles 
Back to step 2 for 29 more 
cycles 
Final extension 72 1 minute ---- ---- 
Table 2-13: Primer sequences for subcloning of Kdm3 constructs.  
Red highlight- Xho I restriction site; yellow highlight- Bam HI restriction site; green 
highlight- Sal I restriction site. 





















2.18.2 Cloning/ligation in P-Gem T-Easy vector 
The Kdm3 PCR products were then cloned/ligated in a P-Gem T-easy plasmid vector 
(Promega, A1360), with a single reaction as follows: 1µl P-Gem vector, 1µl T4 
ligase (Promega, M180A), 1µl 10x buffer and 6µl dH2O and 1µl of 1/10 diluted PCR 






2.18.3 Transformation of library efficiency cells 
 Ligated constructs were transformed in Dh5α competent cells (Invitrogen, 18263-
012) as follows: E.coli Dh5α cells were thawed in ice. 1µl of the ligation reaction 
was added to 50µl of Dh5α cells and incubated on ice for 30 minutes. The bacteria 
were then heat shocked for 45 seconds at 42
o
C and replace on ice for 2 more 
minutes. SOC media (0.5% Yeast Extract, 2% Tryptone, 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 10 mM MgSO4, 20 mM Glucose) (950µl) was added to the cells, 
followed by an hour of incubation at 37
o
C with shaking (250 rpm). Cells were plated 
in LB plates (with Ampicillin selection), to which X-Gal and IPTG were added for 
blue-white screening.  
2.18.4 Minipreps and plasmid purification 
Following blue-white screening, bacterial colonies were selected and grown 
overnight (37
o
C with shaking at 250 rpm) in LB supplemented with 50mg/ml 
ampicillin. The next day, the plasmids were purified using the QIAprep spin 
miniprep kit (Qiagen, 27104) and sequenced.  
2.18.5 Restriction enzyme digests and subcloning 
The purified plasmids with the Kdm3 constructs, was well as the pEGFP-C1 
(Clontech, 6084-1) and RFP (Evrogen, FP182) eukaryotic plasmid vectors (both with 
cytomegalovirus immediate early promoters- PCMV IE), were restriction enzyme-
digested overinight at 37
o
C in a water bath. The Kdm3 fragments were then extracted 
using the QIAquick gel extraction kit. Digested vectors were purified with the 
QIAquick PCR purification kit. Digested vectors were then dephosporylated with 
shrimp alkaline phosphatase (SAP) (Affymetrix, 70092Y) for 1 hour at 37
o
C in water 
bath as follows: 1µg digested vector, 4µl 10x SAP buffer, 2µl SAP and 24µl dH2O.  
Subcloning/ligation single reactions: 4µl dH2O, 1µl 10x buffer, 1µl T4 ligase, 
vector and insert with a of 1:3 ratio. Ligation reactions were left overnight at 4
o
C. 
The next day, ligations were transformed in Dh5α cells with antibiotic selection and 
colonies were pick-up for miniprep preparation. Kdm3 construct - vector control 




the appropriate plasmids were then used for maxipreps (Qiagen, 12163). Vector 
maps are represented on Figure 7.7. 
2.19 Quantitative reverse transcriptase PCR (qRT-PCR) 
Performed with the Qiantitect SYBR Green kit (Qiagen, 204243) or Roche 
LightCycler 480 SYBR Green I Master (Roche, 04707516001) as per manufacturer’s 
protocol. Individual reactions totalled 10µl (Qiagen) or 20µl (Roche) with a final 
primer concentration of 0.5mM. Input cDNA in reactions was diluted ½ for Kdm3a 
and 1/10 for the rest. qRT-PCR protocols as listed in Tables 2-14 & 2-15. Primers 
for qRT-PCT are listed in Table 2-16.Relative quantification of gene expression was 
obtained using the comparative CT method. 




Initial denaturation 95 15 seconds 
Denaturation 95 15 seconds 
Annealing 60 30 seconds 
Extension 72 30 seconds 
Back to step 2 for 39 more cycles 
 




Initial denaturation 95 5 minutes 
Denaturation 95 10 seconds 
Annealing 60 30 seconds 
Extension 72 30 seconds 





Table 2-16: qRT-PCR primers 
Primer name Sequence (5’- 3’) 
Kdm3a-i2 Forward GGGACTGGAAGAACATCATGGAAGGA 
Kdm3a-i2 Reverse GTGCCACGATGTTAACACAGGAGT 
Kdm3a-FL Forward TGGGAGCCATAACTTCTGTTCGGT 
Kdm3a-FL Reverse TCAGTAAGGGAAAGCCGAAGACTGT 
Kdm3b-exon1 Forward GCGGTAGTGAGCGGAGATCCTG 
Kdm3b-exon2 Reverse AGCACGTCTTCAGCGTGAACCTTA 
Kdm3b-exon11 Forward ACTGGGTCTGTCGGAAATGTGGAT 
Kdm3b-exon12 Reverse ATGATCTGGGTGGGCATGAGGTTT 
Kdm3b-exon20 Forward ATGGTGTATGTTGGGATCCCTGTC 
Kdm3b-exon21 Reverse TGCCATAAAGCTCCTGGCTTCTCT 
Gh Forward GAAACTGAAGGACCTGGAAGAG 
Gh Reverse GTTGGCGTCAAACTTGTCATAG 
Ghrhr Forward CCATCACTGGCTGGTCTAATC 
Ghrhr Reverse CACCGTGGAGAAGTACGATTT 
Ghr Forward CCCTACTGCATCAAGCTAACTAC 
Ghr Reverse CACGAATCCCGGTCAAACTAA 
Igf1 Forward TGGTGGATGCTCTTCAGTTC 
Igf1 Reverse CTCATCCACAATGCCTGTCT 
Igf1r Forward TAAATACGGGTCGCAAGTCG 
Igf1r Reverse GCTGTATAGTTCCCTGGGTTTAG 
Igfbp3 Forward AACCTGCTCCAGGAAACATC 
Igfbp3 Reverse GGAACTTGGAATCGGTCACT 




Igfals Reverse ACGTTGAAGAGGCCAAAGAA 
Tshb Forward TACTGCCTGACCATCAACAC 
Tshb Reverse GACATCCTGAGAGAGTGCATATT 
Apoa4 Forward CAATGTGGTGTGGGATTACTTTAC 
Apoa4 Reverse GTTTGTCCTGGAAGAGGGTA 
Gapdh Forward CATGGCCTTCCGTGTTCCTA 
Gapdh Reverse CCTGCTTCACCACCTTCTTGAT 
2.20 Zebrafish and Mouse Whole Mount in-situ Hybridisations (WISH) 
2.20.1 Anti-sense riboprobe production 
2.20.1.1 Polymease chain reaction 
PCR products were amplified from cDNA. For zebrafish, the cDNA was 
derived from 4dpf embryos and for mice from wild type MEFs. The standard PCR 
Taq Platinum protocol was followed as in Table 2-17. The PCR products were 
subsequently cleaned using the PCR purification kit. Amplicons were run on a 1% 
TBE gel to verify the presence of a band of the correct size. Primer sequences for 
riboprobe production are listed in Table 2-18. 
Table 2-17: PCR protocol for riboprobe production 












94 2 minute 94 2 minutes 
Denaturation 94 30 seconds 94 30 seconds 
Annealing 60 30 seconds 55 30 seconds 
Extension 72 90 seconds 72 60 seconds 




Final extension 72 1 minute 72 1 minute 
 
Table 2-18: PCR primer sequences for riboprobe production.  
In capital letters are the gene primer sequences and in small letters the T7 RNA 
polymerase promoter sequence 
Riboprobe Primer sequences (5’-3’) 















2.20.1.2 Digoxigenin (DIG) RNA labelling 
The reactions were carried out as instructed by manufacturer (Roche, 
11277073910). Single reactions were performed as follows: 2µl 10x T7 buffer 
(Roche), 2µl 10x DIG RNA labelling mix (Roche), 1µl RNase inhibitor (Promega, 
N2611), 2µl T7 polymerase (Roche, 10881767001), 5µl dH2O. RNA labelling was 
carried out for 2 hours at 37
o
C Removal of double stranded DNA was carried out by 
adding DNase for 15 minutes. The reactions were terminated by adding EDTA, 
followed by Lithium chloride and ethanol to precipitate the riboprobes on dry ice. 
The labelled riboprobes were pelleted by full speed centrifugation at 4
o
C, washed 
with EtOH, air-dried and resuspended in RNase/DNase-free H2O. The concentrations 
were determined by the Nanodrop 1000.  
2.20.2 Zebrafish Whole mount in-situ hybridisation 
2.20.2.1 Rehydration of embryos and hybridisation 
Fixed zebrafish embryos stored in methanol (Dr. Shipra Bhatia, Institute of 
Genetics and Molecular Medicine, University of Edinburgh) were rehydrated in a 




17', 3dpf for 20' and 4dpf for 25') to assist riboprobe penetration. The embryos were 
then PFA re-fixed and blocked in pre-hybridisation mix (50% formadide, 5X SSC, 
0.1% Tween-20, Citric acid at pH6, Heparin, tRNA) for several hours and then 
hybridised with the riboprobe (1/3000 dilution in pre-hybridisation mix) overnight at 
65 °C (water bath). 
2.20.2.2 Washes, blocking and antibody hybridisation 
After the riboprobe hybridisation, the embryos were briefly washed in a 
hybridisation mix (withour tRNA and heparin) and then with an increasing 2x SSC 
series at 65°C (75% hybridisation mix: 25% 2x SSC, 50% hybridisation mix: 50% 2x 
SSC, 25% hybridisation mix: 75% 2x SSC and 2x SSC), followed by a 0.2x SSC- 
PBT series at room temperature ( 0.2x SSC, 75% 2x SSC: 25% PBT,  50% 2x SSC: 
50% PBT, 25% 2x SSC: 75% PBT, 100% PBT). The embryos were then blocked for 
several hours (sheep serum and BSA in PBT) at room temperature, and incubated 
with anti-DIG antibody (1/5000) (Roche, 11214667001) overnight at 4°C. 
2.20.2.3 Washes and staining 
Following the antibody incubation, the embryos were washed extensively in PBT 
and then with the staining buffer (100mM Tris HCl pH9.5, 50mM MgCl2, 100mM 
NaCl, 0.1% Tween-20). Staining was accomplished with NBT and BCIP (50 mg/ml 
NBT, 50 mg/ml BCIP in staining buffer). The embryos were monitored with a 
microscope. The staining reaction was terminated by aspirating the staining solution 
and adding PBS/ 1mM EDTA (3 washes, 5 minutes each).  
2.20.3 Mouse whole mount in-situ hybridisation 
2.20.3.1 Embryo collection and dehydration 
Embryos at E9.5, E10.5 and E11.5 were dissected in PBS and fixed in 4% 
PFA overnight. They were then washed with PBT (PBS/0.1% Triton X-100), 
dehydrated through a MeOH- PBT series (25% MeOH: 75% PBT, 50% MeOH: 50% 




2.20.3.2  Rehydration and prehybridisation 
Embryos were rehydrated through a MeOH- PBT series (75% MeOH: 25% 
PBT, 50% MeOH: 50% PBT, 25% MeOH: 75% PBT), bleached with H2O2 for 1 
hour, proteinase K treated (E9.5 for 10', E10.5 for 20' and E11.5 for 30') and re-fixed 
with 0.2% gluteraldehyde/4% PFA for 20 minutes at room temperature. They were 
then incubated overnight in pre-hybridisation mix (50% formamide, 5X SSC, 
50µg/ml Heparin, 2% blocking powder [Roche, 11096176001], 0.5% CHAPS, 5mM 
EDTA, 100 µg/ml yeast tRNA, 0.1%Triton X-100 and H2O to the desired volume) 
overnight at 65°C. 
2.20.3.3 Hybridisation and post-hybridisation washes 
Following incubation in the pre-hybridisation mix, the embryos were 
incubated overnight with the hybridisation mix (ribiprobe dilution 1/2000 in pre-
hybridisation mix). They were then washed 2 time for 5 minutes with solution A 
(50% formamide, 5X SSC pH8, 0.1% Triton X-100, 0.5% CHAPS), and then with 
50% solution A: 50% (2x SSC; 0.1% CHAPS) for 5 minutes, 2x SSC: 0.1% CHAPS 
for 1 hour, 0.2x SSC: 0.1% CHAPS for 1 hour and left overnight in 1X TBST at 4°C. 
All the above washes were performed at 65°C. 
2.20.3.4 Blocking and antibody hybridisation 
 Embryos were blocked in 10% inactivated sheep serum in TBST buffer for 
several hours and incubated with anti-DIG antibody in blocking buffer (1/5000) 
overnight at 4°C. 
2.20.3.5 Washes and staining 
Following the antibody incubation, the embryos were washed extensively (1 
full day of only washes) in TBST and then with the NTMT (100mM NaCl, 100mM 
Tris HCl pH9.5, 50mM MgCl2, 0.1% Triton X-100) staining buffer. Staining was 
accomplished with NBT and BCIP in NTMT in the dark. For embryos >E10.5, 
levamisole was added in the staining buffer to block endogenous alkaline 
phosphatases. The staining was monitored with a microscope.Once the colour 




terminated by PBS/ 1mM EDTA (3 washes, 5 minutes each). The embryos were 
0.1% gluteraldehyde/4% PFA post-fixed for 20 minutes at room temperature and 
stored in PBS at 4°C. 
2.21 Protein alignments 
Protein sequences were retrieved the from the Uniprot website 
(http://www.uniprot.org/) and aligned in Clusta; Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/) Protein accession numbers are listed in 
Table 2-19. 
Table 2-19: Uniprot protein accession numbers for Kdm3 subfamily members 
Protein Accession number 
Human KDM3A Q9Y4C1 
Mouse Kdm3a Q6PCM1 
Human KDM3B Q7LBC6 
Mouse Kdm3b B9EKS2 
Human JMJD1C Q15652 
Mouse Jmjd1c G3UZM1 
Human HAIRLESS O43593 
Mouse Hairless Q61645 
Zebrafish kdm3 E7F3X7 
2.22 Nuclear localisation signal predictions 
The prediction of nuclear localisation signal was performed with the cNLS mapper 
(http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi), which predicts 
importin α-dependent nuclear localisation signals, and also NLStradamus 
(http://www.moseslab.csb.utoronto.ca/NLStradamus/) which employs a hidden 




2.23 Image acquisition and analysis 
2.23.1 Macroscope 
The Nikon AZ100 macroscope was employed for brightfield imaging of embryos. 
Image acquisition was accomplished using Micropublisher 5.0 (Qimaging) camera 
and IPLab software (Scanalytics).  
2.23.2 Fluorescence microscope 
For visualisation of immunofluorescence in cultured cells, theAxioskop 2 
fluorescence microscope (Carl Zeiss) was used, with Plan neofluar objectives(Carl 
Zeiss) and a triple-band filter set (Chroma technology, series 83000). Image 
acquisition was performed with the Coolsnap HQ2 CCD camera (Photometrics) and 
scripts written for the IPLab (Scanalytics) software. 
2.23.3 Dotslide microscope brightfield microscopy 
The slide scanning system is based around an Olympus BX51 upright microscope 
(Olympus KeyMed, Southend on Sea, UK) with Marzhauser motorized stage 
(Marzhauser Wetzlar GmbH & Co, Wetzlar, Germany). The system uses Olympus 
plan Apochromat and UplanS Apochromat objective lenses with magnifications from 
2x-40x. Images are acquired using an Olympus XC10 colour CCD camera, with a 
x20 magnification lens. All hardware is controlled through Olympus Dotslide VS-
ASW software. 
2.24 Fluorescence-activated cell sorting 
The thymus was retrieved from p23 mice. It was mashed through a 40µm cell 
strainer in PBS and the cells were counted. The same number of cells were pipette in 
eppendorf  tubes, the volume was brought to 100µl and the antibodies were added 
(for 5 million cells: 0.25µl CD4, 0.1µl CD8, 1µl CD25, 1µl CD44). OneComp beads 
(eBiosciences, 01-1111-42) were incubated with each antibody as positive controls. 
A negative cell control without antibodies was also used. The samples were 
incubated for 30 minutes in the dark at room temperature. Following antibody 




and then  re-suspended in 200µl PBS (experimental samples) or 100µl PBS (control 
samples). FACS sorting was performed using a BD FACSAriaII cell sorter (Becton 
Dickinson). Data acquisition was performed with the BS FACSDiva software version 
6.1.3 (Becton Dickinson) (Dr.Elizabeth Freyer, Institute of Genetics and Molecular 
Medicine, University of Edinburgh) and analysed with the FloJo software (FloJo 
LLC, 385 Williamson Way, Ashland, Oregon, 97520) (Dr. Andrew Wood, Institute 
of Genetics and Molecular Medicine, University of Edinburgh). All antibodies were 
from eBiosciences: CD4-FITC (11-0042-81), CD8-PE (12-0081-81), CD25-APC780 
(47-0251-80) and CD44-e450 (48-0441). 
2.25 Quantifications and statistics 
2.25.1 Ciliation assays 
Percentage ciliation in transfected cells was divided to the percentage ciliation in 
untransfected neighbouring cells. The resultant normalized ciliation in three 
repetitions was averaged and compared with the t test. If the p-value <0.05, then 
there is a significant difference between the datasets. 
2.25.2 Demethylation assays 
50-100 cells were counted and divided into two categories: 1) unchanged 
fluorescence and 2) reduced or absence fluorescence. Statistical analysis was 
performed with the Fisher’s exact test (2x2 contingency table) using the results of the 
EGFP-C1 or RFP vectors as the comparison. If the p-value <0.05, then there is a 
significant difference between the datasets. 
2.25.3 qRT-PCR 
Normalised and calibrated values were compared with the t-test. If the p-value <0.05, 
then there is a significant difference in the gene expression between the genotypes. 
2.25.4 Mouse weights 
Mouse weights between genotypes were compared with one-way ANOVA test. If the 




2.26 Densitometric analysis 
2.26.1 Western blot 
Densitometric analysis of the western blots were performed using the Gel Analysis 
Tool from Image J (Rasband, W.S., ImageJ, U. S. National Institutes of Health, 
Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2014). The relative density 
of Kdm3a and histone epigenetic bands were normalized to the relative density of the 
corresponding α-tubulin or pan-H3 bands, respectively. Results for the histone 
extraction western blot were compared with the one-way ANOVA test. If the p-value 



























 At present, there is no information on whether the demethylase function for 
the KDM3 family members is conserved through evolution beyond the mouse and 
human studies. Previous synteny analysis, by Dr. Philippe Guatier (Institute of 
Genetics and Molecular Medicine, University of Edinburgh), show that the human 
and mouse genomes contain all four KDM3 family members: KDM3A, KDM3B, 
JMJD1C and HAIRLESS. However, the zebrafish genome only contains two of the 
four demethylases: kdm3b and jmjd1c (kdm3a and hairless are missing) (Figure 3.1). 
Through over-expression assays, it was shown that the human KDM3B functions as 
an H3K9me1 and H3K9me2 demethylase, whereas the demethylation potential of 
JMJD1C is still controversial (Brauchle et al., 2013; Kim et al., 2010; Kuroki et al., 
2013b; Sroczynska et al., 2014). In this study: I investigate 1) whether the zebrafish 
kdm3b functions as histone demethylase, 2) how the human, murine and zebrafish 
KDM3B orthologues are related in terms of protein sequence and 3) the localisation 





Figure 3.1: Genomic synteny in human, mouse and zebafish genomes suggest 
that KDM3A and HAIRLESS (HR) are absent from the zebrafish genome. 
In human and mouse genomes, KDM3 subfamily genes are in synteny with receptor 
accessory protein (REEP) genes, known to affect the endoplasmic reticulum shaping 
(Park et al., 2010; Schlaitz et al., 2013; Voeltz et al., 2006). In the zebrafish genome, 
kdm3a is absent from its genomic position, and the hailess genomic has been 
replaced by the adam metallopeptidase domain 9 (adam9). It is a member of the 
ADAM (a disintegrin and metalloprotease domain) family of membrane anchrored 
proteins, which are involved in cell to cell and cell to matrix interactions (White, 
2003). kdm3b and jmjd1c are uncharacterised genes in the zebrafish genome, with 




deserts are areas of the genome that contain no genes. Gene symbols:  IMMT- inner 
membrane protein, mitochondrial; MRPL35- mitochondrial ribosomal protein L35; CHMP3- charged 
multivesicular body protein 3; RNF103- ring finger protein 103; NT5C1A- 5'-nucleotidase, cytosolic 
IA; HSPA4L- heat shock protein 4 like; CDC25C- cell division cycle 25C; FAM53C- family with 
sequence similarity 53, member C; EGR1- early growth response 1; ETF1- eukaryotic translation 
termination factor 1; RAN- RAN, member RAS oncogene family; NDUFS8- NADH dehydrogenase 
(ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase); EGR2- early growth response 2; 
NRBF2- nuclear receptor binding factor 2; CYP26A1- cytochrome P450, family 26, subfamily a, 
polypeptide 1; EXOC6- exocyst complex component 6; FAM160B2- family with sequence similarity 
160, member B2; NUDT18- nudix (nucleoside diphosphate linked moiety X)-type motif 18; LGI3- 
leucine-rich repeat LGI family, member 3; SFTPC- surfactant protein C. 
3.2 Results 
  Searching for a kdm3a or kdm3b orthologue in the zebrafish genome 
Previous data on genomic synteny around the KDM3 family members in 
humans, mice and zebrafish showed that zebrafish have lost kdm3a and hairless (Dr. 
Philippe Guatier, Institute of Genetics and Molecular Medicine, University of 
Edinburgh). To compare how similar the predicted zebrafish kdm3b is to the mouse 
Kdm3a and Kdm3b, I blast searched in the ZFIN website (zfin.org) using the mouse 
Kdm3a or Kdm3b protein as the query sequences. Both searches generated the same 
top hits (XP_005173195.1, XP_005173197.1, XP_005173198.1, XP_005173199.1, 
E7F3X7), which were labelled as uncharacterised proteins or predicted lysine 
demethylase 3B isoforms. Alignment of these predicted sequences resulted in 97% 
identity (data not shown), therefore all the entries encoded the same protein, with a 
small sequence variation between them. The results suggested that the zebrafish 
genome contains not both but one of the kdm3a or kdm3b paralogues. 
To identify which paralogue is present in the zebrafish genome, I aligned the 
predicted zebrafish E7F3X7 protein sequence, which is the only one found in 
Uniprot (http://www.uniprot.org/), with the KDM3A or KDM3B human and mouse 
sequences. I chose the E7F3X7 sequence because an independent in silico prediction 
(by Philippe Gautier) resulted in 99% sequence identity with this zebrafish sequence.  
Alignment of the human (Uniprot ID: Q9Y4C1) and mouse (Q6PCM1) 
KDM3A with the zebrafish E7F3X7 prediction resulted in 34.4% sequence identity 
(616 identical positions) (for complete alignments see Figure 7.2). The human and 




sequence alignment of the human and mouse JmjC domain (both spanning 224 
amino acids), I was able to identify zebrafish JmjC domain (232 amino acids). All 
species shared 78% identity (181 positions) (Figure 3.2- yellow and brown 
highlights), whereas human-mouse comparison yielded a 98.6% (221 positions) 
identity. Within the zinc finger, all species showed 77% (20/26) identity, with all 
cysteine residues conserved (Figure 3.2- blue and grey highlight). Notably, the 
human and mouse zinc fingers were 100% (26/26) identical. In addition, there was 
80% (4/5) identity within the nuclear receptor motif between all three species 
(Figure 3.2- green highlight). Human and mouse nuclear receptor motifs were 100% 
(5/5) identical. All iron (II) [Fe (II)] and α-ketoglutarate (α-KG) binding sites within 
the JmjC domains, critical for the demethylase activity, were conserved in all species 
(Figure 3.2- red highlight and blue highlight, respectively).  
 
Figure 3.2: Alignments of the human and mouse KDM3A and zebrafish kdm3b 
domains and motifs.  
Light blue highlight: zinc finger with cysteine residues in grey; green highlight: 
nuclear receptor motif; yellow and brown highlights: JmjC domain; red highlights: 
predicted iron binding sites; blue highlights: α-ketoglutarate binding sites; DANRE: 
Danio rerio (zebrafish) HUMAN: Homo sapiens, MOUSE: Mus musculus. Complete 




* indicates fully conserved residue 
: indicates residues of strongly similar properties 
. indicates residues of weakly similar properties 
Similar properties of amino acids are defined by the presence of: hydrophobic 
aliphatic side chains, hydrophobic aromatic side chains, polar neutral side chains, 
electrically charged-acidic side chains, electrically charged-basic side chains and 
covalent cross-linking (disulfide bonds). 
 
I then compared the human (Uniprot ID: Q7LBC6) and mouse (B9EKS2) 
KDM3B protein sequences with the zebrafish prediction (for complete alignments 
see Figure 7.3). All three homologues shared 48% identity (921 positions), whereas 
human and mouse homologues were 93% identical (1648 positions). 
Within the JmjC domain, all three species shared 84% identity (195 positions) 
(Figure 3.3-yellow and brown highlights). Human and mouse domains were 98% 
identical (221 positions). The predicted Fe(II) and α-KG binding sites within the 
JmjC domain (Figure 3.3- red and blue highlights respectively) were conserved in all 
species. In addition, there was 100% sequence identity between species for the zinc 
finger (blue highlight- 26 amino acids) and the nuclear receptor sequences (green 
highlight- 5 amino acids).  
Thus, zebrafish E7F3X7 has a higher level of sequence identity to mammalian 
KDM3B than KDM3A, both across the entire protein and within the key JmjC 
domain, the zinc finger and the nuclear receptor motif. Therefore I will refer it 





Figure 3.3: Alignments of the human, mouse and zebrafish Kdm3b domains, 
motifs and predicted nuclear localisation sequences.  
Purple highlight: predicted nuclear localisation signal by NLStradamus; underline: 
predicted nuclear localisation signal by cNLS Mapper; light blue highlight: zinc 
finger with cysteine residues in grey; green highlight: nuclear receptor motif; yellow 
and brown highlights: JmjC domain; red highlights: predicted iron binding sites; blue 
highlights: α-ketoglutarate binding sites. DANRE- Danio rerio (zebrafish), 
HUMAN-Homo sapiens, MOUSE- Mus musculus. Complete sequence alignments 
on Figure 7.3. 
* indicates fully conserved residue 
: indicates residues of strongly similar properties 
. indicates residues of weakly similar properties 
Similar properties of amino acids are defined by the presence of: hydrophobic 
aliphatic side chains, hydrophobic aromatic side chains, polar neutral side chains, 
electrically charged-acidic side chains, electrically charged-basic side chains and 




3.2.1.1 Prediction of nuclear localisation signal in KDM3B orthologues 
To carry out their histone demethylation function, all KDM3B orthologues 
must be imported to the nucleus, thus they should contain a nuclear localisation 
signal (NLS) (Lange et al., 2007). To predict potential NLS in the KDM3B 
orthologues, I primarily used the cNLS Mapper (Kosugi et al., 2009). The algorithm 
predicts classical importin α/β pathway NLS based on the yeast genome sequences 
(http://nls-mapper.iab.keio.ac.jp/cgi-bin/NLS_Mapper_form.cgi). cNLS Mapper 
predicted the bipartite NLS of human and mouse KDM3B to localise to 282-305 and 
283-306 respectively (22 identical positions out of 24, thus 98% identity) (Figure 
3.3- underlined regions). The software was unable to predict any NLS in the 
zebrafish protein sequence. 
Since the zebrafish kdm3b localises to the nucleus (for example see Figure 
3.7), I used a second prediction algorithm called NLStradamus (Nguyen Ba et al., 
2009) (http://www.moseslab.csb.utoronto.ca/NLStradamus/). The algorithm 
predicted NLS through a simple Hidden Markov model based again on yeast genome 
sequences. NLStradamus predicted the NLS of human, mouse and zebrafish KDM3B 
to localise to 265-288, 266-289 and 256-273, respectively (Figure 3.3-purple 
highlight). The NLS of all species show 21% identity (5 positions). Human and 
mouse NLS were 96% identical (23 out of 24 positions). A comparison between 
mouse and zebrafish sequences yielded 25% identity (6 positions) and 8 similar 
positions, showing the the zebrafish prediction could as well represent a NLS. 
Although the predicted NLS sequences derived from the two websites were not 
identical, they partly overlapped (human and mouse predictions) and combined 
covered a stretch of about 40 amino acids. 
The data suggest that the human and mouse predicted NLSs are almost 
identical. The predicted zebrafish NLS has a different sequence, but could represent 




3.2.2 Cloning of the zebrafish kdm3b  
Human KDM3B functions as a mono- and di-methyl lysine 9 histone 3 
(H3K9me1/2) demethylase (Brauchle et al., 2013; Kim et al., 2012). To test whether 
the demethylation function is maintained in the zebrafish kdm3b, I carried out over 
expression-based demethylation assays. For these experiments, kdm3b cDNA was 
synthesized on a plasmid vector (Life technologies, vector backbone pMA-T) based 
on an earlier in silico prediction (Dr. Philippe Gautier, Insitute of Genetics and 
Molecular Medicine, University of Edinburgh). I then sub-cloned it in an pEGFP-C1 
vector, with a N-terminal GFP tag (GFP-Zf-kdm3bΔ2aa). When translated, this 
kdm3b protein prediction was missing two conserved amino acids, which were 
present in the current zebrafish Uniprot prediction (E7F3X7) and also in the human 
and mouse KDM3A and KDM3B homologues (Figure 3.4- yellow highlight). This 
two amino acid- deletion was closest to the zinc finger (Figure 7.2 and 7.3- dark 
grey highlight) Thus, the two amino acids were added (Dr. Patricia Yeyati, Insitute 
of Genetics and Molecular Medicine, University of Edinburgh), recreating a WT 
(GFP-Zf-kdm3b) and a deletion mutant (GFP-Zf-3bΔ2aa) GFP reporter constructs.  
 
Figure 3.4: The two amino acids absent in GFP-Zf-3bΔ2aa zebrafish kdm3b are 
evolutionarily conserved. 
Alignment of human, mouse and zebrafish KDM3B and also of the human and 
mouse KDM3A orthologues around the site of mutation (yellow highlight) showed 
that the two amino acids absent in the zebrafish kdm3b mutant construct are 
conserved. 
I validated the size of both GFP-tagged kdm3b constructs by over-expressions 
in TERT-RPE1 cells followed by Western blot. The GFP antibody detected the GFP-
Zf-kdm3b band of about 250 kilodalton (kDa) and the GFP vector band of 30 kDa, 
but no bands in the untransfected cell lysate (Figure 3.5 - GFP). An antibody against 
a C-terminal epitope conserved in human, mouse and zebrafish Kdm3b (Figure 3.5 - 




lower bands in Figure 3.5 B may represent degradation products or the loss of the 
GFP tag from the over-expressed protein. An antibody against an N-terminal epitope 
of human KDM3B (Figure 3.5 - KDM3B-NT), not conserved in zebrafish kdm3b, 
was used as a negative control. As expected, it did not pick up the over-expressed 
GFP-Zf-kdm3b or GFP-Zf-3bΔ2aa, but recognised the endogenous human KDM3B 
in all three conditions/lanes of a predicted size of about 190 kDa. 
I then validated the specificity of the antibodies by immunofluorescence. Both 
the GFP and KDM3B-CT antibodies recognised the GFP-Zf-3bΔ2aa over-expression 
(Figure 3.5C,D). When the KDM3B-CT was used, the low fluorescence nuclear 
signal in the neighbouring untransfected cells represented the endogenous KDM3B 
of the TERT-RPE1 cells. The KDM3B-NT antibody picked up only the endogenous 
KDM3B in all cells, as the KDM3B fluorescent intensity in transfected versus 
untransfected cells remained unchanged (Figure 3.6E). Also, the KDM3B-CT 
antibody did not recognise the GFP protein tag (Figure 3.6F). 
The results showed that kdm3b was correctly cloned and validated the 









(A-B) Western blot of TERT-RPE1 cell lysates. TERT-RPE1 cells were tranfected 
with GFP-Zf-3bΔ2aa, GFP-Zf-kdm3b, GFP vector or left untransfected. The GFP 
antibody recognised the GFP-Zf-3bΔ2aa, GFP-Zf-kdm3b and the GFP vector 
protein. The KDM3B-CT antibody recognised the over-expressed GFP-Zf-3bΔ2aa 
and GFP-Zf-kdm3b. The two lower bands in the GFP-Zf-kdm3b blot may represent 
degradation products or the loss of the GFP tag from the over-expressed protein. The 
KDM3B-NT antibody whose epitope is not present in the zebrafish kdm3b picked up 
the endogenous KDM3B of the TERT-RPE1 cells. α-tubulin was used as a loading 
control. Numbers beside the Western blot are molecular weight markers in kDa. (C-
F) GFP and KDM3B antibody validation. GFP-ZF-3bΔ2aa or the GFP vector were 
transfected in TERT-RPE1 cells. (C) The GFP antibody recognised the over-
expressed GFP-Zf-3bΔ2aa. (D) The KDM3B-CT antibody recognised the over-
expressed GFP-Zf-3bΔ2aa. The low nuclear fluorescence intensity in the 
untransfected cells represented the endogenous KDM3B. (E) The KDM3B-NT 
antibody, used as a negative control, recognised only the endogenous KDM3B. (F) 
The KDM3B-CT antibody did not recognise the over-expressed GFP tag. Scale bar: 
20 μm. 
3.2.2.1 The two amino acid deletion within GFP-Zf-3bΔ2aa affects its subcellular 
localisation 
The GFP-Zf-kdm3b and GFP-Zf-3bΔ2aa transfections had a noticeable 
difference in relation to their subcellular localisation. Figure 3.6 provides an 
example. In Figure 3.6A, GFP-control hTERT-RPE1 transfected cells showed both 
nuclear and cytoplasmic localisation (arrowheads). In figure 3.6B three out of five 
GFP-Zf-kdm3b transfected cells showed nuclear localisation (arrows), whereas the 
other two had both nuclear and cytoplasmic localisation (arrowheads). In contrast, all 
three GFP-Zf-3bΔ2aa transfected cells (Figure 3.6C) showed nuclear-cytoplasmic 
localisation (arrowheads). The difference in the distribution of these two constructs 
was quantified. While GFP-Zf-kdm3b was 69% (162/235) nuclear and 31% (73/235) 
nuclear-cytoplasmic, the GFP-Zf-3bΔ2aa was 28% (48/172) nuclear and 72% 
(124/172) nuclear-cytoplasmic (Figure 3.6C). The nuclear fluorescence in the 
nuclear-cytoplasmic category tended to be stronger than that of the cytoplasmic for 
both constructs. Fisher’s exact test (2x2 contigency table) resulted in a significant 
difference between the localisation of the two constructs (p< 0.0001). The 





The results suggested that the two amino acid deletion in GFP-Zf-3bΔ2aa 
affected its subcellular distribution. This could be due to changed folding of the 
mutant protein, affecting the binding of the nucleo-cytoplasmic shuttling complex. 
 
Figure 3.6: GFP-Zf-3bΔ2aa shows a higher nuclear-cytoplasmic localisation 




(A) All of the GFP vector transfected cells show nuclear and cytoplasmic 
localisation. (B) Three GFP-Zf-kdm3b transfected cells show nuclear localisation 
while the other two show nuclear-cytoplasmic localisation. (C) All three GFP-Zf-
3bΔ2aa transfected cells showed nuclear-cytoplasmic localisation. Arrowheads 
indicate nuclear-cytoplasmic localisation whereas arrows indicate nuclear 
localisation. (D) The subcellular localisation of GFP-Zf-kdm3b and GFP-Zf-3bΔ2aa 
was quantified. GFP-Zf-kdm3b showed 69% nuclear localisation and 31% nuclear-
cytoplasmic localisation. In contrast, GFP-Zf-3bΔ2aa showed 28% nuclear and 78% 
nuclear-cytoplasmic localisation. The GFP vector control showed 100% nuclear-
cytoplasmic localisation. The numbers in bars represent the number of cells 
counted.The difference in sub-cellular localisation between the constructs is 
statistically significant. ** = significant, Fisher’s exact test p<0.0001.  Scale bar: 20 
μm. 
3.2.2.2 In low serum growth media, the zebrafish and human KDM3B can function 
as H3K9me2 demethylases 
The human KDM3B functions as an H3K9me1/2 demethylase (Brauchle et al., 
2013; Kim et al., 2012). To investigate the demethylation function of human 
KDM3B is evolutionary conserved, GFP-tagged zebrafish Kdm3b constructs were 
transfected in TERT-RPE1 cells, in low serum (0.25% FCS). Twenty-four hours post 
transfection, the cells were fixed and processed for immunofluorescence with 
antibodies against the epigenetic marks H3K9me1, H3K9me2 and H3K27me3. Cells 
were divided into two categories: a) transfected cells with unchanged fluorescence of 
the epigenetic marks and b) transfected cells with reduced or absent fluorescence of 
the epigenetic marks. Loss or reduction of the epigenetic mark fluorescence indicated 
that the zebrafish kdm3b constructs can function as demethylase enzymes. The 
results from the over-expressions were then compared to the results of their 
respective vectors by Fisher’s exact test (2x2 contingency table). The fluorescence of 
H3K9me1/2 and H3K27me3 epigenetic marks was evaluated twenty four hours post-
transfection. Quantifications were presented as the percentage of transfected cells 
with unchanged fluorescence. As a positive control, a murine Kdm3a isoform (GFP-
Kdm3a-i2) was also transfected. The latter isoform functions as both a H3K9me1 
and H3K9me2 demethylase (discussed in Chapter 5). One hundred cells (100) per 




Neither the GFP-Zf-kdm3b nor the GFP-Zf-3bΔ2aa transfections significantly 
affected the H3K9me1 fluorescence compared to the GFP vector (Figure 
3.7A,B,D,E- Fisher’s exact test: GFP-Zf-kdm3b, p= 0.77; GFP-Zf-3bΔ2aa, p= 0.33). 
The GFP-Kdm3a-i2 positive control transfection resulted in 65% (65/100) 
decreased/absent H3K9me1 fluorescence. The difference was statistically significant 
(Fisher’s exact test, p< 0.0001) (Figure 3.7C,E). Moreover, the Halo-Hm-Kdm3b 
(Kazusa, pFN21A HaloTag CMV Flexi vector), used as another positive control for 
the assay, did not significantly affect the H3K9me1 fluorescence (Figure 3.7E- 
Fisher’s exact test, p= 0.37). This result could be due to low expression levels for the 
Kdm3b constructs, which do not suffice to cause the demethylation effect. 
In contrast, 39% (39/100) of the GFP-Zf-kdm3b transfected cells showed 
reduced the H3K9me2 fluorescence intensity compared to neighbouring 
untransfected cells (Figure 3.9A,E- Fisher’s exact test- p< 0.0001). Notably, the 
GFP-Zf-3bΔ2aa was unable reproduce this effect (0%- 0/100) (Figure 3.9B,E- 
Fisher’s exact test- p=1). As expected, GFP vector transfection did not affect the 
H3K9me2 fluorescence (0%- 0/100). The GFP-Kdm3a-i2 construct, used as a 
positive control for the assay, caused global demethylation of the H3K9me2 mark 
(Figure 3.8C,E- Fisher’s exact test, p < 0.0001).  
The Halo-Hm-Kdm3b transfection reduced the H3K9me2 fluorescence 
intensity in 9% (9/100) compared to neighbouring untransfected cells, whereas the 
Halo vector did not (0%- 0/100) (Figure 3.8E- Fisher’s exact test, p < 0.0001).  
The fluorescence of H3K27me3 mark, used as a negative control, was 
unchanged for all transfections (0%- 0/100). The p-value for all comparisons was 1; 
therefore none of the transfections produced a significant result (Figure 3.9A-E). 
Under the experimental conditions used, both GFP-Zf-kdm3b and Halo-Hm-
Kdm3b can function as H3K9me2, but not H3K9me1, demethylases. GFP-Zf-
3bΔ2aa was unable to decrease H3K9me2 fluorescence. To further validate this 
result, the fluorescence signal in transfected versus untransfected cells should be 




employed. Furthermore, in agreement with previous published data, Halo-Hm-
KDM3B was able to demethylate both H3K9me1 and H3K9me2, when the cells 
were maintained in 10% FCS (Figures 7.4 – 7.6). 
 
Figure 3.7: In low serum growth media, over-expressed zebrafish and mouse 
Kdm3b do not affect the fluorescence signal of the H3K9me1 mark.  
(A-B) The GFP-Zf-kdm3b and GFP-Zf-3bΔ2aa transfections did not reduce the 




control for the assay, caused global demethylation of the H3K9me1 mark, whereas 
(D) the GFP tag protein had no effect. (E) Bar chart showing the percentage of cells 
with unchanged H3K9me1 fluorescence for all transfections. ** = significant, 
Fisher’s exact test p<0.05. Yellow circles indicate nuclei of transfected cells. Scale 
bar: 10 μm.  
 
Figure 3.8: In low serum growth media, over-expressed zebrafish and mouse 




(A)The GFP-Zf-kdm3b construct decreased the fluorescence of the H3K9me2 mark 
compared to neighbouring untransfected cells, but (B) the GFP-Zf-3bΔ2aa did not. 
(C) The GFP-Kdm3a-i2 construct, used as a positive control for the assay, caused 
global demethylation of the H3K9me2 mark, whereas (D) the GFP-tag protein had 
no effect. (E) Bar chart showing the percentage of cells with unchanged H3K9me2 
fluorescence for all transfections. ** = significant, Fisher’s exact test p<0.05. Yellow 





Figure 3.9: In low serum growth media, the zebrafish and mouse Kdm3b do not 
affect the fluorescent intensity of the H3K27me3 mark.  
(A-D) Transfections with GFP-Zf-kdm3b, GFP-Zf-3bΔ2aa, GFP vector, Halo-Ms-
Kdm3b and the Halo vector did not affect the H3K27me3 fluorescence intensity. (E) 
Bar chart showing the percentage of cells with unchanged H3K27me3 fluorescence 





3.2.2.3 Over-expressions of GFP-Zf-kdm3b and GFP-Zf-3bΔ2aa result in reduced 
ciliation efficiency 
Unpublished data by Dr. Patricia Yeyati (Insitute of Genetics and Molecular 
Medicine, University of Edinburgh) showed that morpholino knock-down of kdm3b 
in zebrafish recapitulates ciliary phenotypes such as body curvature, hydrocephalus, 
situs inversus and reduced number of otoliths (personal communication). However, it 
is unknown if this effect is due to the histone lysine demethylation potential of 
kdm3b or through a demethylase-independent function. 
To investigate the putative role of kdm3b in ciliation, I over-expressed GFP-
Zf-kdm3b, GFP-Zf-3bΔ2aa, and the controls GFP-Kdm3a-i2 and GFP vector 
inTERT-RPE1 cells. The cells were allowed to ciliate in 0.25% FCS growth media 
for forty-eight hours before fixation. Ciliation was assessed by using the ciliary 
marker IFT88. The percentage of ciliated transfected cells was then normalised to the 
percentage of ciliated neighbouring untransfected cells to obtain a normalised 
percentage of ciliation. 
Compared to a 10% ciliation reduction in GFP vector transfected cells (37/112) 
when normalised to ciliation in neighbouring untransfected cells (50/137), the GFP-
Zf-kdm3b and GFP-Zf-3bΔ2aa transfections resulted in 59% and 58% reduction, 
respectively (GFP-Zf-kdm3b: transfected cells – 13/133; untransfected cells – 
33/140, GFP-Zf-3bΔ2aa: transfected cells – 11/101; untransfected cells – 30/116)  
(Figure 3.10). 
The results show that increased levels of zebrafish kdm3b in the cell hinder its 
ability to ciliate. Since both the GFP-Zf-kdm3b and GFP-Zf-3bΔ2aa were able to 
produce the same effect, and GFP-Zf-3bΔ2aa did not decrease histone methylation 
(Figure 3.7 and 3.8), it can be suggested that the effect on ciliation loss is 
disconnected from the histone demethylase/enzymatic function of kdm3b. The 
experiment was performed once, therefore, more replicas are necessary to further 





Figure 3.10: Over-expressing GFP-Zf-kdm3b and GFP-Zf-3bΔ2aa results in 
reduced ciliation efficiency.  
Representative images of ciliated and non-ciliated GFP-Zf-kdm3b and GFP-Zf-
3bΔ2aa transfected cells. One out of two GFP-Zf-kdm3b and one out of three GFP-
Zf-3bΔ2aa transfected cells (circled with yellow dashed lines) are ciliated (arrows). 
Cilia were marked with the intraflagellar transport  protein 88 (IFT88). Transfected 
cells are circled with yellow dashed lines and cilia of transfected cells are indicated 




reduction, whereas the GFP-Zf-kdm3b and GFP-Zf-3bΔ2aa transfections resulted in 
59% and 58% reduction, respectively. 
3.2.3 Investigating Kdm3b spatial expression in zebrafish and mouse by whole 
mount in situ hybridisation 
Spatial gene expression is often conserved between species during 
development, since the proteins has to fulfil the same (evolutionary conserved) 
functions. One such example is Sox2. Within the developing retina, Sox2 is expressed 
in retinal neural progenitors and as development proceeds, it is downregulated. Its 
expression is maintained in some amacrine cells both in mice and zebrafish. 
However, some differences between species exist. That is, although Müller glial cells 
maintain Sox2 expression in mice, these cells are sox2 negative in zebrafish (Pujic et 
al., 2006; Taranova et al., 2006). 
To check the spatial expression of Kdm3b in zebrafish and mice during 
development, I performed whole mount in situ hybridisation in a number of 
embryonic stages for both species. For zebrafish, I used 1-4 days post fertilisation 
(dpf) and for mice, the embryonic stages 9.5-11.5 (E9.5-E11.5). 
kdm3b was widely expressed in zebrafish at 1 dpf, with elevated expression 
levels in the hindbrain (Figure 3.12A-hb). At 2 dpf, expression was restricted to the 
brain region with higher expression in the otic vesicles (Figure 3.12B and B’-ov). At 
3 dpf expression in the brain and otic vesicles was still present. In addition, kdm3b 
expression appeared in the gut (or intestinal bulb) (Figure 3.12C-gut). At 4 dpf, 
kdm3b was maintained in the brain and gut and possibly appeared in the swim 





Figure 3.11: Whole mount in situ hybridisation on zebrafish embryos.  
(A) At 1dpf, kdm3b was widely expressed with higher levels in the hindbrain (hb). 
(B, B’) The expression became restricted in the brain at 2 dpf, with increased 
expression in the otic vesicles (ov). (C) At 3 dpf, expression was still present in the 




in the brain, otic vesicles and gut was maintained at 4 dpf . It was possibly expressed 
in the swim bladder (sb) and the pronephric duct (pd). Scale bars: 250 μm. 
In mouse embryos, Kdm3b was widely expressed at all stages (Figure 3.13A-
C). The sense probe (for the Kdm3b probe) was used as a negative control and 
resulted in no staining (Figure 3.13D-F). Sox2 probe was used as a positive control 
for the technique. It displayed the expected Sox2 expression in the brain, eyes and 
neural tube (Figure 3.13G-I) (Ellis et al., 2004). 
 
Figure 3.12: Kdm3b expression in mouse embryos.  
(A-C) Kdm3b was widely expressed at all stages. (D-F) The sense probe (of the 
Kdm3B probe) was used as a negative control and resulted in no staining. (G-I) The 





Alongside, I checked the expression of Kdm3b in tissues of adult mice by 
Western blot, loading 100 μg of protein for all tissues except the white adipose tissue 
(WAT) where I loaded 50 μg. 
The Kdm3b band between 150 and 250 kDa (as determined by the MEFs 
Western blot in Figure 3.13) was present in lysates from many tissues such as the 
pituitaty gland, spleen, testis, eye, heart, lungs, WAT and thymus. Long exposure 
times of membranes also brought up Kdm3b in the pancreas, brown adipose tissue 
(BAT) and the brain (Figure 3.13A,B). Kdm3b was not detected in the kidney and 
liver under the experimental conditions used. 
 Another prominent band at about 55 kDa was present in a number of tissues 
such as the spleen, testis, eye and the thymus. This band may represent a Kdm3b 
alternatively spliced isoform that includes both N- and C-terminal Kdm3b sequences 
present in the full-length isoform. This was supported by the thymus Western blot, 
where the N- and C-terminal KDM3B antibodies revealed the same band on two 





Figure 3.13: Kdm3b was expressed in many adult tissues.  
Western blot of tissue lysates from wild type adult mice. (A) Using the 
KDM3B-NT antibody, Kdm3b protein (arrowhead) was expressed in the pituitary 
gland, spleen, testis, eye, heart, lungs and WAT. Long exposures of membranes also 
showed Kdm3b expression in the pancreas, BAT and the brain. (B) Both the 
KDM3B-NT and KDM3B-CT antibodies picked up Kdm3b in the thymus. The 55 
kDa band (arrow) recognised by both antibodies may represent an alternative Kdm3b 
isoform. Numbers beside the Western blot are molecular weight markers in kDa. 
Under the experimental conditions used, zebrafish showed a more restricted, 




3.2.4 Summary of chapter 3 
Based on the genomic synteny data by Philippe Gautier kdm3a was lost from the 
zebrafish genome, whereas kdm3b was present. Through blast searches and protein 
alignments, I showed that the zebrafish orthologue is closest to the mouse Kdm3b 
than Kdm3a. I subcloned and tagged the zebrafish kdm3b with GFP and found that it 
shows mainly nuclear localisation, whereas a deletion mutant was predominantly 
both nuclear and cytoplasmic. In addition, demethylation assays showed that the 
zebrafish kdm3b could function as a di-methyl lysine 9 histone 3 (H3K9me2) 
demethylase, whereas a deletion mutant could not. Based on previous unpublished 
data that kdm3b zebrafish morphants recapitulate ciliopathy phenotypes, over-
expression of tagged kdm3b in cultured cells resulted in ciliation reduction. Finally, 
Kdm3b whole mount in situ hybridisations showed that zebrafish had a restricted 
spatial expression whereas mouse embryos a widespread expression. Murine Kdm3b 
is widely expressed, both in embryogenesis and adulthood. (Dr. Patricia Yeyati, 



























The aim of this study was to dissect the phenotype of Kdm3b gene-trapped mice. 
The decision for the phenotypic dissection was based on previous unpublished data 
(Dr. Patricia Yeyati, Insitute of Genetics and Molecular Medicine, University of 
Edinburgh) that the zebrafish kdm3b morphants show the classical ciliopathy 
phenotypes, such as body curvature, hydrocephalus, situs inversus and reduced 
number of otoliths. A potential involvement of Kdm3b in ciliary function is novel, as 
no other demethylase gene trap or knock-out mouse model was previously shown to 
affect the ciliary structure or function. 
4.1 Results 
4.1.1 Gene trap and validation of Kdm3b depletion 
4.1.1.1 The Kdm3b gene-trap and genotyping strategy 
To investigate the biological role(s) of Kdm3b in development and adult life, a 
mouse model was generated, from ES cells that contained the gene trap in intron 1 of 
the Kdm3b locus (ES cell clone: EUCE305b07, EUCOMM). It consisted of a strong 
splice acceptor site, a β-gal/neomycin (β-geo) sequence that allowed the selection of 
positive embryonic stem (ES) cells by G418 treatment and the visualisation of the 
targeted gene expression in vivo (Figure 4.1A).  
Genotyping was accomplished by three independent PCR reactions. One 
amplified the wild type allele (A-B), the other the gene-trapped allele (A-C) and the 
last PCR amplified part of the β-gal sequence within the gene trap. Wild type mice 
whose Kdm3b alleles do not contain the gene trap only amplify the A-B primer pair 
band. Heterozygous gene-trapped mice have a wild type allele and a gene-trapped 
allele. For this reason, all three primer pairs produced a band. As expected, 
homozygous gene trapped mice, whose both alleles contained the gene trap failed to 
amplify the A-B (wild type) primer pair, but did amplify the other two (A-C and  β-





Figure 4.1: The Kdm3b gene trap and genotyping strategy.  
(A) The gene-trap was inserted in intron 1 of the Kdm3b locus and consisted of a 
strong splice acceptor site (SA), a β-gal/neomycin (β-geo) sequence and a poly A 
(pA) sequence. Positions of genotyping primers are indicated. (B) The wild type 
allele was amplified by a PCR reaction with the A-B primer pair, present in wild type 
and heterozygous gene-trapped mice. The gene trap allele, present in heterozygous 
and homozygous gene-trapped mice was amplified by the A-C primer pair. The A-C 
primer pair results were confirmed with the β-gal PCR reaction. 
4.1.1.2 E18.5 homozygous embryos closely follow Mendelian ratios but mice more 
than two week old do not 
Chimeric male Kdm3b gene-trapped mice were crossed with C57BL/6J 
females to generate heterozygous gene-trapped offspring. Heterozygous males were 
backcrossed for one generation with C57BL/6J females. I started setting up crosses 
from generation one heterozygous male and females, to obtain homozygous gene-
trapped mice. 
To check if homozygotes follow Mendelian ratios prenatally, I genotyped six 
litters of E18.5 embryos. The chi-square test, comparing observed to expected 
numbers, resulted in p=0.038, which suggests a statistically significant difference 
between the three genotypes (Table 4-1). The significant difference result is possibly 
due to the small number of litters analysed. Homozygotes, however, closely followed 




Table 4-1: Homozygous E18.5 embryos closely follow Mendelian ratios. 
N represents the total number of mice from 6 litters. 
N= 42, p=0.038 Wild type Heterozygote Homozygote 
Observed 5 29 8 
Expected 10.5 21 10.5 
In addition, I counted the numbers of postnatal mice of all three genotypes, 
earclipped from postnatal week two onwards. The number of homozygous gene-
trapped mice was reduced compared to the expected value. I carried out a chi-square 
test of observed versus expected numbers (for all three genotypes) for a total of 19 
litters. The chi-square test showed that there is a significant difference (p= 0.007) and 
therefore the genotypes did not follow Mendelian ratios. (Table 4-2). 
Table 4-2: More than two week old earclipped mouse litters of heterozygous 
pairs do not follow Mendelian ratios.  
N represents the total number of mice from 19 litters. 
N= 116, p=0.0007 Wild type  Heterozygote Homozygote 
Observed 25 74 17 
Expected 29 58 29 
  The analysis of Mendelian ratios of pre-natal embryo and post-natal mouse 
litters indicates that the reduction in the numbers of homozygous mice can be 
narrowed to the first two weeks of post-natal age. Further analysis of genotypes 
during the first two post-natal weeks is important to investigate the possibility of 
peri-natal lethality; for example, genotyping of litters at post-natal day 2 (p2). 
Moreover, I checked whether backcrosses to C57BL/6J females generated 
wild type to heterozygous mice at a ratio of 1:1, for a total of 42 litters. The p-value 
was 0.9, suggesting that there is no statistically significant difference between the 





Table 4-3: Backcrosses generated the expected 1:1 ratio of wild type to 
heterozygous mice 
N represents the total number of mice from 42 litters. 
N= 268, p= 0.9 Wild type Heterozygote 
Observed 134 132 
Expected 133 133 
4.1.1.3 Kdm3b is significantly reduced in homozygous gene-trapped mice 
In order to investigate whether the gene-trap results in significant reduction of 
Kdm3b expression, quantitative reverse-transcriptase PCR (qRT-PCR), Western blot 
and immunofluorescence experiments were employed. 
To check the transcript levels in all three genotypes, I performed qRT-PCR 
using cDNA from E9.5 embryos. Three primer pairs across the Kdm3b transcript 
(exons 1-2, exons 11-12 and exons 20-21) were used. The first primer pair flanked 
the gene trap (exons 1-2) and the other two were more 3’ (exons 11-12 and exons 20-
21). The purpose of using three primer pairs along the transcript was to check 
whether transcription continued after the gene-trap sequence or the presence of 
possible transcripts with alternative start sites not affected by the gene-trap insertion. 
The qRT-PCR results were analysed pairwise, using the t-test. 
There was reduced Kdm3b expression in heterozygous and no expression in 
homozygous E9.5 embryos (Figure 4.2). The results were not significant for the 
exons 1-2 primer pair possibly due to variation in the Ct values of wild type and 
heterozygous biological replicas (+/+ vs -/-, p= 0.50; +/+ vs +/-, p= 0.06; +/- vs -/-, 
p= 0.05 ). For exons 11-12, there was a statistically significant difference between 
wild types and heterozygotes (p=0.004), wild types and homozygotes (p< 0.0001) 
and heterozygotes and homozygotes expression levels (p= 0.0012). The same was 
true for the exons 20-21; there as a statistically significant difference between wild 
types and heterozygotes (p=0.0005), wild types and homozygotes (p< 0.0001) and 





Figure 4.2: Kdm3b expression is reduced in heterozygous and absent in 
homozygous gene-trapped E9.5 embryos.  
qRT-PCR across the Kdm3b transcript using three primer pairs. For each primer pair, 
the wild type Kdm3b expression was used as a calibrator. In all three primer pairs, 
heterozygous Kdm3b expression is reduced and the homozygous expression is barely 
detectable. The results were not significant for the first primer pair, but were highly 
significant for the other two primer pairs. ** = significant, t-test p<0.05. Error bars 
represent ± standard error. +/+ : wild type; +/- : heterozygotes; -/- : homozygotes. 
Western blot on MEF lysates (Figure 4.3), using both an N-terminal 
(KDM3B-NT) and a C-terminal (KDM3B-CT) antibody, showed that compared to 
the wild type Kdm3b protein levels, there was less Kdm3b protein in the 
heterozygous MEFs (the band between 150 and 250 kDa, with a predicted size of 
190 kDa). No Kdm3b protein was detected with either antibody in Kdm3b 





Figure 4.3: The Kdm3b protein is reduced in the heterozygous and is absent in 
the homozygous gene-trapped MEFs.  
Western blot using antibodies against an N-terminal (KDM3B-NT) and a C-terminal 
(KDM3B-CT) epitope of Kdm3b. Compared to the wild type MEFs Kdm3b protein 
band (arrowhead), there was less Kdm3b protein in the heterozygous MEFs and no 
Kdm3b protein in the homozygous MEFs. The bands of lower molecular weight 
possibly represent unspecific bands. α-tubulin was used as a loading control. 
Numbers beside the Western blot are molecular weight markers in kDa.  
 Further, Western blot on adult tissues (eyes and spleen) validated the 
significant reduction of Kdm3b protein levels (Figure 4.4). Although no Kdm3b 
band was present in homozygous-derived extracts under short exposures when 
blotting with the KDM3B-NT antibody (arrowhead for the full length protein), a 
faint band was in some cases visible when the membranes were exposed for a longer 
time. The significant Kdm3b reduction in homozygous tissues was further confirmed 
with the KDM3B-CT antibody, again with a faint full length band in the eye extract 
of the first homozygote. In addition, the loss of the ~55 kDa band in homozygous 






Figure 4.4: Kdm3b is significantly reduced in adult tissues of homozygous 
Kdm3b gene-trapped mice. 
A Western blot for Kdm3b was performed using eye and spleen extracts of adult 
mice of all genotypes. Both the N-terminal (KDM3B-NT) and C-terminal (KDM3B-
CT) antibodies were used. Kdm3b full-length protein (arrowheads) is significantly 
reduced in homozygous gene-trapped mice, as evidenced by the long exposure with 
the KDM3B-NT antibody. An additional band at about 55 kDa (arrows), was lost in 
homozygous-derived tissues, and therefore appeared to be Kdm3b-specific, 
representing a shorter isoform. Numbers beside the Western blot are molecular 
weight markers in kDa. 
In wild type MEFs, immunofluorescence revealed strong nuclear Kdm3b 
localisation with both antibodies, as confirmed by DAPI staining (Figure 
4.5A,B,E,F). The result was not surprising since it is already known that the human 




2012). In homozygous MEFs the nuclear localisation of Kdm3b was absent (Figure 
4.5C,D,G,H). 
Further immunofluorescence on wild type or heterozygous adult tissues, eyes 
and testis, revealed that Kdm3b is expressed in the nucleus of pachytene 
spermatocytes in testis (Figure 4.6), and also in the ganglion cell layer (faint 
staining), inner nuclear layer and outer nuclear layer in the eyes (Figure 4.7). Under 
this experimental method, Kdm3b expression was absent in the tissues of 
homozygous gene-trapped mice. 
The results from the qRT-PCR, Western blot, immunofluorescence 
experiments indicated that the homozygous Kdm3b gene-trapped mice had 





Figure 4.5: The Kdm3b protein is absent in homozygous MEFs.  
Immunofluorescence of wild type (+/+) and homozygous (-/-) gene-trapped MEFs 
using both KDM3B-NT and KDM3B-CT antibodies. (A-B, E-F) Both antibodies 
show strong nuclear localisation in wild type MEFs. (C-D, G-H) The nuclear 





Figure 4.6: Immunofluorescence Kdm3b expression is testis. 
 (A,C,D, E,G,H) In heterozygous (+/-) adult testis, Kdm3b is expressed in pachytene 
spermatocytes and is absent in the testis of homozygous (-/-) gene-trap mice. (B,F) 
Acetylated alpha tubulin was used as a positive control for the assay, and marks the 





Figure 4.7: Immunofluorescence of Kdm3b expression in the eyes. 
(A,C,D) In the eyes of wild type mice, Kdm3b is expressed in the ganglion cell layer 
(GCL), the inner nuclear (INL) and outer nuclear layer (ONL). (E,G,H) A higher 
magnification showed that Kdm3b is nuclear in the INL but cytoplasmic in the ONL. 
(I,K,L) Kdm3b was absent in the eyes of the homozygous mice. (B,F,J) Islet 1 was 
used as a positive control for the assay, and marks a subset of the GCL and INL cells. 
Scale bars: 50 μm. 
4.1.2 Adult homozygous gene-trapped mice are small 
The next step was to characterise the phenotype of heterozygous and 
homozygous gene-trapped mice. Homozygous mice presented a small body size 
compared to wild type and heterozygous littermates (Figure 4.8A). Both sexes were 




age. The homozygous mice were significantly underweight compared to wild type 
(Tukey, p= 0.0000009) and heterozygous (Tukey, p= 0.0000009) mice. There was no 
statistically significant difference in weight between wild type and heterozygous 
mice (Tukey, p= 0.4301627) (Figure 4.8B). 
The small size phenotype of the homozygous gene-trapped mice was further 
validated by Alcian blue- Alizarin Red skeletal preparations (Figure 4.9). The 
preparations showed no gross skeletal abnormalities in homozygous mice. 
Furthermore, the homozygous mice failed to thrive and died, for example some 
died at 2 weeks, others at 4, 6 or 10 weeks. Although no survival curve was produced 
for the time of death, only one homozygous gene-trapped mouse survived up to 10 





Figure 4.8: Homozygous gene-trapped mice presented a small body size and are 
lighter than wild type and heterozygous gene-trapped mice. 
(A) Homozygous mice were small compared to their wild type and heterozygous 
littermates. (B) Dot plot of weight (at six weeks of age) versus genotype. The lines 
represent the median values. Homozygous mice were significantly underweight 
when compared to wild type or heterozygous mice. There was no statistically 
significant difference in weight between wild type and heterozygous mice. The 






Figure 4.9: The skeleton of gene-trapped mice is not grossly deformed. 
Alcian blue- alizarin red skeletal preparations were performed for 6-week old wild 
type, heterozygous and homozygous gene-trapped mice. The preparations revealed 
no gross skeletal abnormalities in gene-trapped  mice. 
The reduced body size phenotype of the Kdm3b homozygous mice was 
confirmed by a second gene-trap mouse line (ES cell clone: EUCE0244g12, 
EUCOMM) (Figure 4.10C). In this mouse line, the gene trap was inserted in intron 
11 of the Kdm3b locus (Figure 4.10A). The gene trap has the same features as the 
one inserted in intron one: a strong splice acceptor site (SA), a β-geo sequence and a 
poly A (pA) tail. Again, genotyping followed the same logic: an A-B primer pair for 
the amplification of the wild type allele, an A-C primer pair for the amplification of 
the gene-trap allele and a β-gal primer pair to further confirm the presence of the 
gene trap (Figure 4.10B). No further work has been undertaken with this mouse line. 
Collectively, the data show that the reduction in body size is due to the 





Figure 4.10: A second gene-trap line for Kdm3b confirms the small body size 
phenotype of the homozygous mice.  
(A) The gene-trap was inserted in intron 11 of the Kdm3b locus and consisted of a 
strong splice acceptor site (SA), a β-gal/neomycin (β-geo) sequence and a poly A 
(pA) sequence. Positions of genotyping primers are indicated. (B) The genotyping 
strategy. The wild type allele was amplified by a PCR reaction with the A-B primer 
pair, present in wild type mice. The gene trap allele, present in homozygous gene-
trapped mice was amplified by the A-C primer pair. The A-C primer pair results 
were confirmed with the β-gal PCR reaction. (C) Picture of a homozygous small 
mouse (top) and a wild type littermate (bottom). 
4.1.2.1 Growth retardation commences post-natally 
To determine whether the growth retardation of homozygous mice commences 
pre-natally or post-natally, I initially weighted (to two decimal places) E18.5 
embryos from six litters of heterozygous pairs (Figure 4.11A). One-way ANOVA 
test showed that there was no statistically significant difference in weight between 




Having established that homozygous embryos are not growth retarded in utero, 
I carried out weight monitoring of heterozygous pair litters at post-natal day 14 (p14) 
and p21, to determined the timing of growth retardation. 
The data showed that growth retardation was already evidenced at p14 and was 
maintained at p21. The difference in weight between wild type or heterozygous to 
homozygous mice was statistically significant at p14 (One-way ANOVA, p= 0.02 
and p= 0.01). The same was true for p21 (One-way ANOVA, p< 0.001 and p< 0.001) 
(Figure 4.12). Also, between p14 and p21, homozygous mice gained minimal, if 
any, weight and this was reflected from the p-value result of 0.97. 
Pre-natal and post-natal weight measurements indicate that growth retardation 
commences post-natally. Further weight monitoring at younger post-natal ages is 





Figure 4.11: Growth retardation of homozygous mice does not commence pre-
natally.  
(A) Picture of E18.5 embryos of all genotypes. (B) Dot plot of E18.5 embryo weights 
(from six litters) versus genotype. There was no statistically significant difference in 
weight between genotypes. The lines represent median values. Numbers below 





Figure 4.12: Growth retardation is already evidenced from p14.   
Mice of all genotypes were weighted on p14 and p21. Both at p14 and p21, wild type 
or heterozygous mice were significantly heavier than homozygous mice. The lines 
represent median values. Numbers below genotypes represent number of embryos. 
One-way ANOVA, **= p< 0.05 
4.1.3 Investigating perturbations of the growth hormone and thyroid hormone 
pathways 
4.1.3.1 Kdm3b does not function as a global H3K9me1/2 demethylase 
Previous knock-out mouse models have shown that post-natal growth is 
determined by the expression of hormones (Alba and Salvatori, 2004; Efstratiadis, 
1998; Eicher and Beamer, 1976; Fraichard et al., 1997; Zhou et al., 1997). The 




prompted me to investigate possible perturbations in the expression of the growth 
and thyroid hormone pathway genes.  
Firstly, I checked in more detail Kdm3b localization in MEFs. Kdm3b showed 
a widespread nuclear localisation. It was depleted from the nucleoli regions (dark 
regions in DAPI staining indicated by the yellow circles) and the pericentric 
heterochromatin regions, which are transcriptionally silent (bright DAPI staining, 
few indicated by the red asterisks) (Figure 4.13).  
The immunofluorescence results suggested that Kdm3b localised in 
euchromatic regions of the MEFs nuclei. 
 
Figure 4.13: Kdm3b shows a widespread nuclear localisation and is excluded 
from nucleoli and heterochromatic regions.  
Immunofluorescence on wild type MEFs with the KDM3B-NT antibody. Nuclear 
Kdm3b localisation was assessed by comparison to DAPI staining. The Kdm3b 
protein showed a widespread nuclear localisation. It was excluded from the nucleoli 
(yellow circles) and heterochromatic regions (red asterisks). Scale bars: 10 μm. 
The 93% sequence identity between the human and mouse KDM3B 
orthologues,and a further 98% and 100% identity within the JmjC and Zinc finger 
domains, respectively, suggests that the mouse Kdm3b can function as a H3K9me1/2 
demethylase, although no demethylation assays were carried out. To test whether 
Kdm3b loss can result in global alternations of H3K9me1/2 levels, I carried out a 
Western blot of MEF histone protein extracts from all genotypes. I used the 
antibodies for the H3K9me1/2 epigenetic marks and also H3K9me3 as control 




to pan-histone 3, used as a loading control, for all genotypes and epigenetic marks, to 
derive to the adjusted relative density. Three biological replicates were used for wild 
type, two for heterozygous and two for homozygous gene trapped MEFs. An 
ANOVA test for each epigenetic mark showed that there was no statistically 
significant difference in the adjusted relative density between genotypes (H3K9me1: 
p= 0.38; H3K9me2: p= 0.72; H3K9me3: p= 0.99) (Figure 4.14B). 
The results showed that Kdm3b loss does not have detectable effects on the 
global H3K9me1/2 methylation. However, its sequence similarity with the human 
orthologue suggests a potential demethylation function. 
 





Histone proteins from MEFs of all genotypes were isolated by acid extraction. (A) 
Western blot analysis of H3K9me1/2/3 epigenetic marks resulted in no differences 
between genotypes. Pan-histone 3 antibody was used as a loading control. Numbers 
beside the Western blot are molecular weight markers in kDa. (B) The western blot 
results were quantified and compared for all genotypes. There was no statistically 
significant difference in adjusted relative intensity between genotypes for any 
epigenetic mark. One-way ANOVA test. Error bars represent ± standard deviation. 
4.1.3.2 Investigating perturbation in the growth and thyroid hormone pathways 
I checked the expression levels of genes involved in the growth hormone 
pathway. qRT-PCR results from wild type and heterozygous mice were pooled 
together (Co= control), as heterozygous mice do not show a growth retardation 
phenotype. I analysed gene expression from three wild type, three heterozygous and 
four homozygous mice. The expression levels were compared with the t-test. 
 Ghrhr (p= 0.08) and Gh (p= 0.20) expression, in the pituitary glan was not 
statistically significant between controls and homozygotes. In the liver, the 
expression of the Ghr (p= 0.33), Igf1 ( p= 0.22), Igf1r (p= 0.06) and Igfbp3 (p= 0.80) 
were again not statistically significant.. However, the expression of Igfals was 
statistically significant between controls and homozygotes (p= 0.0098) (Figure 
4.15). 
Moreover, the levels of Tshb, involved in the thyroid hormone pathway, were 
significantly increased in homozygous pituitary glands (p= 0.028), but the levels of 
the thyroid hormone pathway target gene Apoa4 (Weitzel et al., 2003) were not 
significantly altered. (p= 0.11) (Figure 4.16). 
Altogether, the qRT-PCR results suggest not significant perturbations of the 






Figure 4.15: Gene expression analysis for the growth hormone pathway. 
qRT-PCR of pituitary gland and liver. In the pituitary gland, there was no statistical 
change in the levels of the Ghrhr and Gh between controls and homozygotes. In the 
liver, expression of the Ghr, Igf1, Igf1r and Igfbp3 were again not statistically 
significant, while Igfals levels were significantly reduced in homozygues liver. t-test, 






Figure 4.16: Gene expression analysis for the thyroid hormone pathway 
qRT-PCR of pituitary gland and liver RNA extracts. Tshb expression levels were 
significantly increased in homozygous mice pituitary glands and Apoa4 levels were 
not significantly altered in controls and homozygous liver extracts. t-test, ** p< 0.05 
Error bars represent ± standard error. Co= wild type and heterozygous; Ho= 
homozygous. 
4.1.4 The gross morphology of several organs of Kdm3b gene-trapped 
homozygous mice was unaffected 
To check whether any organs of the Kdm3b homozygous gene-trapped mice 
were affected by the absence of Kdm3b protein, I paraffin embedded and sectioned 
several organs. 
Hematoxylin and eosin staining (H&E) of eyes, kidney, pancreas and testis 
grossly suggested no changes in the overall tissue organisation of homozygous mice. 
In the eye sections, retinal layers such as the ganglion cell layer (GCL), the inner 
nuclear layer (INL) and the outer nuclear layer (ONL) were present (Figure 4.17A). 
The kidneys contained the characteristic round renal corpuscles located in the renal 
cortex (Figure 4.17B- arrowheads), while the pancreas contained the white coloured 
islets of Langerhans (Figure 4.17C- circles) and the ducts that carry digestive 
enzymes to the stomach (Figure 4.17C- arrows). Moreover, spermatogenesis is not 
affected in homozygous mice as they produce mature spermatozoa (Figure 4.17D), 
as revealed by the presence of stage 6-7 spermatids and mature spermatozoa (stage 




The small size of homozygous mice could imply reduced feeding and 
subsequent utilisation of fat stores for energy provision. To check for the presence of 
fat depots, p28 mice were dorsally skinned (Jacek Mendrychowski, Transgenics 
facility) (Figure 4.18). I chose weaned mice to eliminate the mother effect (as a food 
provider) and to check whether the homozygous mice could independently feed 
sufficiently to maintain their fat depots. I compared wild type, heterozygous and 
homozygous littermates of the same sex (all females). The comparison showed that 
homozygous mice maintained all the fat depots that were visible from the dorsal side, 
such as the brown adipose tissue (BAT), the anterior subcutaneous, the visceral 
retroperitoneal and the posterior subcutaneous. The weight of fat depots in 
proportion to total body weight was not recorded. 
Therefore, apart from the small body size phenotype, examination by 
hematoxylin and eosin of several organs of homozygous mice revealed the gross 
morphology was unaffected. In addition, fat deposits were still present suggesting 








Figure 4.17: The gross morphology of several organs of homozygous adult mice 
was unaffected, as determined by hematoxylin and eosin staining.  
(A) All cell layers are present in the of homozygous eye section; GCL-ganglion cell 
layer, INL- inner nuclear layer, ONL- outer nuclear layer. (B) Kidneys contained 
renal corpuscles (arrowheads). (C)The Islets of Langerhans (circles), as well as the 
ducts (arrows) for digestive enzyme excretion, were present in the pancreas. (D) 
Spermatogenesis was completed in the testes. Scale bar: A-C:100 μm; D: 10 μm. 
 
Figure 4.18: Homozygous gene-trap mice maintain their fat deposits.  
Female littermates (one wild type, one heterozygote and two homozygote) at p28 
were skinned dorsally and presence of fat deposits was assessed. Homozygous mice, 
like the wild type and heterozygous littermates, maintain their brown adipose tissue 
(BAT), anterior subcutaneous (AS), visceral retroperitoneal (VR) and posterior 
subcutaneous (PS) deposits. Genotype, weight in grams and percentage weight 




4.1.5 Reduced weight and heterogeneous thymus phenotype in homozygous 
gene-trapped mice  
To gain insights into the phenotype causation, a litter of mice, which included 
two homozygotes, was sent for necropsy analysis (Dr. Mary Diaz, Centre for 
Cardiovascular Science, University of Edinburgh). The analysis confirmed the 
previous H&E results of Figure 4.17 that the majority of organs remain grossly 
unaffected. However, an interesting finding from the necropsy analysis was that the 
thymuses of both homozygotes were missing the cortical cell layer (Figure 4.19B), 
whereas thymuses of wild type mice consisted of both the cortical and medullary cell 
layers (Figure 4.19A- Co, Me). Moreover, the thymuses of both mice were reduced 
in weight, which was validated by normalising the thymus weight to total body 
weight; in other words, the weight of the thymuses in homozygous mice was not in 
proportion to the body weight when compared to the values obtained for the wild 
type and heterozygous gene-trapped mice. The ratio revealed a 3-4 times reduction in 
homozygous gene trapped-mice (Table 4-4). Unpaired t-test statistics revealed that 
there was no significant difference in thymus weight between the wild type and 
heterozygous gene trapped mice (p= 0.51). However, there was a significant weight 
difference between wild type and homozygous (p= 0.02), as well as between 
heterozygous and homozygous gene trapped mice (p< 0.0001). 
 
Figure 4.19: Kdm3b homozygous gene-trapped mice were missing the cortical 
cell layer.  
Thymuses of homozygous and wild type littermates were sectioned and stained with 




(A) The thymus of wild type mice comprised of the cortical (Co) and medullary (Me) 
cell layers. (B) The thymus of homozygous mice was reduced in size and was 
missing the cortical cell layer. Scale bar: 500 μm. 
 
Table 4-4: Thymus weight and thymus weight\body ratio were reduced in 
homozygous gene trapped mice 
Genotype Body weight 
(g) 
Thymus (mg) Thymus/body weight 
ratio 
Average ratio (± 
standard deviation) 
+/+ 11.8 80.9 6.9 
6.25 (± 0.92) 
+/+ 13.2 74 5.6 
+/- 14.4 96 6.7 
6.63 (± 0.21) +/- 13.5 87 6.4 
+/- 16.2 110 6.8 
-/- 5.6 8.7 1.6 
1.70 (± 0.14) 
-/- 6.7 12 1.8 
To confirm the abnormal thymus phenotype in homozygous gene-trapped 
mice, more thymuses from all three Kdm3b genotypes were isolated, sectioned and 
H&E stained (Figure 4.20). The stains revealed a normal thymic cell layers for the 
heterozygous thymuses, like the wild type (Figure 4.20A, B). The thymuses of 
homozygous gene-trapped mice showed a heterogeneous phenotype, including 
normal cortical and medullary layers (Figure 4.20C), reduced cortical layers (Figure 
4.20D) and loss of the two layers’ identity to what seems more cortical-like in 






Figure 4.20: Thymuses of homozygous gene-trapped mice show a range of 
phenotypes. 
H&E stains of thymus sections of wild type, heterozygous and homozygous gene-
trapped mice. (A, B) wild type and heterozygous gene-trapped mice show normal 
thymic cell layering, with the cortical layer sourrounding the internal medullary 
layer. (C - F) The thymuses of homozygous gene-trapped mice show a range of 
phenotypes, such as normal cortical-medullary layers (C), reduced cortical layer (D) 
and loss of thymic layer identity (E, F). Co= cortex, Me= medulla. Scale bar: 500 
μm. 
 Furthermore, immunohistochemistry on thymus sections revealed that 
Kdm3b is expressed in both the medullary and cortical layers, with more positive 
cells in the medulla. In line with the significant reduction of Kdm3b gene expression 
in homozygous gene-trapped mice, as demonstrated before, the thymuses of the latter 






Figure 4.21: Kdm3b is densly expressed in the medulla and more sparsly 
expressed in the cortex. 
 (A, B) Immunohistochemistry for Kdm3b revealed that it is expressed both in the 
cortical and medullary layers. Its expression is more dense in the medulla. (C- E) 
Kdm3b expression is lost in the homozygous mice, irrespective of normal or 
abnormal thymic cell layering. Co= cortex, Me= medulla. Scale bar: 100 μm. 
 In summary, a proportion of Kdm3b homozygous gene-trapped mice show 
abnormal thymic cell layering. This observation suggests possible defects in T-cell 




4.1.6 T-cell maturation is maintained in the thymuses of homozygous gene-
trapped mice 
The abnormal thymic architecture in a proportion of homozygous mice 
implied a plausible perturbation of T-cell maturation. For this season, I characterised 
the profile of maturing T-cells in the thymus of p23 mice, using the cell surface 
markers CD4, CD8, CD25 and CD44. 
The thymus is a specialised organ of the immune system, responsible for the 
commitment and education of early lymphoid progenitors to the T-cell lineage. 
These processes are accomplished through an elaborate course of positive and 
negative selection, which ensures the elimination of T-cells that are reactive to self-
presenting antigens (Figure 4.22) (Bhandoola et al., 2007; Ciofani and Zúñiga-
Pflücker, 2007; Lind et al., 2001; Petrie and Zúñiga-Pflücker, 2007; Zlotoff and 
Bhandoola, 2011). 
 
Figure 4.22: Maturation and selection of T-lymphocytes 
The lymphoid progenitors, known as double negative 1 (DN1), enter the thymus at 
the cortico-medullary junction (CMJ) and proliferate extensively. They are 




(CD44+ CD25-). DN1 cells differentiate into DN2 cells (CD44+ CD25+), which 
continue to proliferate in order to further expand the cell population. DN2 cells then 
migrate to the cortical subcapsular zone (SCZ) and become DN3 cells (CD44- 
CD25+). The latter cells are now terminally committed to the T-lymphocyte lineage. 
At this stage, the cells can further differentiate to become αβ-lineage or γδ-lineage T 
cells by rearranging their β, γ and δ T-cell receptor (TCR) gene loci. T-lymphocytes 
towards the γδ lineage do not require further differentiation. DN4 (CD44- CD25-) 
become double positive (DP), defined by the expression of the surface markers CD4 
and CD8 (CD4+ CD8+), further proliferate. Double positive cells undergo T-cell 
receptor alpha rearrangement, downregulate one of the two cell surface markers 
(either CD4 or CD8) to become single positive cells (SP) and enter the medulla. 
They then undergo negative selection to remove cells that show strong reaction to 
self-antigens. SP cells that pass the negative selection, exit the thymus and move to 
the periphery (Bhandoola et al., 2007; Ciofani and Zúñiga-Pflücker, 2007; Zlotoff 
and Bhandoola, 2011). cTEM= cortical thymic epithelial cells; mTEC= medullary 
thymic epithelial cells. 
 
 Since heterozygous mice present with a normal thymic architecture, I 
combined the results of the wild type and heterozygous thymuses together. I analysed 
the data from two wild type, six heterozygous and two homozygous-derived 
thymuses. Figure 4.23A shows that all stages of T-cell maturation are present in 
heterozygous and homozygous mice, with a similar profile in terms of percentage of 
cells (Figure 4.23B).  
The results show that the thymuses of Kdm3b homozygous gene-trapped 





Figure 4.23: T-cell maturation completes in the thymuses of homozygous Kdm3b 
gene-trapped mice.  
(A) A representative profile of thymic maturation, using the cell surface markers 
CD4 vs CD8 and CD44 vs CD25. The CD4 vs CD8 profile was gated on single cells. 
The CD44 vs CD25 profile was gated in CD4- CD8- cells (red boxes). (B) The 
thymuses of homozygous gene-trapped mice (Ho) presented a similar profile to the 
controls. Co= wild type and heterozygous. 
4.1.7 Summary of chapter 4 
In this chapter, significant reduction of Kdm3b expression resulted in postnatal - 
but not prenatal- growth retardation in Kdm3b homozygous gene-trapped mice, 
possibly attributed to perturbations in the thyroid hormone pathway. Several organs 




undefined cortico-medullary boundaries. T-cell maturation completed, with no 




























As discussed in section 1.5 of the introduction, isoforms of chromatin-binding 
proteins can perform specialised functions (Verrier et al., 2011a; Zibetti et al., 2010). 
Kdm3a gene-trap and knock-out mice present with obesity, infertility, pre-disposal to 
diabetes and frequent partial sex reversal (Inagaki et al., 2009; Kasioulis et al., 2014; 
Kuroki et al., 2013a; Liu et al., 2010a; Okada et al., 2007; Okada et al., 2010; 
Tateishi et al., 2009). The aim of this project was to verify the existence and 
investigate the putative function/s for a predicted alternative murine Kdm3a isoform 
(Kdm3a-i2) that had not been experimentally characterised before. 
5.1.1 The cloning of an alternative Kdm3a isoform from an Ensembl 
prediction 
Apart from the full-length Kdm3a isoform (Kdm3a-FL), the Ensembl build 
software (http://www.ensembl.org/index.html) predicted an alternative Kdm3a 
isoform (Ensembl transcript ID ENSMUST00000101304). This isoform, which I 
named Kdm3a-i2, is missing the first eleven exons of Kdm3a-FL and contains a 
unique exon one within intron eleven of Kdm3a-FL (Figure 5.1A - asterisks). I 
confirmed by RT-PCR that this isoform is expressed in MEFs. For this, I used a 
common forward primer within the unique exon1 of Kdm3a-i2 and reverse primers 
to exons18-19, exon 25 and exon 27 (numbering according to the Kdm3a-FL 
transcript). I observed a band of the correct size to the Kdm3a-i2 prediction for all 
RT-PCRs (Figure 5.2). 
I designed primers based on the Ensembl prediction to specifically amplify the 
coding sequence, cloned the Kdm3a-i2 isoform in p-Gem T-easy vector (Promega) 
and confirmed its nucleotide sequence by sequencing and aligning. The Kdm3a-i2 
isoform was PCR amplified from homozygous Kdm3a gene-trapped MEFs cDNA 
(gene trap discussed in section 5.2). 
Additionally, I confirmed that Kdm3a-i2 is a transcribed gene by amplifying 
and sequencing from its 5’ untranslated region (UTR) into the coding regions. The 




sequencing from the 5’ UTR, the predicted translation start site, as well as the 
splicing pattern was confirmed (data not shown). These experiments validate the 
Kdm3a-i2 prediction and show that it is expressed in homozygous gene-trapped 
MEFs. 
When translated, this newly cloned cDNA lacks the first 492 N-terminal amino 
acids of the full-length Kdm3a protein, but retains the zinc finger (ZF), the nuclear 
receptor (LXXLL) motif and the catalytic JumonjiC (JmjC) domain. The predicted 
protein size of Kdm3a-i2 is 91 kDa (Figure 5.1B). 
 
Figure 5.1: The Kdm3a-i2 isoform genomic locus.  
(A) The predicted Kdm3a-i2 was missing the first eleven exons of Kdm3a-FL and 
contained a unique exon one within intron eleven, as indicated by the asterisks. (B) 
The Kdm3a-i2 protein retained all domains/motifs, present in Kdm3a-FL: the zinc 
finger (ZF), the nuclear receptor (LXXLL) and the catalytic JmjC domain. In red is 





Figure 5.2: Kdm3a-i2 is expressed in MEFs. 
RT-PCR from MEF cDNA. A common forward primer was used to the unique exon1 
of Kdm3a-i2and reverse primers to exons 18-19, exon 25 and exon 27. Numbering of 
reverse primers according to the Kdm3aFL transcript. 
5.1.1.1 Sub-cloning of the predicted Kdm3a-i2 isoform into tag vectors 
To investigate the subcellular localisation of Kdm3a-i2, the cloned Kdm3a-i2 
described above was subcloned and GFP-tagged at the amino (N-) terminus (GFP-
Kdm3a-i2) or RFP-tagged at the carboxyl (C-) terminus (Kdm3a-i2-RFP) (Table 5-
1).  
Table 5-1: Kdm3a-i2 cloning primers.  
Highlighted nucleotides represent the restriction enzyme cut sites; red- Xho I, green- 
Bam HI 
Primer Sequence (5’- 3’) 
GFP-Kdm3a-i2 Forward CCGCTCGAGCTTTTTGGGGGGACTGGAAGAAC 
GFP-Kdm3a-i2 Reverse CGGGGATCCTTAAGGTTTGCCCAAACTGGATTCACTGGC 
Kdm3a-i2-RFP Forward CCCTCGAGCCATGTTTTGGGGGGACTGGAAGAAC 
Kdm3a-i2-RFP Reverse CGGGATCCCGAGGTTTGCCCAAACTGGATTCAC 
I also subcloned and RFP-tagged, at the C-terminus, the Kdm3a-FL (Kdm3a-




RFP). This deletion mutant of Kdm3a encodes a protein missing most of the N-
terminus, the zinc finger and the nuclear receptor motif (Kdm3a-Δ2-18-RFP) 
(Figure 5.3A).  
I validated the subcloning (data not shown) by sequencing and over-
expressions in TERT-RPE1 cells, followed by Western blot. An antibody raised 
against the unique exon one epitope of Kdm3a-i2 detected a band of about 120 kDa, 
the expected size for GFP-Kdm3a-i2. The antibody did not recognise the GFP- tag 
protein (GFP vector) or any bands in the untransfected cell lysates (Figure 5.3B). 
The pre-bleed of the Kdm3a-i2 antibody, used as a negative control, did not detect 
the over-expressed GFP-Kdm3a-i2, although it detected an unspecific band close to 
60 kDa, present in all cell lysates. The GFP antibody detected both the GFP-tag 
protein and GFP-Kdm3a-i2 and gave no bands in the untransfected cell lysates 
(Figure 5.3B).  
Similarly, the Kdm3a-i2 antibody recognised the predicted over-expressed 
Kdm3a-i2-RFP of 115 kDa (Figure 5.3C). The lower band is possibly a cleavage 
product, where over-expressed Kdm3a-i2-RFP was cleaved from RFP tag at the 
connecting hinge region. The size of the band did support this hypothesis, although 
no cleaved RFP protein was seen in the RFP-antibody blot. The RFP antibody 
recognised all the over-expressed constructs: the RFP-tag protein of 25 kDa, Kdm3a-
FL-RFP of 175 kDa, Kdm3a-i2-RFP of 115 kDa and Kdm3a-Δ2-18-RFP of 75 kDa. 
A non-specific faint band of about 100 kDa was present in all lanes. The pre-bleed 
did not recognise the over-expressed Kdm3a-i2-RFP but brought up some unspecific 
bands in all lanes (Figure 5.3C).  
Thus, the Western blots validated the correct subcloning of all the constructs 
and the specificity of the Kdm3a-i2 antibody towards the over-expressed GFP-





Figure 5.3: Cloning of Kdm3a isoforms and mutant, and size validation by 




(A) The Kdm3a-i2 isoform was GFP-tagged at the N-terminus and RFP-tagged at the 
C-terminus. Further, Kdm3a-FL and a deletion mutant missing exons 2-18, resulting 
in a protein missing most of the N-terminus, the zinc finger and the nuclear receptor 
motif were also RFP tagged at the C-end (Kdm3a-FL-RFP and Kdm3a-Δ2-18-RFP 
respectively). The red colour on Kdm3a-i2 represents the unique exon 1 of this 
isoform.  (B) The size of the GFP-Kdm3a-i2 tagged protein was validated by 
Western blot. The Kdm3a-i2 antibody detected only the GFP-Kdm3a-i2 over-
expression, the pre-bleed of the polyclonal antibody an unspecific band close to 60 
kDa and the GFP antibody both the GFP-tag protein and GFP-Kdm3a-i2. (C) Size of 
RFP-tagged Kdm3 proteins validated by Western blot. The Kdm3a-i2 antibody 
detected only the Kdm3a-i2-RFP over-expression and a possible cleavage product. 
The RFP antibody detected all over-expressions and the pre-bleed did not detect the 
over-expressed Kdm3a-i2-RFP, but brought up some unspecific bands in all lanes. 
Numbers beside the Western blot represent molecular weight markers in kDa. 
5.1.1.2 The over-expressed Kdm3a-i2 can function as an H3K9me1 and H3K9me2 
demethylase and distorts the nuclear localisation of the H3K9me3 mark  
Previous publications have demonstrated that Kdm3a-FL functions as an 
H3K9me1/2 demethylase (Yamane et al., 2006).  
Since, Kdm3a-i2 protein retains the catalytic JmjC domain, I hypothesised that 
the Kdm3a-i2 isoform will retain the H3K9me1/2 demethylation function. To test 
this hypothesis, I over-expressed the GFP- and RFP-tagged Kdm3a-i2 in TERT-
RPE1 cells and assessed the state of H3K9me1, H3K9me2, H3K9me3 and 
H3K27me3 methyl marks, by comparing transfected and untransfected neighbouring 
cells. I assessed 100 cells per experiment. Additionally, I transfected Kdm3a-FL-RFP 
as positive control for the assay and the Kdm3a-Δ2-18-RFP mutant as a negative 
control since the zinc finger is essential for the demethylation function (Yamane et 
al., 2006) .The experiment was performed in triplicate under 0.25% FCS growth 
conditions. The demethylation potential of Kdm3a-Δ2-18-RFP mutant was assessed 
in two experiments. 
Over-expression of GFP-Kdm3a-i2 resulted in global loss or decrease of 
H3K9me1 fluorescence (Figure 5.4A,E) in 31% (94/300) of transfected cells. The 
GFP vector resulted in 0% (0/300) HeK9me1 global loss or decrease (Figure 5.4E). 
The result was statistically significant with a p-value of p<0.0001. Similarly, Kdm3a-




0% (300/300) for the RFP vector. The result was again statistically significant with a 
p-value of p<0.0001 (Figure 5.4B, E). Over-expression of the control Kdm3a-FL-
RFP resulted in 12% (36/300) of transfected cells with decreased or no fluorescence, 
which gave a Fisher’s exact test p-value of 0.0001. (Figure 5.4C,E). However, 
Kdm3a-Δ2-18-RFP over-expression resulted in 1% (198/200) H3K9me1 
fluorescence change which was not statistically significant (Fisher’s exact test, p= 
0.5) (Figure 5.4D,E). 
Similar results were obtained for the H3K9me2 mark. Over-expression of 
GFP-Kdm3a-i2 and Kdm3a-i2-RFP resulted in reduced or absent fluorescence in 
40% (121/300) and 30% (90/300) of transfected cells, respectively. GFP and RFP 
vectors did not affect the fluorescence intensity (0%- 0/300) (Figure 5.5A,B,E). The 
difference in the percentages of cells with reduced/absent fluorescence between the 
GFP-Kdm3a-i2 or Kdm3a-i2-RFP and their corresponding vectors was statistically 
significant, with a p-value of p< 0.0001. As expected the Kdm3a-FL-RFP control 
transfection resulted in 15% (45/300) of cells showing reduced or absent H3K9me2 
(p< 0.0001) (Figure 5.5C,E). Kdm3a-Δ2-18-RFP over-expression resulted in no 





Figure 5.4:The Kdm3a-i2 isoform can function as an H3K9me1 demethylase.  
TERT-RPE1 cells were transfected with GFP-Kdm3a-i2, Kdm3a-i2-RFP, Kdm3a-
FL-RFP or Kdm3a-Δ2-18-RFP. The cells were then fixed and stained with 




RFP resulted in global loss or decrease of the H3K9me1 fluorescence. (C) The 
Kdm3a-FL-RFP control transfection resulted in H3K9me1 fluorescent loss. (D) The 
Kdm3a-Δ2-18-RFP mutant was unable to reduce H3K9me1 fluorescence. (E) 
Compared their control vector transfections, the percentage of cells with unchanged 
H3K9me1 fluorescence was significantly reduced in GFP-Kdm3a-i2, Kdm3a-i2-RFP 
and Kdm3a-FL-RFP transfections. Kdm3a-Δ2-18-RFP transfections resulted in no 
significant difference. Yellow circles indicate nuclei of transfected cells. ** = 






Figure 5.5: The Kdm3a-i2 isoform can function as an H3K9me2 demethylase.  
TERT-RPE1 cells were transfected with GFP-Kdm3a-i2, Kdm3a-i2-RFP, Kdm3a-
FL-RFP or Kdm3a-Δ2-18-RFP. The cells were then fixed and stained with 




RFP resulted in global loss of the H3K9me2 fluorescence. (C) As expected the 
Kdm3a-FL-RFP control transfection resulted in H3K9me2 fluorescent loss. (D) The 
Kdm3a-Δ2-18-RFP mutant was unable to change H3K9me2 fluorescence. (E) 
Compared their control vector transfections, the percentage of cells with unchanged 
H3K9me2 fluorescence was significantly reduced in GFP-Kdm3a-i2, Kdm3a-i2-RFP 
and Kdm3a-FL-RFP transfections. Kdm3a-Δ2-18-RFP transfections resulted in no 
significant difference. Yellow circles indicate nuclei of transfected cells. ** = 
significant, Fisher’s exact test p<0.05. Error bars represent ± standard error. Scale 
bar: 40μm. 
In TERT-RPE1 untransfected cells, the H3K9me3 mark spread evenly 
through the nucleus. Sometimes, puncta were visible but were not very prominent. 
However, in GFP- Kdm3a-i2, Kdm3a-i2-RFP and Kdm3a-FL-RFP transfected cells, 
the methyl mark became punctuated with a decrease of fluorescent intensity in the 
rest of the nucleus (Figure 5.6A-C). This effect was evidenced in 67% (200/300) of 
GFP-Kdm3a-i2 transfected cells, as well as for 47% (140/300) and 40% (120/300) of 
Kdm3a-i2-RFP and Kdm3a-FL-RFP transfected cells, respectively. Compared to the 
GFP and RFP vector transfections that had no effect on H3K9me3 (0%- 0/300), the 
difference in the percentage of affected cells was statistically significant (p< 0.0001, 
all comparisons) (Figure 5.6E). Again, this was not the case for Kdm3a-Δ2-18-RFP 
where the nuclear H3K9me3 remained unchanged (0%- 0/200- Fisher’s exact test, p= 
1) (Figure 5.6D,E). This effect on H3K9me3 may be due to the significant decrease 





Figure: 5.6: Over-expression of Kdm3a-i2 and Kdm3a-FL distorted the nuclear 
H3K9me3 localisation.  
TERT-RPE1 cells were transfected with GFP-Kdm3a-i2, Kdm3a-i2-RFP, Kdm3a-




H3K9me3 antibody. (A-C) Over-expression of GFP-Kdm3a-i2, Kdm3a-i2-RFP and 
Kdm3a-FL produced a punctuated H3K9me3 phenotype. (D) Over-expression of 
Kdm3a-Δ2-18-RFP resulted in no distortion of the H3K9me3 mark. (E) Compared 
their control vector transfections, the percentage of cells with unchanged H3K9me3 
fluorescence was significantly reduced in GFP-Kdm3a-i2, Kdm3a-i2-RFP and 
Kdm3a-FL-RFP transfections. Kdm3a-Δ2-18-RFP transfections resulted in no 
significant difference.  Yellow circles indicate nuclei of transfected cells. ** = 
significant, Fisher’s exact test p<0.05. Error bars represent ± standard error. Scale 
bar: 40μm. 
The H3K27me3 mark was used as a negative control and resulted in no 
change (0%- 0/300) of the fluorescent intensity in any of the transfections (Fisher’s 
exact test: GFP-Kdm3a-i2, p = 1; Kdm3a-i2-RFP, p= 1; Kdm3a-FL-RFP, p= 1, 






Figure 5.7: Over-expression of Kdm3a constructs did not affect the fluorescent 




TERT-RPE1 cells were transfected with GFP-Kdm3a-i2, Kdm3a-i2-RFP, Kdm3a-
FL-RFP or Kdm3a-Δ2-18-RFP. The cells were then fixed and stained with 
H3K27me3 antibody. (A-D) There was no change in the fluorescent H3K27me3 
intensity of the transfected cells for any of the constructs. (E) There was no 
significant difference in the percentage of Kdm3a transfected cells with unchanged 
fluorescence in comparison to their vector transfections. Scale bar: 40 μm. 
 The results suggest that Kdm3a-i2 can function as an H3K9me1/2 
demethylase, having the same substrate specificity as Kdm3a-FL. In addition, the 
presence of excess Kdm3a-FL or Kdm3a-i2 protein in the cell nucleus disrupted the 
H3K9me3 nuclear distribution. Deletion of the exons 2-18 resulted in the loss of 
demethylase activity. 
5.1.2 The murine Kdm3a gene trap 
To test the expression levels of Kdm3a-i2 upon Kdm3a-FL reduction, I took 
advantage of a gene-trap mouse model where the gene trap was inserted upstream of 
the Kdm3a-i2 start site but within the genomic locus of Kdm3a-FL. As shown in 
Figure 5.8, the gene trap was inserted in intron 5-6 of the Kdm3a-FL locus and 
consisted of a splice acceptor site and a β-gal/neomycin (β-geo) sequence that 
allowed the selection of positive embryonic stem (ES) cells by G418 treatment and 
the visualisation of the targeted gene expression in vivo. 
 
Figure 5.8: The gene trap within the Kdm3a locus.  
The gene trap was inserted within intron 5-6 of the Kdm3a locus. It consisted of a 
strong splice acceptor site (SA), a β-gal/neomycin (β-geo) and a poly A (pA) 
sequence. The genomic Kdm3a-i2 locus was unaffected. 
I tested the efficiency of the gene trap by Western blot and qRT-PCR. Western 
blot with an antibody against the N-terminus of Kdm3a-FL (not present in Kdm3a-




(GT Homo) compared to the wild type (WT) MEFs. In addition, in GT Homo MEFs 
a β-gal positive band was detected, possibly reflecting a Kdm3a/β-geo hybrid fusion 
protein. Densitometry analysis, with the Image J software, revealed 3-4% residual 
Kdm3a-FL protein remaining in GT Homo MEFs after normalising with α-tubulin 
and comparing with WT Kdm3a-FL expression (Figure 5.9A-B).  
qRT-PCR was performed with a primer pair in exons 5-6 that flanked the gene 
trap (forward primer in exon 5 and reverse primer in exon 6). I used the t-test to 
check whether the reduction of Kdm3a transcript was statistically significant. The 
qRT-PCR showed a statistically significant (p= 0.004) decrease of 74% in Kdm3a-
FL transcript of primary gene-trapped homozygous MEFs (Primary GT Homo 
MEFs) compared to primary wild type MEFs (Primary WT MEFs) (Figure 5.9C). In 
SV40 large T antigen-immortalised MEFs, there was a 70% decrease in homozygous 
(GT Homo-SV40) versus the wild type (WT-SV40) MEFs (p= 0.03). Kdm3a-FL 
transcripts from homozygous liver, kidney and testis showed a statistically 
significant reduction of 98%, 85% and 99% decrease compared to their wild type 
counterparts, respectively (liver, p= 0.0005; kidney, p= 0.03; testis, p< 0.0001). The 
qRT-PCR results confirmed previous publications where Kdm3a was found to be 
expressed at high levels in the testis (Tateishi et al., 2009) (Figure 5.9C). 
The results of the Western blot and the qRT-PCR show that gene-trapped mice 






Figure 5.9: Validation of the gene trap efficiency in Kdm3a gene-trapped MEFs 
and tissues.  
(A) Western blot of cell lysates from wild type (WT) and homozygous gene-trap (GT 
Homo) MEFs. Full length Kdm3a (band above 150 kDa) is expressed at low levels in 




to a possible Kdm3a-FL/β-geo fusion protein containing the first five translated 
Kdm3a exons and the β-geo hybrid protein. Numbers beside the Western blot are 
molecular weight markers in kDa. (B) Densitometry analysis of the Western blot 
showed that after normalisation with the alpha tubulin (α-tubulin) loading control 
and comparison to WT Kdm3a-FL, about 4% of the full length Kdm3a protein is 
expressed in the homozygous gene-trapped MEFs. (C) qRT-PCR in WT, GT Homo 
MEFs and adult-derived tissues such as the liver, kidney and testis. Results from wild 
type-SV40 MEFs (WT-SV40 MEFs) were used as the calibrator (red bar). ** = 
significant, Tukey, p<0.05. Error bars represent ± standard deviation. 
5.1.2.1 Comparing Kdm3a-i2 expression in wild type and homozygous-derived 
cells and tissues 
As shown above, Kdm3a-FL expression was significantly reduced in MEFs 
and tissues of homozygous mice. To check whether Kdm3a-i2 expression is altered 
in response to the significant reduction of the Kdm3a-FL transcript and protein 
levels, I performed qRT-PCR on MEFs and tissues of WT and GT Homo mice. The 
forward primer bound to the unique exon one of Kdm3a-i2 transcript and the reverse 
in the shared exon two of Kdm3a-i2 (that corresponds to exon 12 of Kdm3a-FL). 
As shown in Figure 5.10, Kdm3a-i2 transcript levels were significantly 
reduced by 48%in primary GT Homo MEFs compared to primary WT MEFs (p= 
0.009). Kdm3a-i2 transcript levels remained unchanged in immortalised MEFs 
(Tukey, p= 0.94), as well as in testis (Tukey, p= 0.92) of wild type and homozygous 
gene-trapped mice when compared to the wild type. The minimal expression of 
Kdm3a-i2 observed in WT kidneys is lost in GT Homo. The result was significant 
(p= 0.009). No Kdm3a-i2 expression was detected in the liver.  
Although a comparison between the Kdm3a-FL and Kdm3a-i2 transcript levels 
cannot be made due to the qRT-PCR experimental design, it should be noted that the 
Kdm3a-i2 appeared be expressed at lower levels than Kdm3a-FL. For example, in 
wild type-SV40 MEFs, the average Ct value for Kdm3a-FL was 27.89 and for 
Kdm3a-i2 was 33.94. Likewise, in the wild type testis, the average Ct value for 
Kdm3a-FL was 24.8 and for Kdm3a-i2 was 39.96 (data not shown).  
The qRT-PCR experiment showed that the SV40 transformation reduced the 




than tissues. In two cases, (primary MEFs and kidney) there was a correlation 
between Kdm3a-FL and the Kdm3a-i2 levels in wild types and homozygotes; that is, 
reduction of Kdm3a-FL expression resulted in the reduction of Kdm3a-i2. In 
contrast, there was no difference in Kdm3a-i2 levels in SV40 MEFs and testis of wild 
type and homozygotes, despite the Kdm3a-FL reduction in homozygotes.  
 
Figure 5.10: Kdm3a-i2 expression is unaffected or decreased/absent in 
homozygous MEFs and tissues.  
There was a significant decrease in Kdm3a-i2 expression in primary GT Homo 
MEFs compared to WT MEFs (Tukey, p= 0.0009). This decrease was not evident in 
SV-40 immortalised homozygous MEFs (Tukey, p= 0.99). Compared with MEFs, 
WT kidneys express minimal Kdm3a-i2. The expression is lost in GT Homo Kidney 
however the difference was not significant (Tukey, p=0.72). WT and GT Homo testis 
show similar levels of Kdm3a-i2 expression (Tukey, p= 0.99). No expression was 






5.1.3 Subcellular localisation of Kdm3a constructs  
Previous studies report nuclear as well as cytoplasmic Kdm3a localisation 
(Okada et al., 2007; Yamada et al., 2011). To investigate the subcellular localisation 
of Kdm3a-i2, I over-expressed GFP-Kdm3a-i2 and Kdm3a-i2-RFP in TERT-RPE1 
cells for 24 hours, and fixed with formaldehyde. GFP- and RFP- vector transfections 
were used as a control.  
I first investigated the localisation in cells that were kept in 10% FCS growth 
media. In 100% (300/300) of the RFP and GFP vector transfected cells the signal 
was present evenly throughout the nucleus and the cytoplasm (nuclear-cytoplasmic 
localisation) (Figure 5.11A and D). However, 64% (193/300) of Kdm3a-i2-RFP 
transfected cells showed nuclear-cytoplasmic localisation (Figure 5.11B,D) whereas 
36% (107/300) showed strong cytoplasmic with none or limited nuclear localisation 
(Figure 5.11C,D). Similarly, 78% (235/300) of Kdm3a-i2-GFP transfected cells 
showed nuclear-cytoplasmic and 22% (65/300) showed strong cytoplasmic 
localisation (Figure 5.11D). The similar percentage between GFP and RFP Kdm3a-
i2 constructs suggests that the tags do not affect the Kdm3a-i2 subcellular 
distribution. 
When transfected cells were kept in 0.25% FCS growth media, there was an 
increase in the nuclear presence of Kdm3a-i2. More precisely, RFP-Kdm3a-i2 and 
GFP-Kdm3a-i2 transfected cells showed 94% (282/300) and 98% (6/300) nuclear 
cytoplasmic localisation respectively, with a significant decrease in the strong 
cytoplasmic category (Figure 5.11E). 
The data suggested that subcellular localisation of GFP-Kdm3a-i2 and Kdm3a-





Figure 5.11: Subcellular localisation of Kdm3-i2 over-expressions.  
TERT-RPE1 cells were transfected separately with either Kdm3a-i2-RFP or GFP-
Kdm3a-i2 and their control vectors. (A) Localisation of RFP vector is nuclear-
cytoplasmic. (B) Kdm3a-i2-RFP showed nuclear-cytoplasmic or (C) strong 
cytoplasmic localisation. (D) The subcellular localisation of the over-expressions 
under 10% FCS and 0.25% FCS growth media was quantified. Bars represent the 




5.1.3.1 Over-expressed GFP-Kdm3a-i2 is a potential centrosomal protein 
Apart from the widespread cytoplasmic localisation of GFP-Kdm3a-i2 and 
Kdm3a-i2-RFP, I noticed that the signal was also concentrated as a single or two dots 
next to the nucleus (Figure 5.12A,D). To check whether this specific localisation 
represented the centrosome, I used the centrosomal marker gamma-tubulin (γ-
tubulin) (Fuller et al., 1995; Stearns et al., 1991) on methanol-acetone fixed TERT-
RPE1 cells. Indeed, GFP-Kdm3a-i2 and Kdm3a-i2-RFP co-localised with γ-tubulin 
at the centrosomal material (Figure 5.12B-C, E-F and insets).  
The above experiment suggested that GFP-Kdm3a-i2 is a potential 
centrosomal protein. 
 




TERT-RPE1 cells were transfected with GFP-Kdm3a-i2, methanol-acetone fixed and 
labelled using a γ-tubulin antibody. (A-C) Over-expressed Kdm3a-i2-RFP localised 
diffusely in the cytoplasm and the pericentriolar material, as marked by γ-tubulin. 
(D-F) Cytoplasmic and pericentriolar localisation was also evidenced for GFP-
Kdm3a-i2. Scale bar: 20 μm. 
5.1.3.2 A fraction of GFP-Kdm3a-i2 retained its centrosomal localisation after 
detergent pre-extraction 
To further characterise the centrosomal localisation of GFP-Kdm3a-i2, I over-
expressed GFP-Kdm3a-i2 in TERT-RPE1 cells. The cells were briefly pre-extracted 
with 0.2% Triton X-100 in PBS and fixed with 4% formaldehyde. Figure 5.13A 
shows that GFP-Kdm3a-i2 co-localised with the pericentriolar marker pericentrin 
(Delaval and Doxsey, 2010). Centrosomal co-localisation of Kdm3a-i2 was observed 
in about 5% (30/546) of the transfected and pre-extracted cells (Figure 5.13E), based 
on a calculated transfection efficiency of 58% for GFP-Kdm3a-i2 (not pre-extracted). 
As positive controls for the assay, I over-expressed GFP-centrin-2 and GFP-γ-
tubulin, which are centriolar and pericentriolar markers, respectively (Lee and 
Huang, 1993; Stearns et al., 1991). GFP only over-expression was used as a negative 
control. Both GFP-centrin-2 and GFP-γ-tubulin maintained their centriolar and 
pericentriolar localisation, while the GFP vector did not show pericentriolar 
localisation after detergent pre-extraction (Figure 5.13B-D). 
Under the experimental conditions used, a small percentage of GFP-Kdm3a-i2 





Figure 5.13: A fraction of GFP-Kdm3a-i2 retained its centrosomal localisation 
after detergent pre-extraction.  
GFP-Kdm3a-i2, GFP-centrin-2, GFP-γ-tubulin and the GFP vector were transfected 
in TERT-RPE1 cells, detergent pre-extracted and then formaldehyde fixed. 
Pericentrin was used as a marker of the pericentriolar material. (A-C) GFP-Kdm3a-
i2, GFP-centrin-2 and GFP-γ-tubulin localised at the centrosomes but (D) the GFP 
protein was no longer present. (E) About 5% of GFP-Kdm3a-i2 transfected cells 
retained their centrosomal localisation. Scale bar: 5 μm. 
5.1.3.3 Kdm3a-i2 over-expression reduces the number of ciliated cells 
The presence of GFP-Kdm3a-i2 at the centrosome prompted me to investigate 
whether over-expression of GFP-Kdm3a-i2 could affect ciliation. Thus, I over-
expressed the GFP-Kdm3a-i2 isoform or the GFP vector in TERT-RPE1 cells, and 
following transfection, I replaced the 10% FCS growth media with 0.25% FCS 




of transfected cells and normalised that value to the percentage ciliation of 
neighbouring untransfected cells. The derived values were then compared. 
Whereas ciliation was reduced by 34% in the GFP vector-transfected cells 
compared to their neighbouring untransfected cells, a 64% reduction in ciliation was 
observed in GFP-Kdm3a-i2 transfected cells. The reduction in ciliation, caused by 
the GFP-Kdm3a-i2 transfections, was statistically significant according to Student’s 
t-test (t-test, p=0.01) (Figure 5.14).  
The results show that over-expression of Kdm3a-i2 hinders the cell’s ability to 
promote ciliation. 
 
Figure 5.14: Over-expression of GFP-Kdm3a-i2 reduces the number of ciliated 
cells.  
GFP-Kdm3a-i2 or the GFP vector constructs were transfected in TERT-RPE1 cells, 
and following transfection, 10% FCS media were replaced with 0.25% FCS media to 
induce ciliation. Forty-eight hours later, the percentage ciliation in transfected cells 
was quantified and normalised to the percentage ciliation of neighbouring 
untransfected cells. The reduction in ciliation by the GFP-Kdm3a-i2 transfections 
was statistically significant. ** = significant, t-test p= 0.01. Error bars represent ± 




5.1.4 Summary of chapter 5 
In this study, Kdm3a-i2 was cloned and shown to retain the H3K9me1/2 
demethylase function. Interestingly, over-expressed Kdm3a-i2 localised both at the 
nucleus and the cytoplasm and co-localised with the centrosomal marker γ-tubulin. 
Further, over-expression of Kdm3a-i2 resulted in ciliation loss. Therefore, these 





























In the present study, I utilised model organisms and cell culture to investigate: 1) the 
conservation of Kdm3b function and spatial expression through evolution 2) the phenotype of 
Kdm3b gene-trapped mice and 3) plausible functions of an alternative murine Kdm3a 
isoform. Understanding the biological roles and molecular functions of lysine demethylases is 
important, since mutations in a subset these genes have already been identified in a number of 
diseases, such alopecia universalis, popular atrichia, X-linked mental retardation and cancer 
(Ahmad et al., 1998; Jensen et al., 2005; Kruse et al., 1999; Laumonnier et al., 2005; 
Sprecher et al., 1999; Tzschach et al., 2006; van Haaften et al., 2009). Furthermore, by 
dissecting the molecular pathways that Kdm3b participates in, I aimed to gain an insight into 
how Kdm3b controls a number of biological processes, such as growth and maintenance of 
immune system organs.  
6.1 Conservation of demethylation function through evolution 
 The conversation of the demethylation function through evolution has already been 
demonstrated for a number of lysine demethylase protein families. In those instances, the S. 
cerevisiae demethylase homologues of the KDM2, KDM4 and KDM5 subfamilies possess 
histone lysine substrate specificities identical to the already characterised human proteins 
(Klose et al., 2007; Liang et al., 2007; Yamane et al., 2006). The same principle applies to 
non-vertebrate eukaryotic organisms such as C. elegans, where ceKDM7A shows histone 
lysine demethylase activity, like its human counterparts (Lin et al., 2010).From an 
evolutionary perspective, this observation demonstrates the essential need for control of the 
chromatin state via histone lysine demethylation, from low to higher eukaryotic organisms, 
such as the vertebrates.  
 In this study, I demonstrated that the zebrafish kdm3 protein, most closely related to 
the murine Kdm3b in protein sequence, retains H3K9me2 demethylation function when over-
expressed in human cells. Interestingly, neither the zebrafish kdm3b nor the human 
homologue display H3K9me1 demethylase activity in low serum conditions. However, 
H3K9me1/2 demethylase activity is observed when the human KDM3B is over-expressed in 
cells incubated in growth media supplemented with 10% FCS (normal serum conditions). 
This is in agreement with publications that show that the human KDM3B is a H3K9me1/2 
demethylase (Brauchle et al., 2013; Kim et al., 2012). It is unclear how serum levels may 




essential since the experiment was performed only once. It is possible that the level of over-
expression was not sufficient to drive global H3K9me1 demethylation, or that H3K9me1 
demethylation within the KDM3B-over-expressed cell was counteracted by the accumulation 
of H3K9me1, via H3K9me2 demethylation. Alternatively, it is also possible that the 
zebrafish kdm3b has lost its H3K9me1 demethylase potential. 
 Furthermore, I showed that a mutant zebrafish kdm3b construct, lacking two amino 
acids, does not show any demethylase activity. Interestingly, the mutation does not localise 
within the catalytic JmjC domain or the zinc finger, which are necessary for histone lysine 
demethylation (Brauchle et al., 2013; Yamane et al., 2006), but is close to the zinc finger 
domain. Furthermore, over-expression of this mutant construct, results in a greater 
cytoplasmic, in addition to the nuclear localisation of the protein. Therefore, the mutation 
may distort the protein conformation, reducing its ability to bind the nuclear import-transport 
machinery and impeding its demethylation capacity by affecting the structure of the 
substrate-binding site. Alternatively, its histone binding capacity may be reduced. 
 Moreover, I demonstrated that the murine Kdm3a-i2 isoform can function as a 
H3K9me1/2 demethylase, as the already characterised full length isoform (Yamane et al., 
2006). The Kdm3a-i2 isoform is missing the N-terminal domain of the full length isoform, 
and instead contains a unique exon one. This result is interesting because it shows that the N-
terminal domain of the full length Kdm3a isoform is dispensible for the demethylase 
enzymatic function.  
The demethylation potential of the zebrafish kdm3b can be further investigated by in 
vitro experiments. Purified kdm3b can be incubated with methylated peptides or nucleosomal 
substrates and the demethylation potential can be checked by western blot, using antibodies 
to methylated lysines (Liu et al., 2010b; Tsukada et al., 2006). Given: 1) the high percentage 
similarity of the human, mouse, and zebrafish KDM3B protein sequences within the JmjC 
domain and the zinc finger (78% and 77%, respectively), 2) the retention of the α-KG and Fe 
(II) binding sites in the zebrafish kdm3b protein, and 3) the histone lysine demethylase 
activity of the human KDM3B (Klose et al., 2006b), I am in favour of the zebrafish kdm3b as 




6.2 Kdm3a and Kdm3b: novel ciliary candidate proteins? 
 Ciliation is a highly regulated process, in a spatiotemporal manner, that requires the 
gradual building of the axoneme and the selective trafficking of signaling proteins within the 
cilium (Gerdes et al., 2009a; Plotnikova et al., 2009). Although, in recent years, the processes 
of ciliary assembly and disassembly have been under intense scrutiny, the functional control 
of ciliary proteins via post-translational modification has not been thoroughly investigated. 
Interestingly, the over-expression of the Kdm3a-i2 isoform, as well as the zebrafish kdm3b, 
in cultured cells results in the reduction of ciliary assembly under conditions of low serum 
(that encourages ciliation). 
 Furthermore, the over-expression of both the wild type, as well as the mutant 
zebrafish kdm3b, shows the same ciliary-inhibiting efficiency, suggesting that the potential 
lysine demethylation function of kdm3b could be dispensible for this process. In addition, the 
over-expression of both constructs results in a proportion of cells with cytoplasmic kdm3b 
localisation, although their ciliary or centrosomal localisation was not investigated. 
Furthermore, whole mount in-situ hybridisation in zebrafish embryos showed that kdm3b is 
expressed in the otoliths, whose formation is dependent on fluid flow, generated by beating 
(motile) cilia (Stooke-Vaughan et al., 2012). These results correlate with unpublished data 
(Dr. Patricia Yeyati, Insitute of Genetics and Molecular Medicine, University of Edinburgh 
personal communication), where zebrafish kdm3b morphants recapitulate classical ciliary 
phenotypes, such as body curvature, situs inversus and reduced number of otolithis. How the 
knock-down of kdm3b in zebrafish morphants results in ciliary phenotypes is still unclear. 
Several models can be put forward such as: 1) kdm3b, via H3K9me2 promoter 
demethylation, allows the expression of genes involved in ciliation, 2) kdm3b promotes 
ciliation by demethylating lysine residues on ciliary proteins, thus controlling their function 
and 3) kdm3b functions as a scaffold to assist the interaction of ciliary proteins.  
Moreover, as mentioned above, the over-expression of the murine Kdm3a-i2 isoform 
results in a reduction in ciliation efficiency. Strikingly, detergent pre-extraction resulted in 
about 5% of transfected cells retaining their Kdm3a-i2 binding on the centrosome. This is an 
interesting result, as no demethylase protein has yet been reported to localise to the 
centrosome. The plausible centrosomal function of Kdm3a-i2 at the centrosome is still 




unable to detect a band at the correct molecular size by Western blot, possibly due to its low 
expression levels compared to the full length isoform. Furthermore, this antibody still needs 
optimisation for immunofluorescence experiments. It is, however, very interesting that the 
phenotype of Kdm3a gene-trapped and knock-out mice (obesity, infertility and predisposal to 
diabetes) also recapitulates ciliary phenotypes. Kdm3a has been shown to localise to the 
nucleus and cytoplasm of spermatids (Okada et al., 2007), as well as the acrosome of mature 
sperm (Kasioulis et al., 2014). Loss of Kdm3a in knock-out mice results in disrupted 
acrosome and manchette formation. Testis extracts from Kdm3a knock-out mice show altered 
fractionation of γ-tubulin and β-actin. The unaltered levels of these proteins between wild 
type and homozygous Kdm3a knock-out mice suggests that the localisation but not the 
expression of these proteins is affected by the knock-down of Kdm3a.  
Bearing in mind that the over-representation of Kdm3a-i2 and the zebrafish kdm3b 
leads to a reduced ciliation, these proteins may be involved in ciliary assembly. Methylation 
of ciliary proteins may be critical for the assembly and maintenance of the ciliary structure. 
Therefore, the demethylation of lysine residues on ciliary proteins may inhibit ciliary 
assembly. Alternatively, we cannot reject the hypothesis that reduction in ciliation could also 
be mediated through H3K9me1/2 demethylase activity. On the other hand, these ciliation 
assays should be approached with caution, as reduction in ciliation may be an indirect effect, 
owing to the global H3K9me1/2 demethylation or the high levels of these proteins in the 
cytoplasm. A negative control should also be incorporated in future experiments, for 
example, a protein that is not involved in the modulation of ciliation. 
6.3 The Kdm3b mouse model 
6.3.1 The Kdm3b mouse model: non-redundant biological roles compared to the other 
Kdm3 family members 
 The phenotype analysis of gene-trap, knock-out or mutant mouse models for the 
Kdm3 family (Kdm3a, Jmjd1C and Hairless) suggests minimal overlap in their biological 
roles: 
a) Kdm3a is involved in male fertility, control of metabolic gene expression and sex 
determination (Inagaki et al., 2009; Kasioulis et al., 2014; Kuroki et al., 2013a; Liu et 




b) Jmjd1c is important for the maintenance of male fertility in age-dependent fashion 
(Kuroki et al., 2013b) 
c) Hairless controls hair regeneration and white adipose tissue maintenance (Cachón-
González et al., 1999; García-Atares et al., 1998; Kumpf et al., 2012; Thompson, 
2009) 
 In the present study, I dissected the phenotype of heterozygous and homozygous 
gene-trap mice for Kdm3b, the only member of the Kdm3 family whose function has not been 
studied using mouse models. The data suggest that Kdm3b is involved in promoting growth 
and thumic-tissue maintenance, which represent unique biological roles among the Kdm3 
subfamily.  
6.3.2 The thyroid hormone pathway as candidate for the growth retardation 
phenotype in Kdm3b homozygous gene-trapped mice 
 Homozygous Kdm3b gene-trapped mice are not prenatally growth retarded, as their 
weight at E18.5 is indistinguishable from their wild type and heterozygous gene-trap 
littermates. Growth retardation is evidenced from p14 (two weeks), and from that time point, 
the homozygous mice will gain little or no weight, as evidenced by the weight monitoring 
performed at p21 (three weeks) and p42 (six weeks). Monitoring litter weights at earlier 
stages, such as p3 and p7, will provide more information on when growth retardation 
commences.  
Moreover, at prenatal stage E18.5, homozygous embryos are found at Mendelian ratios, 
in contrast to p14 and onwards, where homozygous mice are under-represented compared to 
wild type and heterozygous mice. These data suggest that a proportion of homozygous mice 
die during the first two postnatal weeks. In postnatal life, the health of homozygous mice 
deteriorates, and the majority do not thrive past p28.  
To complement the results on growth, based on weight, and further dissect the phenotype 
observed in homozygous Kdm3b gene-trapped mice, the following experiments are 
necessary: 
a) Check the development of the proximal growth plate of long bones, such as the tibia, 
to investigate if Kdm3b homozygous gene-trapped mice show delayed development of 




b) Perform apoptosis and proliferation assays on tissue sections of organs. In particular, 
investigate proliferation on organs that show high cell turn-over in adult life, i.e. 
intestines 
c) Investigate apoptosis and cell proliferation on MEFs 
d) Measure the average cell size and area 
e) Organ weights to body weights, apart from the thymus  
6.3.2.1 The growth hormone pathway 
The commencement of growth retardation, as assessed by weight monitoring, in 
Kdm3b homozygous mice is reminiscent of the growth retardation observed in knock-out 
mice of the growth and thyroid hormone pathways. For example, knock-out mice for Ghrhr, 
Ghrh and Ghr show post-natal growth retardation that is already evidenced at p14. These 
mice, however, follow Mendelian ratios in their adult life and are not short lived (Alba and 
Salvatori, 2004; Coschigano et al., 2000; Coschigano et al., 2003; Flurkey et al., 2001; Lupu 
et al., 2001). Absence of Ghrh and Ghr expression results in the perturbation of the growth 
hormone pathway, as the serum levels of Igf1 are significantly reduced (Alba and Salvatori, 
2004; Lupu et al., 2001). In Kdm3b homozygous gene-trapped mice, I found that the 
expression of the Ghrhr, Gh, Igf1, Igf1r and Igfbp3 are not significantly reduced compared to 
the control wild type and heterozygous gene-trapped mice. The Igfals expression, necessary 
for the stabilisation of Igf1 in the serum (Clemmons, 1997) was significantly reduced in 
homozygous mice. However, reduction of Igfals expression in homozygous mice cannot 
explain the growth retardation phenotype, since Igfals knock-out adult mice show a minor 
weight decreases (Ueki et al., 2000). Therefore, based on the qRT-PCR data, the growth 
hormone pathway is not perturbed in Kdm3b homozygous gene-trapped mice. 
If necessary, further work that can be undertaken to dissect any possible perturbation of 
the growth hormone pathway in the homozygous mice includes: 
a) Check the serum levels of Igfs, Igf-binding proteins and Igfals in adult mice 





6.3.2.2 The thyroid hormone pathway 
 In the thyroid hormone pathway, Trh from the hypothalamus promotes the expression 
of Tsh in the pituitary, which binds the Tshr in the thyroid gland. Thyroid hormones (T3 and 
T4) are synthesized, which enter the blood stream and then are imported into cells. There 
they enter the nucleus, where the active T3 binds Thrs and to induce target gene expression. 
T3 and T4 also exert a negative feedback to the pituitary, in order to finely control Tsh 
expression. (Figure 1.8 in introduction) (Brent, 2012; Dayan and Panicker, 2009; Oetting and 
Yen, 2007). 
The growth retardation phenotype of homozygous mice can also be explained by the 
disruption of the thyroid hormone pathway. Interestingly, knock-out mice of the Thra, 
involved in the thyroid hormone pathway, show postnatal growth retardation evidenced at 
p14 and tend to die by four-five weeks of age, depending on the litter size. Also, Thra 
homozygous mice display a degenerated thyroid gland with reduced T3 and T4 hormone 
production (Fraichard et al., 1997). This phenotype closely resembles that of Kdm3b gene-
trapped mice, as the growth retardation is already evidence from p14 and further, these mice 
do not thrive in adult life, with deaths occurring at 2, 4, 6 and rarely 10 weeks of age. Based 
on the qRT-PCR experiments, I found a statistically significant increase of Tshb-subunit 
expression in homozygous compared to the control mice, suggesting a perturbation of the 
thyroid hormone pathway.  
Notably, it is already known that members of the Kdm3 subfamily interact with 
nuclear hormone receptors, acting as co-activators or co-repressors. Kdm3a and the s-Jmjd1c 
variant interact and function as co-activators of the androgen receptor-mediated gene 
activation (Wolf et al., 2007; Yamane et al., 2006). Hairless interacts and functions as a co-
repressor of the thyroid receptor, the retinoic acid receptor-related orphan receptor and the 
vitamin D receptor (Thompson, 2009). Based on the published data and the qRT-PCR results, 
the following model can be put forward (Figure 6.1) where Kdm3b functions as a co-
activator of the Thrα, via H3K9me2 promoter demethylation of T3 target genes. Like the 
Thrα knock-out mice, production and circulation of T3 and T4 hormones would be reduced in 
Kdm3b homozygous mice, resulting in the loss of the negative feedback loop to the pituitary 




 This hypothesis is further re-enforced by the presence of an LXXLL domain in 
Kdm3b protein sequence, which is a signature motif of nuclear hormone binding proteins 
(Aranda and Pascual, 2001). In an alternative scenario. Kdm3b may control the expression of 
Thra by H3K9me2 demethylation. These hypotheses are very intriguing and require further 
experimentation, such as:  
 a) Validate the elevated expression of Tshb 
b) Check the thyroid gland organ structure for any abnormalities in homozygous mice 
c) Check the serum levels of T3 and T4 
d) Investigate probable Kdm3b interaction with Tshα 
e) Check whether Kdm3b functions to promote Thra expression 











In wild type mice, the pituitary gland expresses and releases thyroid stimulating 
hormone (Tsh), which binds to the thyroid stimulating hormone receptor (Tshr). 
The thyroid gland is stimulated to produce and release the thyroid hormones T3 
and T4 in the bloodstream, which feed back to the pituitary to reduce Tsh 
expression. In the event of T3 binding to the Thrα, Kdm3b will interact with the 
receptor(s) and function as a co-activator of T3-mediated gene expression, via 
H3K9me2 promoter demethylation. In the homozygous Kdm3b gene-trapped 
mice, reduced Kdm3b expression results in the downregulation of T3 target 
genes, since gene promoters have increased H3K9me2 levels.. Furthermore, the 
thyroid gland produces less T3 and T4 and this results in the upregulation of Tsh 
expression.  
6.4 Kdm3b as a candidate regulator of thymus development or 
maintenance 
Kdm3b homozygous gene-trapped mice presented with reduced thymus/body 
weight ratio. Furthermore, for a proportion of homozygous-derived thymuses, the 
cortical layer was reduced or the two layers could not be clearly defined by H&E 
staining. This phenotype is reminiscent of thymic involution, an age-related process 
seen both in older mice and humans. In an age-related involuting thymus, the cortex 
and medulla lose their definition, as a result of thymic epithelial cell decrease. In 
addition, in this condition there is a reduction in lymphoid progenitor and 
differentiating thymocytes, as well as deposition of adipocytes that fill up the thymic 
space (Taub and Longo, 2005; Taub et al., 2010). However, Kdm3b homozygous 
mice were only three weeks of age when the thymic cell layer defect was observed, 
suggesting that Kdm3b may be necessary for the development and/or the 
maintenance of the organ. As revealed by immunohistochemistry, Kdm3b is 
expressed in the thymus (more densely in the medullary layer), implying a direct role 
for the proper function of the organ. Thus, it is possible that Kdm3b loss results in an 
age-accelerated decrease of progenitors being supplied to the organ, or that the 
thymic epithelial cells are not maintained due to the loss of Kdm3b-mediated gene 
expression. Suprisingly, however, the process of T-cell maturation was complete in 
the homozygous thymuses. As in some cases the homozygous mice express minimal 
levels of Kdm3b, it may be possible that these low levels are enough to support 




expression is completely lost, may provide a clearer picture for the contribution of 
Kdm3b on thymopoiesis. 
To further define the thymic defect, more experiments are necessary, such as: 
a) More FACS sorting with surface markers CD4, CD8, CD25 and CD44 
from the third post-natal week onwards, to investigate whether thymocyte 
development stalls at any time point. 
b) H&E staining of thymuses at younger ages to investigate whether the 
cortico-medullary layers initially develop normally in the homozygotes 
and later lose their definition 
c) Immunofluorescence with markers of the cortical and medullary cell 
epithelial layers to better define the defect 
d) Identification of cell type(s) that express Kdm3b 
6.4.1 Neuroendocrinology meets immunity 
 Both the growth retardation and thymus defects observed in Kdm3b 
homozygous mice are interesting, but is there any connection between them? 
Intriguingly, dwarf mice that lack anterior pituitary cells, therefore deficient in the 
production of the growth hormone and thyroxine, have several immunological 
defects. The thymuses of these mice show post-natal involution, already evidenced at 
30 days of age, characterised by a reduced thymus weight relative to body weight. At 
this age, the cortex width is reduced and the cortico-medullary boundary becomes 
undefined. Additionally, all cell types present in the bone marrow are reduced in 
number, and the peripheral white blood cell count is lower than wild type littermates 
throughout life (Fabris et al., 1971). A closer inspection at thymic lymphocyte 





positive cells, which becomes more pronounced with increasing age. Strikingly, 
treatment of these mice with recombinant human GH increases thymus size and 




 double positive cells in the thymus 




Increase in thymus size and cellularity is also evidenced when Igf1, which 
functions as the downstream effector of the Gh, is administered in insulin 
deficient/diabetic rats, or rats whose immune system has been compromised by 
cyclosporine treatment (Beschorner et al., 1991; Binz et al., 1990; García-Suárez et 
al., 2003). Igf1 receptor is expressed in the thymus (García-Suárez et al., 2003), 
therefore systemic Igf1 can bind and exert its growth promoting/mitogenic effect on 
thymus epithelial cells. It is therefore possible that Kdm3b indirectly maintains the 
thymus architecture, by promoting expression of growth hormones. A way to 
investigate this possibility is to inject Igf1 in Kdm3b homozygous mice and check 
thymic cellularity about two weeks after administration. 
6.5 Concluding remarks 
In this study, I checked the demethylation potential and expression pattern of 
the zebrafish and mouse Kdm3b, during embryogenesis. I also dissected the 
phenotype of Kdm3b gene-trapped mice, the first mouse model for this demethylase, 
and attempted to uncover the plausible function(s) of an alternative murine Kdm3a 
isoform (Kdm3a-i2). 
Both the zebrafish kdm3b morphants and the Kdm3a gene-trapped and knock-
out mice resemble a ciliopathy syndrome phenotype. Furthermore, the murine 
Kdm3a-i2 isoform appears to have both a histone demethylation and a plausible 
unknown centrosomal function. In contrast, the phenotype of Kdm3b gene-trapped 
mice is not reminiscent of a ciliapathy syndrome. Rather, Kdm3b is involved in post-
natal growth by promoting the expression of growth regulators, and in immunity, by 
maintaining the organisation of thymic layers. Based on these data, it is proposed that 
1) functionally, the zebrafish kdm3b is closer to the murine Kdm3a and 2) the murine 
Kdm3a and Kdm3b paralogues are not redundant, but rather have distinct/non-




























Figure 7.1: Alignment of the human and mouse KDM3A and KDM3B 
paralogues with Uniprot identifiers: Q7LBC6, B9EKS2, Q9Y4C1 and 
Q6PCM1.  
Highlights: Grey: predicted NLS; light blue: zinc finger; green: nuclear receptor 
motif; yellow: JmjC domain; red: predicted iron binding sites and dark blue: α-
ketoglutarate binding sites.  
* indicates fully conserved residue 
: indicates residues of strongly similar properties 










Figure 7.2: Alignment of human and mouse KDM3A and zebrafish prediction 
with Uniprot identifiers Q9Y4C1, Q6PCM1 and E7F3X7 respectively. 
Highlights: Light blue: zinc finger with cysteine residues in grey; green: nuclear 




JmjC domain; brown: hypothetical zebrafish JmjC domain; red: predicted iron 
binding sites and dark blue: α-ketoglutarate binding sites. 
* indicates fully conserved residue 
: indicates residues of strongly similar properties 














Figure 7.3: Alignment of human and mouse KDM3B and zebrafish prediction 
with Uniprot identifiers Q7LBC6, B9EKS2 and E7F3X7 respectively. 
Highlights: Purple: predicted NLS by the NLStradamus software; blue: zinc finger 
with cysteine residues in grey; green: nuclear receptor motif; dark grey: the two 
amino acids missing in GFP-Zf-3bΔ2aa; yellow: JmjC domain; brown: hypothetical 
zebrafish JmjC domain; red: predicted iron binding sites and dark blue: α-
ketoglutarate binding sites.  
* indicates fully conserved residue 
: indicates residues of strongly similar properties 










Figure 7.4: Halo-Hm-KDM3B can function as an H3K9me1/2 demethylase. 
(A-B) The Halo-Hm-KDM3B transfected cells reduce H3K9me1 and H3K9me2 
fluorescence compared to neighbouring untransfected cells. (C) The H3K9me3 mark 
formed puncta in two out of four cells upon Halo-Hm-Kdm3b transfection. (D) The 
H3K27me3 mark remained unaffected. Yellow circles indicate nuclei of transfected 





Figure 7.5: The Halo vector transfections did not affect the fluorescence of the 
epigenetic marks. 
(A-D) The fluorescence of epigenetic marks remained unchanged in Halo vector 
transfected and neighbouring untransfected cells. Yellow circles indicate nuclei of 





Figure 7.6: In 10% FCS growth media, the Halo-Hm-KDM3B can function as 
an H3K9me1 and H3K9me2 demethylase. 
Thirty two percent (32%) and 26% of Halo-Hm-KDM3B transfected cells showed 
reduced H3K9me1 and H3K9me2 fluorescence respectively. In addition, 26% of 
Halo-Hm-KDM3B transfected cells showed a punctuated H3K9me3 pattern. There 
was no change in fluorescence for the control H3K27me3 mark. Compared to the 
Halo vector transfections, the results for H3K9me1, H3K9me2 and H3K9me3 were 
significant. The experiment was repeated in triplicate. ** = significant, Fisher’s exact 





















The murine Kdm3a-i2 isoform and the zebrafish kdm3b transcripts were subcloned in 
the pEFGP-C1 vector (Clontech, 6084-1). The Kdm3a-FL, Kdm3a-i2 and Kdm3a-
Δ2-18 transcripts were subcloned in an mKate2 (RFP) vector (Evrogen, FP182). 
Vector maps adapted from www.clontech.com and www.evrogen.com, and modified 
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